|
OMIM |
Link |
Information gain |
01 |
|
VRNI
|
[NCBI]
|
0.03423038
|
|
|
MAFD1
|
[NCBI]
|
0.01674708
|
|
|
RA
|
[NCBI]
|
0.00770557
|
|
|
SCZD3
|
[NCBI]
|
0.00699429
|
|
|
mental health wellness 1
|
[NCBI]
|
0.00655209
|
|
|
SLE
|
[NCBI]
|
0.00616108
|
|
|
diabetes mellitus, noninsulin-dependent, 3
|
[NCBI]
|
0.00444531
|
|
|
MRX1
|
[NCBI]
|
0.00419981
|
|
|
graves disease, susceptibility to, x-linked
|
[NCBI]
|
0.00353905
|
|
|
SCZD7
|
[NCBI]
|
0.00333153
|
|
|
ICCA
|
[NCBI]
|
0.00312464
|
|
|
FSHMD1A
|
[NCBI]
|
0.00305315
|
|
|
autism
|
[NCBI]
|
0.0029957
|
|
|
EKD2
|
[NCBI]
|
0.00270927
|
|
|
ATOD6
|
[NCBI]
|
0.00270927
|
|
|
acute myelogenous leukemia
|
[NCBI]
|
0.002358545
|
|
|
convulsions, benign familial infantile, 2
|
[NCBI]
|
0.002358545
|
|
|
hepatic fibrosis, severe, susceptibility to, due to schistosoma mansoni infection
|
[NCBI]
|
0.002358545
|
|
|
WS2B
|
[NCBI]
|
0.002358545
|
|
|
ENUR2
|
[NCBI]
|
0.002358545
|
|
|
epilepsy, partial, with variable foci
|
[NCBI]
|
0.002358545
|
|
|
myopia 4
|
[NCBI]
|
0.002358545
|
|
|
ENUR1
|
[NCBI]
|
0.002358545
|
|
|
IBD7
|
[NCBI]
|
0.002358545
|
|
|
epilepsy, nocturnal frontal lobe, type 2
|
[NCBI]
|
0.00234034
|
|
|
OB10P
|
[NCBI]
|
0.00234034
|
|
|
FEB1
|
[NCBI]
|
0.002016151
|
|
|
prostate cancer, hereditary, 3
|
[NCBI]
|
0.002009174
|
|
|
CMTX3
|
[NCBI]
|
0.002009174
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.002009174
|
|
|
restless legs syndrome, susceptibility to, 3
|
[NCBI]
|
0.002009174
|
|
|
WTS
|
[NCBI]
|
0.002009174
|
|
|
wilms tumor 4
|
[NCBI]
|
0.002009174
|
|
|
OFC2
|
[NCBI]
|
0.002009174
|
|
|
HPCX
|
[NCBI]
|
0.001917823
|
|
|
migraine with or without aura, susceptibility to, 6
|
[NCBI]
|
0.001860013
|
|
|
MRX23
|
[NCBI]
|
0.001860013
|
|
|
DYX6
|
[NCBI]
|
0.001860013
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.001860013
|
|
|
MYP1
|
[NCBI]
|
0.001860013
|
|
|
DSMA3
|
[NCBI]
|
0.001860013
|
|
|
CELIAC2
|
[NCBI]
|
0.00176262
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
0.00176262
|
|
|
OPA2
|
[NCBI]
|
0.001353234
|
|
|
cowchock syndrome
|
[NCBI]
|
0.001353234
|
|
|
CFM1
|
[NCBI]
|
0.001353234
|
|
|
IDDM11
|
[NCBI]
|
0.001353234
|
|
|
malignant hyperthermia, susceptibility to, 3
|
[NCBI]
|
0.001353234
|
|
|
dermatitis, atopic
|
[NCBI]
|
0.00134122
|
|
|
IS1
|
[NCBI]
|
0.0013341712
|
|
|
MAFD2
|
[NCBI]
|
0.001312781
|
|
|
DYX2
|
[NCBI]
|
0.001238278
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
0.001220527
|
|
|
DYX3
|
[NCBI]
|
0.001204073
|
|
|
obesity quantitative trait locus on chromosome 20
|
[NCBI]
|
0.001204073
|
|
|
DFNB15
|
[NCBI]
|
0.001204073
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
0.001204073
|
|
|
EVR3
|
[NCBI]
|
0.001204073
|
|
|
ARVD4
|
[NCBI]
|
0.001204073
|
|
|
MRT5
|
[NCBI]
|
0.001178863
|
|
|
coronary heart disease, susceptibility to, 1
|
[NCBI]
|
0.001178863
|
|
|
FEB7
|
[NCBI]
|
0.001178863
|
|
|
HSCR7
|
[NCBI]
|
0.001178863
|
|
|
MRT10
|
[NCBI]
|
0.001178863
|
|
|
attention deficit-hyperactivity disorder, susceptibility to, 3
|
[NCBI]
|
0.001178863
|
|
|
EIG3
|
[NCBI]
|
0.001178863
|
|
|
DFNB35
|
[NCBI]
|
0.001178863
|
|
|
asperger syndrome, susceptibility to, 4
|
[NCBI]
|
0.001178863
|
|
|
panic disorder 2
|
[NCBI]
|
0.001178863
|
|
|
nephropathy, progressive, with deafness
|
[NCBI]
|
0.001178863
|
|
|
HSCR5
|
[NCBI]
|
0.001178863
|
|
|
renal hypodysplasia, nonsyndromic, 1
|
[NCBI]
|
0.001178863
|
|
|
MRXS11
|
[NCBI]
|
0.001178863
|
|
|
MAFD5
|
[NCBI]
|
0.001178863
|
|
|
GINGF2
|
[NCBI]
|
0.001178863
|
|
|
GINGF4
|
[NCBI]
|
0.001178863
|
|
|
MRX82
|
[NCBI]
|
0.001178863
|
|
|
diamond-blackfan anemia 2
|
[NCBI]
|
0.001178863
|
|
|
ETL4
|
[NCBI]
|
0.001178863
|
|
|
plasmodium falciparum fever episodes quantitative trait locus 1
|
[NCBI]
|
0.001178863
|
|
|
LOH18CR1
|
[NCBI]
|
0.001178863
|
|
|
STHAG5
|
[NCBI]
|
0.001178863
|
|
|
CORDX2
|
[NCBI]
|
0.001178863
|
|
|
STGD4
|
[NCBI]
|
0.001178863
|
|
|
MRT9
|
[NCBI]
|
0.001178863
|
|
|
FEB5
|
[NCBI]
|
0.001178863
|
|
|
DFNB40
|
[NCBI]
|
0.001178863
|
|
|
AGMX2
|
[NCBI]
|
0.001178863
|
|
|
DFNA49
|
[NCBI]
|
0.001178863
|
|
|
SCKL3
|
[NCBI]
|
0.001178863
|
|
|
hypertension, essential, susceptibility to, 6
|
[NCBI]
|
0.001178863
|
|
|
HSCR8
|
[NCBI]
|
0.001178863
|
|
|
DFNB32
|
[NCBI]
|
0.001178863
|
|
|
DFNB39
|
[NCBI]
|
0.001178863
|
|
|
DFNA16
|
[NCBI]
|
0.001178863
|
|
|
AIS4
|
[NCBI]
|
0.001178863
|
|
|
deafness, congenital neurosensory, autosomal recessive 38
|
[NCBI]
|
0.001178863
|
|
|
spondyloarthropathy, susceptibility to, 2
|
[NCBI]
|
0.001178863
|
|
|
SPG27
|
[NCBI]
|
0.001178863
|
|
|
LKE
|
[NCBI]
|
0.001178863
|
|
|
cataract, crystalline coralliform
|
[NCBI]
|
0.001178863
|
|
|
polydactyly, postaxial, type a3
|
[NCBI]
|
0.001178863
|
|
|
asthma-related traits, susceptibility to, 4
|
[NCBI]
|
0.001178863
|
|
|
SCKL2
|
[NCBI]
|
0.001178863
|
|
|
lung cancer 1
|
[NCBI]
|
0.001178863
|
|
|
myopia 11
|
[NCBI]
|
0.001178863
|
|
|
RP33
|
[NCBI]
|
0.001178863
|
|
|
systemic lupus erythematosus, susceptibility to, 4
|
[NCBI]
|
0.001178863
|
|
|
S EYE
|
[NCBI]
|
0.001178863
|
|
|
SPG32
|
[NCBI]
|
0.001178863
|
|
|
MRT8
|
[NCBI]
|
0.001178863
|
|
|
attention deficit-hyperactivity disorder, susceptibility to, 4
|
[NCBI]
|
0.001178863
|
|
|
DFNA52
|
[NCBI]
|
0.001178863
|
|
|
azoospermia, nonobstructive
|
[NCBI]
|
0.001178863
|
|
|
GLC1D
|
[NCBI]
|
0.001178863
|
|
|
MMVP2
|
[NCBI]
|
0.001178863
|
|
|
hyperlipidemia, combined, 2
|
[NCBI]
|
0.001178863
|
|
|
IOPQTL
|
[NCBI]
|
0.001178863
|
|
|
myopathy, limb-girdle, with bone fragility
|
[NCBI]
|
0.001178863
|
|
|
SCA28
|
[NCBI]
|
0.001178863
|
|
|
prostate cancer, hereditary, 5
|
[NCBI]
|
0.001178863
|
|
|
HSCR6
|
[NCBI]
|
0.001178863
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 3
|
[NCBI]
|
0.001178863
|
|
|
MRT11
|
[NCBI]
|
0.001178863
|
|
|
GLC1H
|
[NCBI]
|
0.001178863
|
|
|
muscular dystrophy, congenital, 1b
|
[NCBI]
|
0.001178863
|
|
|
bleeding disorder, east texas type
|
[NCBI]
|
0.001178863
|
|
|
hypertension, essential, susceptibility to, 5
|
[NCBI]
|
0.001178863
|
|
|
MENAQ1
|
[NCBI]
|
0.001178863
|
|
|
DFNA24
|
[NCBI]
|
0.001178863
|
|
|
polydactyly, postaxial, type a4
|
[NCBI]
|
0.001178863
|
|
|
ETM3
|
[NCBI]
|
0.001178863
|
|
|
OTSC3
|
[NCBI]
|
0.001178863
|
|
|
alzheimer disease 9
|
[NCBI]
|
0.001178863
|
|
|
MRT7
|
[NCBI]
|
0.001178863
|
|
|
aneurysm, intracranial berry, 2
|
[NCBI]
|
0.001178863
|
|
|
generalized epilepsy with febrile seizures plus, type 4
|
[NCBI]
|
0.001178863
|
|
|
FEB9
|
[NCBI]
|
0.001178863
|
|
|
HDLCQ1
|
[NCBI]
|
0.001178863
|
|
|
coronary heart disease, susceptibility to, 3
|
[NCBI]
|
0.001178863
|
|
|
narcolepsy 3
|
[NCBI]
|
0.001178863
|
|
|
DFNA31
|
[NCBI]
|
0.001178863
|
|
|
AS
|
[NCBI]
|
0.001119509
|
|
|
CMM
|
[NCBI]
|
0.001106879
|
|
|
SPG12
|
[NCBI]
|
0.00110668
|
|
|
AUTS5
|
[NCBI]
|
0.00110668
|
|
|
WT3
|
[NCBI]
|
0.00110668
|
|
|
DYT7
|
[NCBI]
|
0.00110668
|
|
|
MG
|
[NCBI]
|
0.001063463
|
|
|
UFS
|
[NCBI]
|
0.001035775
|
|
|
CES
|
[NCBI]
|
0.000994674
|
|
|
SCZD6
|
[NCBI]
|
0.000993363
|
|
|
CF
|
[NCBI]
|
0.000990976
|
|
|
SPG5A
|
[NCBI]
|
0.000981177
|
|
|
restless legs syndrome, susceptibility to, 6
|
[NCBI]
|
0.000943175
|
|
|
MYP3
|
[NCBI]
|
0.000943175
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.000943175
|
|
|
HBFQTL4
|
[NCBI]
|
0.000943175
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.000932377
|
|
|
IDDM7
|
[NCBI]
|
0.000932377
|
|
|
EA3
|
[NCBI]
|
0.000929621
|
|
|
DFNA41
|
[NCBI]
|
0.000929621
|
|
|
angioma serpiginosum, x-linked
|
[NCBI]
|
0.000929621
|
|
|
BMND2
|
[NCBI]
|
0.000929621
|
|
|
testicular germ cell tumor 1
|
[NCBI]
|
0.000929621
|
|
|
HCFP2
|
[NCBI]
|
0.000929621
|
|
|
CMD1K
|
[NCBI]
|
0.000929621
|
|
|
friedreich ataxia 2
|
[NCBI]
|
0.000929621
|
|
|
prostate cancer aggressiveness quantitative trait locus on chromosome 19
|
[NCBI]
|
0.000929621
|
|
|
AIS3
|
[NCBI]
|
0.000929621
|
|
|
FSHMD1B
|
[NCBI]
|
0.000929621
|
|
|
SPG14
|
[NCBI]
|
0.000929621
|
|
|
PRS
|
[NCBI]
|
0.000929621
|
|
|
CELIAC5
|
[NCBI]
|
0.000929621
|
|
|
MAFD4
|
[NCBI]
|
0.000929621
|
|
|
cataract, autosomal recessive congenital 2
|
[NCBI]
|
0.000929621
|
|
|
basal ganglia calcification, idiopathic, 2
|
[NCBI]
|
0.000929621
|
|
|
MRT12
|
[NCBI]
|
0.000929621
|
|
|
myopia 5
|
[NCBI]
|
0.000929621
|
|
|
PTLAH
|
[NCBI]
|
0.000929621
|
|
|
PEE2
|
[NCBI]
|
0.000929621
|
|
|
obesity, susceptibility to, on chromosome 4
|
[NCBI]
|
0.000929621
|
|
|
prostate cancer, hereditary, 6
|
[NCBI]
|
0.000929621
|
|
|
CMTX2
|
[NCBI]
|
0.000929621
|
|
|
CRCS1
|
[NCBI]
|
0.000929621
|
|
|
MRSD
|
[NCBI]
|
0.000929621
|
|
|
MGC1
|
[NCBI]
|
0.000929621
|
|
|
AIS2
|
[NCBI]
|
0.000929621
|
|
|
NYS4
|
[NCBI]
|
0.000929621
|
|
|
GLC1I
|
[NCBI]
|
0.000929621
|
|
|
SLI3
|
[NCBI]
|
0.000929621
|
|
|
tumor suppressor gene on chromosome 11
|
[NCBI]
|
0.000929621
|
|
|
DYX8
|
[NCBI]
|
0.000929621
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.000929621
|
|
|
MRX50
|
[NCBI]
|
0.000929621
|
|
|
AUTS8
|
[NCBI]
|
0.000929621
|
|
|
spinal muscular atrophy, facioscapulohumeral type
|
[NCBI]
|
0.000929621
|
|
|
attention deficit-hyperactivity disorder, susceptibility to, 2
|
[NCBI]
|
0.000929621
|
|
|
DYX9
|
[NCBI]
|
0.000929621
|
|
|
MNG2
|
[NCBI]
|
0.000929621
|
|
|
retinal cone dystrophy 2
|
[NCBI]
|
0.000929621
|
|
|
HD
|
[NCBI]
|
0.000911779
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.000911674
|
|
|
HBFQTL2
|
[NCBI]
|
0.0008484951
|
|
|
diabetes mellitus, insulin-dependent, x-linked, susceptibility to
|
[NCBI]
|
0.000845782
|
|
|
OPA4
|
[NCBI]
|
0.000845782
|
|
|
ETM2
|
[NCBI]
|
0.000845782
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.000845782
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
0.000845782
|
|
|
IBD3
|
[NCBI]
|
0.000845782
|
|
|
electroencephalogram, low-voltage
|
[NCBI]
|
0.000845782
|
|
|
IDDM17
|
[NCBI]
|
0.000845494
|
|
|
cavitary optic disc anomalies
|
[NCBI]
|
0.000845494
|
|
|
ATFB1
|
[NCBI]
|
0.000845494
|
|
|
MRX20
|
[NCBI]
|
0.000845494
|
|
|
ALSFTD2
|
[NCBI]
|
0.000845494
|
|
|
branchiootic syndrome 2
|
[NCBI]
|
0.000845494
|
|
|
PFHB2
|
[NCBI]
|
0.000845494
|
|
|
PDR
|
[NCBI]
|
0.000845494
|
|
|
myopia 6
|
[NCBI]
|
0.000845494
|
|
|
alopecia-mental retardation syndrome 1
|
[NCBI]
|
0.000845494
|
|
|
SEMDIT
|
[NCBI]
|
0.000845494
|
|
|
SPG19
|
[NCBI]
|
0.000845494
|
|
|
CMD1F
|
[NCBI]
|
0.000845494
|
|
|
IBD9
|
[NCBI]
|
0.000845494
|
|
|
MDD
|
[NCBI]
|
0.000829771
|
|
|
EGF
|
[NCBI]
|
0.000823303
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.000808112
|
|
|
CMM2
|
[NCBI]
|
0.000805722
|
|
|
mental health wellness 2
|
[NCBI]
|
0.000805194
|
|
|
HMPS1
|
[NCBI]
|
0.000796466
|
|
|
stature quantitative trait locus 6
|
[NCBI]
|
0.000796466
|
|
|
pulmonary function
|
[NCBI]
|
0.000796466
|
|
|
LGMD1D
|
[NCBI]
|
0.000796466
|
|
|
EA4
|
[NCBI]
|
0.000796466
|
|
|
GSM1
|
[NCBI]
|
0.000796466
|
|
|
MVP
|
[NCBI]
|
0.0007900282
|
|
|
ehlers-danlos syndrome, type viii
|
[NCBI]
|
0.000774877
|
|
|
NNO1
|
[NCBI]
|
0.000774877
|
|
|
IGES
|
[NCBI]
|
0.000765106
|
|
|
lethal congenital contracture syndrome 1
|
[NCBI]
|
0.0007641082
|
|
|
SPG23
|
[NCBI]
|
0.0007641082
|
|
|
AUTS6
|
[NCBI]
|
0.00075961
|
|
|
SCZD4
|
[NCBI]
|
0.000753452
|
|
|
VEGF
|
[NCBI]
|
0.000744352
|
|
|
HPC10
|
[NCBI]
|
0.0007415703
|
|
|
GBY
|
[NCBI]
|
0.0007415703
|
|
|
PGL2
|
[NCBI]
|
0.0007415703
|
|
|
NYS2
|
[NCBI]
|
0.0007255217
|
|
|
FRDA
|
[NCBI]
|
0.000721308
|
|
|
AUTS4
|
[NCBI]
|
0.000720279
|
|
|
RP3
|
[NCBI]
|
0.000720102
|
|
|
renal hamartomas, nephroblastomatosis, and fetal gigantism
|
[NCBI]
|
0.0007140859
|
|
|
GO
|
[NCBI]
|
0.0007140859
|
|
|
IDDM4
|
[NCBI]
|
0.000681075
|
|
|
alzheimer disease 6
|
[NCBI]
|
0.00065984
|
|
|
CJD
|
[NCBI]
|
0.000657879
|
|
|
NF1
|
[NCBI]
|
0.000654442
|
|
|
MEN2A
|
[NCBI]
|
0.000648232
|
|
|
MKS2
|
[NCBI]
|
0.000616133
|
|
|
CRC
|
[NCBI]
|
0.000610167
|
|
|
IGAN1
|
[NCBI]
|
0.000592555
|
|
|
AD
|
[NCBI]
|
0.000590584
|
|
|
SCZD2
|
[NCBI]
|
0.000585553
|
|
|
ESD
|
[NCBI]
|
0.000569476
|
|
|
SCZD
|
[NCBI]
|
0.000562878
|
|
|
NGFB
|
[NCBI]
|
0.000562762
|
|
|
renal cell carcinoma, papillary, 3
|
[NCBI]
|
0.000561535
|
|
|
SRS
|
[NCBI]
|
0.0005436255
|
|
|
CMTX1
|
[NCBI]
|
0.000538032
|
|
|
SOST
|
[NCBI]
|
0.000537026
|
|
|
RP1
|
[NCBI]
|
0.000535993
|
|
|
CSNB1A
|
[NCBI]
|
0.00053392
|
|
|
SCA1
|
[NCBI]
|
0.000533033
|
|
|
CMT1A
|
[NCBI]
|
0.000527694
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
0.000520723
|
|
|
neuroticism
|
[NCBI]
|
0.000518037
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000518037
|
|
|
meningioma, familial
|
[NCBI]
|
0.000483653
|
|
|
GCY
|
[NCBI]
|
0.000482599
|
|
|
IBD2
|
[NCBI]
|
0.000482599
|
|
|
PRL
|
[NCBI]
|
0.000476654
|
|
|
TNF
|
[NCBI]
|
0.000473864
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 4
|
[NCBI]
|
0.000471293
|
|
|
myopia 9
|
[NCBI]
|
0.000471293
|
|
|
myopia 7
|
[NCBI]
|
0.000471293
|
|
|
AKE
|
[NCBI]
|
0.000471293
|
|
|
GLC3B
|
[NCBI]
|
0.000471293
|
|
|
CACD
|
[NCBI]
|
0.000471293
|
|
|
hydrocephalus, autosomal dominant
|
[NCBI]
|
0.000471293
|
|
|
myopia 8
|
[NCBI]
|
0.000471293
|
|
|
ATOD5
|
[NCBI]
|
0.000471293
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal recessive
|
[NCBI]
|
0.000471293
|
|
|
HDL3
|
[NCBI]
|
0.000471293
|
|
|
orthostatic hypotensive disorder, streeten type
|
[NCBI]
|
0.000471293
|
|
|
MPD3
|
[NCBI]
|
0.000471293
|
|
|
multiple mitochondrial dysfunctions syndrome
|
[NCBI]
|
0.000471293
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.000471293
|
|
|
aortic aneurysm, familial thoracic 2
|
[NCBI]
|
0.000471293
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant, with thyroid disease
|
[NCBI]
|
0.000471293
|
|
|
RCM2
|
[NCBI]
|
0.000471293
|
|
|
IDDM6
|
[NCBI]
|
0.000471293
|
|
|
thyroid carcinoma, papillary, with papillary renal neoplasia
|
[NCBI]
|
0.000471293
|
|
|
myopia 10
|
[NCBI]
|
0.000471293
|
|
|
leber congenital amaurosis, type ix
|
[NCBI]
|
0.000471293
|
|
|
acute insulin response
|
[NCBI]
|
0.000471293
|
|
|
NF2
|
[NCBI]
|
0.000467265
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
0.00046475
|
|
|
DYT3
|
[NCBI]
|
0.000463827
|
|
|
ACHE
|
[NCBI]
|
0.000457921
|
|
|
MEAX
|
[NCBI]
|
0.000455068
|
|
|
MSSE
|
[NCBI]
|
0.000455068
|
|
|
DYT1
|
[NCBI]
|
0.000452514
|
|
|
polycystic kidneys
|
[NCBI]
|
0.00045001
|
|
|
PGL1
|
[NCBI]
|
0.000442347
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.000435115
|
|
|
HFM
|
[NCBI]
|
0.0004311162
|
|
|
prostate cancer
|
[NCBI]
|
0.000425488
|
|
|
MAFD6
|
[NCBI]
|
0.0004202662
|
|
|
AUTS9
|
[NCBI]
|
0.00041157
|
|
|
HP
|
[NCBI]
|
0.000397072
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000395876
|
|
|
MRX2
|
[NCBI]
|
0.000387166
|
|
|
neuropathy, hereditary motor and sensory, okinawa type
|
[NCBI]
|
0.000387166
|
|
|
diaphyseal medullary stenosis with malignant fibrous histiocytoma
|
[NCBI]
|
0.000387166
|
|
|
migraine with or without aura, susceptibility to, 3
|
[NCBI]
|
0.000387166
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
0.000387166
|
|
|
MCOPS4
|
[NCBI]
|
0.000387166
|
|
|
RMD1
|
[NCBI]
|
0.000387166
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
0.000387166
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.000387166
|
|
|
IDDM13
|
[NCBI]
|
0.000387166
|
|
|
LI5
|
[NCBI]
|
0.000387166
|
|
|
asthma-related traits, susceptibility to, 6
|
[NCBI]
|
0.000387166
|
|
|
mental retardation with optic atrophy, deafness, and seizures
|
[NCBI]
|
0.000387166
|
|
|
leprosy, susceptibility to, 1
|
[NCBI]
|
0.000387166
|
|
|
CHDS8
|
[NCBI]
|
0.000387166
|
|
|
AUTS10
|
[NCBI]
|
0.000387166
|
|
|
SCZD1
|
[NCBI]
|
0.000382511
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.0003786448
|
|
|
BRCA2
|
[NCBI]
|
0.000376558
|
|
|
digeorge syndrome/velocardiofacial syndrome spectrum of malformation 2
|
[NCBI]
|
0.000376132
|
|
|
SHFM1
|
[NCBI]
|
0.0003696096
|
|
|
PWS
|
[NCBI]
|
0.0003662417
|
|
|
AVP
|
[NCBI]
|
0.000365628
|
|
|
RP2
|
[NCBI]
|
0.000365251
|
|
|
BRCA1
|
[NCBI]
|
0.000364904
|
|
|
ATHS
|
[NCBI]
|
0.000360877
|
|
|
DFNB9
|
[NCBI]
|
0.000358465
|
|
|
NPY
|
[NCBI]
|
0.000358099
|
|
|
DMD
|
[NCBI]
|
0.00035317
|
|
|
VIP
|
[NCBI]
|
0.000346927
|
|
|
RP10
|
[NCBI]
|
0.000343264
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
0.000343264
|
|
|
DYX1
|
[NCBI]
|
0.000339802
|
|
|
down syndrome
|
[NCBI]
|
0.000339424
|
|
|
myopathy, hyaline body, autosomal recessive
|
[NCBI]
|
0.000338758
|
|
|
FHM1
|
[NCBI]
|
0.000338665
|
|
|
charcot-marie-tooth disease, dominant intermediate a
|
[NCBI]
|
0.000338138
|
|
|
CELIAC6
|
[NCBI]
|
0.000338138
|
|
|
TKCR
|
[NCBI]
|
0.000338138
|
|
|
ALSFTD1
|
[NCBI]
|
0.000338138
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.000338138
|
|
|
PARK11
|
[NCBI]
|
0.000338138
|
|
|
ARVD3
|
[NCBI]
|
0.000338138
|
|
|
PTOS1
|
[NCBI]
|
0.000338138
|
|
|
cenani syndactylism
|
[NCBI]
|
0.000338138
|
|
|
SCZD5
|
[NCBI]
|
0.000338138
|
|
|
IDDM
|
[NCBI]
|
0.0003377483
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
0.00033742
|
|
|
fecundity gene, booroola, of sheep, homolog of
|
[NCBI]
|
0.000336146
|
|
|
HSAS
|
[NCBI]
|
0.0003329186
|
|
|
PNKD1
|
[NCBI]
|
0.000332259
|
|
|
NIDDM1
|
[NCBI]
|
0.000331156
|
|
|
IBD1
|
[NCBI]
|
0.000328563
|
|
|
HNA
|
[NCBI]
|
0.00032852
|
|
|
GLC1A
|
[NCBI]
|
0.000327717
|
|
|
PKD1
|
[NCBI]
|
0.000323684
|
|
|
ARPKD
|
[NCBI]
|
0.00032093
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000317929
|
|
|
CCM
|
[NCBI]
|
0.000317054
|
|
|
AT
|
[NCBI]
|
0.000315901
|
|
|
CPX
|
[NCBI]
|
0.00031341
|
|
|
stomatocytosis i
|
[NCBI]
|
0.0003130876
|
|
|
CCK
|
[NCBI]
|
0.000312637
|
|
|
SHFM3
|
[NCBI]
|
0.000312187
|
|
|
ND
|
[NCBI]
|
0.000310865
|
|
|
SHFM5
|
[NCBI]
|
0.0003057802
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
0.0003057802
|
|
|
EFMR
|
[NCBI]
|
0.0003057802
|
|
|
nevi flammei, familial multiple
|
[NCBI]
|
0.0003057802
|
|
|
MRX3
|
[NCBI]
|
0.0003057802
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
0.0003056949
|
|
|
CLN5
|
[NCBI]
|
0.000303987
|
|
|
GC
|
[NCBI]
|
0.000301591
|
|
|
MTM1
|
[NCBI]
|
0.000300145
|
|
|
NHS
|
[NCBI]
|
0.000297826
|
|
|
IP
|
[NCBI]
|
0.0002917547
|
|
|
WD
|
[NCBI]
|
0.000287278
|
|
|
obesity, susceptibility to, x-linked
|
[NCBI]
|
0.000287278
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.0002849277
|
|
|
SOST
|
[NCBI]
|
0.00028473
|
|
|
trichoepithelioma, multiple familial
|
[NCBI]
|
0.0002832423
|
|
|
MCOPS6
|
[NCBI]
|
0.0002832423
|
|
|
systemic lupus erythematosus, susceptibility to, 6
|
[NCBI]
|
0.0002832423
|
|
|
SCZD9
|
[NCBI]
|
0.00027687
|
|
|
SMA1
|
[NCBI]
|
0.000276674
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
0.000276574
|
|
|
VMD
|
[NCBI]
|
0.000276181
|
|
|
PCNA
|
[NCBI]
|
0.000275357
|
|
|
RP13
|
[NCBI]
|
0.000274652
|
|
|
CHM
|
[NCBI]
|
0.000274518
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000270261
|
|
|
BOR1
|
[NCBI]
|
0.0002701786
|
|
|
PTH
|
[NCBI]
|
0.000269862
|
|
|
MYP2
|
[NCBI]
|
0.0002695886
|
|
|
HFE
|
[NCBI]
|
0.000260883
|
|
|
MJD
|
[NCBI]
|
0.0002601481
|
|
|
PGP
|
[NCBI]
|
0.000260045
|
|
|
ADLTE
|
[NCBI]
|
0.000259449
|
|
|
GFAP
|
[NCBI]
|
0.000259436
|
|
|
MHS1
|
[NCBI]
|
0.000257515
|
|
|
strabismus, susceptibility to
|
[NCBI]
|
0.0002557579
|
|
|
MTACR1
|
[NCBI]
|
0.0002557579
|
|
|
USH1C
|
[NCBI]
|
0.000255173
|
|
|
telangiectasia, hereditary benign
|
[NCBI]
|
0.000254631
|
|
|
AUTS7
|
[NCBI]
|
0.000254631
|
|
|
HSCR9
|
[NCBI]
|
0.000254631
|
|
|
cataract, autosomal recessive, early-onset, pulverulent
|
[NCBI]
|
0.000254631
|
|
|
bruck syndrome 1
|
[NCBI]
|
0.000254631
|
|
|
IDDM3
|
[NCBI]
|
0.000254631
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal recessive
|
[NCBI]
|
0.000254631
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.000254631
|
|
|
cataract, age-related cortical
|
[NCBI]
|
0.000254631
|
|
|
ALS3
|
[NCBI]
|
0.000254631
|
|
|
split-hand/foot malformation with sensorineural hearing loss
|
[NCBI]
|
0.000254631
|
|
|
CLN1
|
[NCBI]
|
0.000251509
|
|
|
ST3
|
[NCBI]
|
0.0002511692
|
|
|
testicular tumors
|
[NCBI]
|
0.0002501759
|
|
|
MRX46
|
[NCBI]
|
0.0002496854
|
|
|
DFNB16
|
[NCBI]
|
0.0002496854
|
|
|
spinocerebellar ataxia 29
|
[NCBI]
|
0.0002477717
|
|
|
SHFLD1
|
[NCBI]
|
0.0002424636
|
|
|
temporal arteritis
|
[NCBI]
|
0.000239648
|
|
|
HPC1
|
[NCBI]
|
0.0002391467
|
|
|
AVSD
|
[NCBI]
|
0.0002377504
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.000236172
|
|
|
VMCM
|
[NCBI]
|
0.00023604
|
|
|
TRPS2
|
[NCBI]
|
0.0002331279
|
|
|
MS
|
[NCBI]
|
0.000232757
|
|
|
PCLD
|
[NCBI]
|
0.0002303907
|
|
|
HSAN3
|
[NCBI]
|
0.0002282203
|
|
|
amyloidosis vi
|
[NCBI]
|
0.0002256709
|
|
|
WRN
|
[NCBI]
|
0.000224093
|
|
|
KLK3
|
[NCBI]
|
0.000222702
|
|
|
NPHS1
|
[NCBI]
|
0.0002223217
|
|
|
monosomy 9p syndrome
|
[NCBI]
|
0.000221853
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
0.0002217584
|
|
|
SPG17
|
[NCBI]
|
0.0002210172
|
|
|
MCDR1
|
[NCBI]
|
0.0002200757
|
|
|
IL6R
|
[NCBI]
|
0.000220037
|
|
|
hypertension, essential
|
[NCBI]
|
0.0002191782
|
|
|
WT1
|
[NCBI]
|
0.0002182602
|
|
|
masa syndrome
|
[NCBI]
|
0.0002175638
|
|
|
CMT1B
|
[NCBI]
|
0.0002170115
|
|
|
PD
|
[NCBI]
|
0.0002162895
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.0002157248
|
|
|
DWS
|
[NCBI]
|
0.000213396
|
|
|
EPO
|
[NCBI]
|
0.000213376
|
|
|
STGD1
|
[NCBI]
|
0.0002130949
|
|
|
HNPP
|
[NCBI]
|
0.000212987
|
|
|
lipomatosis, multiple
|
[NCBI]
|
0.0002125903
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
0.0002105422
|
|
|
slowed nerve conduction velocity, autosomal dominant
|
[NCBI]
|
0.0002070324
|
|
|
glomerulocystic kidney disease with hyperuricemia and isosthenuria
|
[NCBI]
|
0.0002070324
|
|
|
parotid proline-rich salivary protein pc
|
[NCBI]
|
0.0002070324
|
|
|
HGF
|
[NCBI]
|
0.0002068808
|
|
|
MODY
|
[NCBI]
|
0.000206542
|
|
|
EBN1
|
[NCBI]
|
0.0002064137
|
|
|
RP6
|
[NCBI]
|
0.000205603
|
|
|
MPD2
|
[NCBI]
|
0.000205603
|
|
|
brachydactyly-mental retardation syndrome
|
[NCBI]
|
0.000205603
|
|
|
DYX5
|
[NCBI]
|
0.000205603
|
|
|
RP24
|
[NCBI]
|
0.000205603
|
|
|
dyschromatosis universalis hereditaria
|
[NCBI]
|
0.000205603
|
|
|
CORD5
|
[NCBI]
|
0.000205603
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
0.0002038547
|
|
|
CRH
|
[NCBI]
|
0.0002031322
|
|
|
FA
|
[NCBI]
|
0.00020282
|
|
|
diastrophic dysplasia
|
[NCBI]
|
0.0001992226
|
|
|
MCPH5
|
[NCBI]
|
0.0001969052
|
|
|
CADASIL
|
[NCBI]
|
0.0001965815
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.00019655332
|
|
|
PPD2
|
[NCBI]
|
0.0001962334
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
0.0001947776
|
|
|
SCA2
|
[NCBI]
|
0.0001944902
|
|
|
usher syndrome, type i
|
[NCBI]
|
0.0001933189
|
|
|
RCC1
|
[NCBI]
|
0.0001926227
|
|
|
PSORS1
|
[NCBI]
|
0.0001924721
|
|
|
RP11
|
[NCBI]
|
0.0001908208
|
|
|
SPG6
|
[NCBI]
|
0.0001908208
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
0.0001904058
|
|
|
CELIAC4
|
[NCBI]
|
0.0001904058
|
|
|
bietti crystalline corneoretinal dystrophy
|
[NCBI]
|
0.0001904058
|
|
|
CORDX3
|
[NCBI]
|
0.0001904058
|
|
|
asthma-related traits, susceptibility to, 2
|
[NCBI]
|
0.0001904058
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
0.0001904058
|
|
|
FRAXF
|
[NCBI]
|
0.0001904058
|
|
|
LI3
|
[NCBI]
|
0.0001904058
|
|
|
alzheimer disease 3
|
[NCBI]
|
0.0001875607
|
|
|
MPO
|
[NCBI]
|
0.0001849083
|
|
|
PARK3
|
[NCBI]
|
0.0001837303
|
|
|
HPE3
|
[NCBI]
|
0.0001830388
|
|
|
twinning, dizygotic
|
[NCBI]
|
0.0001828781
|
|
|
PAND1
|
[NCBI]
|
0.0001828781
|
|
|
PMP22
|
[NCBI]
|
0.0001824024
|
|
|
MEN2B
|
[NCBI]
|
0.0001795094
|
|
|
myopathy, centronuclear, autosomal recessive
|
[NCBI]
|
0.0001792
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
0.0001792
|
|
|
CHH
|
[NCBI]
|
0.000177351
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
0.0001767123
|
|
|
PKD2
|
[NCBI]
|
0.0001766665
|
|
|
HRPT2
|
[NCBI]
|
0.0001763463
|
|
|
PSORS2
|
[NCBI]
|
0.00017507
|
|
|
graves disease
|
[NCBI]
|
0.0001743748
|
|
|
HNPCC2
|
[NCBI]
|
0.0001739448
|
|
|
SCA4
|
[NCBI]
|
0.0001732452
|
|
|
USH2B
|
[NCBI]
|
0.0001732452
|
|
|
CEACAM5
|
[NCBI]
|
0.0001728001
|
|
|
EKD1
|
[NCBI]
|
0.0001724668
|
|
|
XS
|
[NCBI]
|
0.0001715995
|
|
|
CMT1C
|
[NCBI]
|
0.0001715995
|
|
|
DSMA1
|
[NCBI]
|
0.0001715081
|
|
|
IGAD1
|
[NCBI]
|
0.0001713001
|
|
|
HOA
|
[NCBI]
|
0.000170768
|
|
|
GTS
|
[NCBI]
|
0.0001685636
|
|
|
CORDX1
|
[NCBI]
|
0.0001671341
|
|
|
FCHL
|
[NCBI]
|
0.0001655726
|
|
|
lynch syndrome i
|
[NCBI]
|
0.0001643712
|
|
|
MCOPS9
|
[NCBI]
|
0.0001640434
|
|
|
ectodermal dysplasia, anhidrotic
|
[NCBI]
|
0.0001640434
|
|
|
SHEP1
|
[NCBI]
|
0.0001637092
|
|
|
MRX21
|
[NCBI]
|
0.0001603937
|
|
|
SCZD8
|
[NCBI]
|
0.0001603937
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
0.0001603937
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
0.0001603937
|
|
|
USH2A
|
[NCBI]
|
0.0001600382
|
|
|
MEN1
|
[NCBI]
|
0.0001579123
|
|
|
BMND1
|
[NCBI]
|
0.0001568944
|
|
|
EVR1
|
[NCBI]
|
0.0001561463
|
|
|
TRPS1
|
[NCBI]
|
0.0001540465
|
|
|
FANCA
|
[NCBI]
|
0.0001533777
|
|
|
VHL
|
[NCBI]
|
0.000152865
|
|
|
DFNA5
|
[NCBI]
|
0.0001519617
|
|
|
CRS2
|
[NCBI]
|
0.0001519617
|
|
|
hyalinosis, infantile systemic
|
[NCBI]
|
0.0001519617
|
|
|
cherubism
|
[NCBI]
|
0.0001519617
|
|
|
SMA2
|
[NCBI]
|
0.0001513001
|
|
|
osteoarthritis
|
[NCBI]
|
0.0001513001
|
|
|
PFHB1B
|
[NCBI]
|
0.0001507073
|
|
|
RNANC
|
[NCBI]
|
0.0001507073
|
|
|
IOSCA
|
[NCBI]
|
0.0001507073
|
|
|
hemangioma, capillary infantile
|
[NCBI]
|
0.0001507073
|
|
|
PGM1
|
[NCBI]
|
0.0001502517
|
|
|
BCPM
|
[NCBI]
|
0.0001500885
|
|
|
fibromatosis, juvenile hyaline
|
[NCBI]
|
0.0001494744
|
|
|
kabuki syndrome
|
[NCBI]
|
0.0001493598
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
0.0001484894
|
|
|
hydatidiform mole
|
[NCBI]
|
0.0001483474
|
|
|
AHDS
|
[NCBI]
|
0.0001483474
|
|
|
RYR1
|
[NCBI]
|
0.0001483333
|
|
|
IDDM10
|
[NCBI]
|
0.0001477537
|
|
|
charcot-marie-tooth disease, dominant intermediate b
|
[NCBI]
|
0.0001452371
|
|
|
MPD1
|
[NCBI]
|
0.0001452371
|
|
|
pierson syndrome
|
[NCBI]
|
0.0001452371
|
|
|
WT5
|
[NCBI]
|
0.0001452371
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
0.0001448905
|
|
|
IGER
|
[NCBI]
|
0.0001448227
|
|
|
OTOF
|
[NCBI]
|
0.0001444298
|
|
|
SCS
|
[NCBI]
|
0.0001438618
|
|
|
mycobacterium tuberculosis, susceptibility to, x-linked
|
[NCBI]
|
0.0001436305
|
|
|
CISS1
|
[NCBI]
|
0.0001436305
|
|
|
ataxia-microcephaly-cataract syndrome
|
[NCBI]
|
0.0001436305
|
|
|
SPRR2C
|
[NCBI]
|
0.0001436305
|
|
|
DFNB30
|
[NCBI]
|
0.0001436305
|
|
|
hypotrichosis-lymphedema-telangiectasia syndrome
|
[NCBI]
|
0.0001436305
|
|
|
dermatoglyphics--arch on any digit
|
[NCBI]
|
0.0001436305
|
|
|
osteoarthritis of distal interphalangeal joints
|
[NCBI]
|
0.0001436305
|
|
|
polysubstance abuse, susceptibility to
|
[NCBI]
|
0.0001436305
|
|
|
HYT8
|
[NCBI]
|
0.0001436305
|
|
|
ASPED
|
[NCBI]
|
0.0001436305
|
|
|
CMH2
|
[NCBI]
|
0.0001436305
|
|
|
hepatic adenomas, familial
|
[NCBI]
|
0.0001436305
|
|
|
ARVD8
|
[NCBI]
|
0.0001436305
|
|
|
peters anomaly with cataract
|
[NCBI]
|
0.0001436305
|
|
|
charcot-marie-tooth disease, axonal, type 2h
|
[NCBI]
|
0.0001436305
|
|
|
NEM4
|
[NCBI]
|
0.0001436305
|
|
|
low density lipoprotein cholesterol, mild elevation of
|
[NCBI]
|
0.0001436305
|
|
|
LGMD2B
|
[NCBI]
|
0.0001425046
|
|
|
DTNBP1
|
[NCBI]
|
0.0001424007
|
|
|
AIED
|
[NCBI]
|
0.0001423609
|
|
|
DYT6
|
[NCBI]
|
0.0001423343
|
|
|
HHC3
|
[NCBI]
|
0.0001423343
|
|
|
ALS5
|
[NCBI]
|
0.0001423343
|
|
|
CTAA2
|
[NCBI]
|
0.0001423343
|
|
|
peeling skin syndrome
|
[NCBI]
|
0.0001423343
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.0001423343
|
|
|
neuroblastoma
|
[NCBI]
|
0.0001405776
|
|
|
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
[NCBI]
|
0.0001393217
|
|
|
EVR4
|
[NCBI]
|
0.0001393217
|
|
|
SLOS
|
[NCBI]
|
0.0001383506
|
|
|
GABRB3
|
[NCBI]
|
0.0001367016
|
|
|
hemophilia a
|
[NCBI]
|
0.0001363043
|
|
|
APC
|
[NCBI]
|
0.00013536349
|
|
|
ED1
|
[NCBI]
|
0.0001352502
|
|
|
WBS
|
[NCBI]
|
0.00013491
|
|
|
ECA1
|
[NCBI]
|
0.0001346587
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.0001346587
|
|
|
MCOP1
|
[NCBI]
|
0.0001346587
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
0.0001346587
|
|
|
CFEOM3
|
[NCBI]
|
0.0001346587
|
|
|
EGFR
|
[NCBI]
|
0.0001342065
|
|
|
VWS
|
[NCBI]
|
0.0001339481
|
|
|
BTHS
|
[NCBI]
|
0.0001328731
|
|
|
RP9
|
[NCBI]
|
0.0001325971
|
|
|
EJM1
|
[NCBI]
|
0.0001325971
|
|
|
IDDM5
|
[NCBI]
|
0.0001325971
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
0.0001323342
|
|
|
CDPX2
|
[NCBI]
|
0.0001317106
|
|
|
RIEG1
|
[NCBI]
|
0.0001303557
|
|
|
CDKN2A
|
[NCBI]
|
0.0001300458
|
|
|
COL6A1
|
[NCBI]
|
0.0001295961
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
0.0001293853
|
|
|
VIL
|
[NCBI]
|
0.0001280138
|
|
|
DYT12
|
[NCBI]
|
0.0001270346
|
|
|
EVR2
|
[NCBI]
|
0.0001270346
|
|
|
AIH2
|
[NCBI]
|
0.0001270346
|
|
|
FTH1
|
[NCBI]
|
0.0001265218
|
|
|
wilson disease
|
[NCBI]
|
0.0001240813
|
|
|
MCOPS1
|
[NCBI]
|
0.0001232229
|
|
|
CCM3
|
[NCBI]
|
0.000123112
|
|
|
MYO7A
|
[NCBI]
|
0.0001225334
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
0.0001222936
|
|
|
ATD1
|
[NCBI]
|
0.000121014
|
|
|
AIS
|
[NCBI]
|
0.000120466
|
|
|
TCP10
|
[NCBI]
|
0.0001201156
|
|
|
CLS
|
[NCBI]
|
0.0001198257
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.0001197296
|
|
|
PBT
|
[NCBI]
|
0.0001182387
|
|
|
NPHP2
|
[NCBI]
|
0.0001175495
|
|
|
KCS
|
[NCBI]
|
0.0001175495
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
0.0001175495
|
|
|
MCKD2
|
[NCBI]
|
0.0001175495
|
|
|
filaminopathy, autosomal dominant
|
[NCBI]
|
0.000116521
|
|
|
velofacioskeletal syndrome
|
[NCBI]
|
0.000116521
|
|
|
ear pits, posterior helical
|
[NCBI]
|
0.000116521
|
|
|
peeling skin syndrome, acral type
|
[NCBI]
|
0.000116521
|
|
|
LGMD2G
|
[NCBI]
|
0.000116521
|
|
|
electroencephalographic peculiarity: fronto-precentral beta wave groups
|
[NCBI]
|
0.000116521
|
|
|
SPG5B
|
[NCBI]
|
0.000116521
|
|
|
angioma serpiginosum, autosomal dominant
|
[NCBI]
|
0.000116521
|
|
|
alzheimer disease without neurofibrillary tangles
|
[NCBI]
|
0.000116521
|
|
|
FIM1
|
[NCBI]
|
0.000116521
|
|
|
HMS1
|
[NCBI]
|
0.0001164475
|
|
|
PKS
|
[NCBI]
|
0.000116279
|
|
|
SSX1
|
[NCBI]
|
0.0001159853
|
|
|
SDHD
|
[NCBI]
|
0.0001157636
|
|
|
CZP3
|
[NCBI]
|
0.000115569
|
|
|
hypertension with brachydactyly
|
[NCBI]
|
0.0001152367
|
|
|
NRCLP1
|
[NCBI]
|
0.0001148466
|
|
|
MKS1
|
[NCBI]
|
0.0001144154
|
|
|
pitt syndrome
|
[NCBI]
|
0.0001143429
|
|
|
PRKAR1B
|
[NCBI]
|
0.0001141986
|
|
|
EA2
|
[NCBI]
|
0.0001136608
|
|
|
EDC
|
[NCBI]
|
0.000113052
|
|
|
FTD3
|
[NCBI]
|
0.000112831
|
|
|
SYNS1
|
[NCBI]
|
0.000112831
|
|
|
TH
|
[NCBI]
|
0.0001120815
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant
|
[NCBI]
|
0.0001119718
|
|
|
ELN
|
[NCBI]
|
0.0001115994
|
|
|
F13B
|
[NCBI]
|
0.0001112744
|
|
|
NPHP1
|
[NCBI]
|
0.0001107791
|
|
|
IBMPFD
|
[NCBI]
|
0.0001100065
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
0.0001099765
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
0.0001099765
|
|
|
OFC3
|
[NCBI]
|
0.0001099765
|
|
|
migraine with or without aura, susceptibility to, 5
|
[NCBI]
|
0.0001099765
|
|
|
APOB
|
[NCBI]
|
0.0001085128
|
|
|
TAF1
|
[NCBI]
|
0.0001077309
|
|
|
SPG4
|
[NCBI]
|
0.0001067851
|
|
|
BDNF
|
[NCBI]
|
0.000106705
|
|
|
NEK1
|
[NCBI]
|
0.0001067024
|
|
|
catel-manzke syndrome
|
[NCBI]
|
0.0001067024
|
|
|
tuberous sclerosis 4
|
[NCBI]
|
0.0001067024
|
|
|
mandibulofacial dysostosis, treacher collins type, autosomal recessive
|
[NCBI]
|
0.0001067024
|
|
|
DDU
|
[NCBI]
|
0.0001067024
|
|
|
RB1
|
[NCBI]
|
0.0001066395
|
|
|
BCR
|
[NCBI]
|
0.000105938
|
|
|
HSPA1L
|
[NCBI]
|
0.0001053537
|
|
|
SPG10
|
[NCBI]
|
0.000105288
|
|
|
RP12
|
[NCBI]
|
0.000105288
|
|
|
ASMD
|
[NCBI]
|
0.0001051804
|
|
|
GVM
|
[NCBI]
|
0.0001051804
|
|
|
NPPA
|
[NCBI]
|
0.0001046038
|
|
|
ACH
|
[NCBI]
|
0.0001044928
|
|
|
myoclonic dystonia
|
[NCBI]
|
0.0001041993
|
|
|
DFNB3
|
[NCBI]
|
0.0001037855
|
|
|
LGMD2A
|
[NCBI]
|
0.0001036232
|
|
|
AFP
|
[NCBI]
|
0.0001033357
|
|
|
GAS
|
[NCBI]
|
0.0001030035
|
|
|
RS1
|
[NCBI]
|
0.0001026969
|
|
|
OA1
|
[NCBI]
|
0.0001025793
|
|
|
myofibrillogenesis regulator 1
|
[NCBI]
|
0.0001017274
|
|
|
HMI
|
[NCBI]
|
0.0001013893
|
|
|
cytochrome p450, family 4, subfamily v, polypeptide 2
|
[NCBI]
|
0.0001013167
|
|
|
gout susceptibility 1
|
[NCBI]
|
0.000100998434
|
|
|
PTLS
|
[NCBI]
|
0.0001005591
|
|
|
EEG
|
[NCBI]
|
0.0001005591
|
|
|
PRD
|
[NCBI]
|
0.0001005591
|
|
|
TYMS
|
[NCBI]
|
9.99486e-05
|
|
|
F5F8D
|
[NCBI]
|
9.95548e-05
|
|
|
sacral defect with anterior meningocele
|
[NCBI]
|
9.91829e-05
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
9.917e-05
|
|
|
CMH4
|
[NCBI]
|
9.9067e-05
|
|
|
ACY1
|
[NCBI]
|
9.8051e-05
|
|
|
HSCR1
|
[NCBI]
|
9.80216e-05
|
|
|
TAZ
|
[NCBI]
|
9.8e-05
|
|
|
GABRG2
|
[NCBI]
|
9.8e-05
|
|
|
LGMD1A
|
[NCBI]
|
9.76374e-05
|
|
|
MCOPS3
|
[NCBI]
|
9.76374e-05
|
|
|
IRID2
|
[NCBI]
|
9.76374e-05
|
|
|
MCOPS7
|
[NCBI]
|
9.71921e-05
|
|
|
ODDD
|
[NCBI]
|
9.7012e-05
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
9.6633e-05
|
|
|
HMN5
|
[NCBI]
|
9.6633e-05
|
|
|
IL23R
|
[NCBI]
|
9.57721e-05
|
|
|
JWS
|
[NCBI]
|
9.49896e-05
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
9.49896e-05
|
|
|
membranoproliferative glomerulonephritis, x-linked
|
[NCBI]
|
9.49571e-05
|
|
|
DFSP
|
[NCBI]
|
9.48834e-05
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
9.4471e-05
|
|
|
SEDT
|
[NCBI]
|
9.4471e-05
|
|
|
IHPS1
|
[NCBI]
|
9.4471e-05
|
|
|
pycnodysostosis
|
[NCBI]
|
9.4471e-05
|
|
|
F13A1
|
[NCBI]
|
9.40005e-05
|
|
|
arbitrary restriction polymorphism 1
|
[NCBI]
|
9.38057e-05
|
|
|
TSD
|
[NCBI]
|
9.29626e-05
|
|
|
hairy ears, y-linked
|
[NCBI]
|
9.27918e-05
|
|
|
FLT4
|
[NCBI]
|
9.27462e-05
|
|
|
IRDN
|
[NCBI]
|
9.27462e-05
|
|
|
DRD2
|
[NCBI]
|
9.25802e-05
|
|
|
seckel syndrome 1
|
[NCBI]
|
9.22178e-05
|
|
|
RENS1
|
[NCBI]
|
9.16399e-05
|
|
|
WS2A
|
[NCBI]
|
9.16399e-05
|
|
|
REN
|
[NCBI]
|
9.15257e-05
|
|
|
OCD1
|
[NCBI]
|
9.14164e-05
|
|
|
MBP
|
[NCBI]
|
9.11572e-05
|
|
|
MTCO2
|
[NCBI]
|
9.10849e-05
|
|
|
SVAS
|
[NCBI]
|
9.03989e-05
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
9.02925e-05
|
|
|
MAS1
|
[NCBI]
|
9.02728e-05
|
|
|
hypospadias, autosomal
|
[NCBI]
|
9.01016e-05
|
|
|
DSAP1
|
[NCBI]
|
9.01016e-05
|
|
|
PDB
|
[NCBI]
|
8.98727e-05
|
|
|
PARK1
|
[NCBI]
|
8.97283e-05
|
|
|
APOC2
|
[NCBI]
|
8.9548e-05
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
8.92738e-05
|
|
|
DGS
|
[NCBI]
|
8.85963e-05
|
|
|
GCKR
|
[NCBI]
|
8.79951e-05
|
|
|
PCOS1
|
[NCBI]
|
8.79887e-05
|
|
|
TCOF
|
[NCBI]
|
8.7824e-05
|
|
|
HCFP1
|
[NCBI]
|
8.74386e-05
|
|
|
CNC2
|
[NCBI]
|
8.74386e-05
|
|
|
HHF1
|
[NCBI]
|
8.67018e-05
|
|
|
ORM1
|
[NCBI]
|
8.60589e-05
|
|
|
BSCL2
|
[NCBI]
|
8.60177e-05
|
|
|
SLSN4
|
[NCBI]
|
8.57915e-05
|
|
|
MRT6
|
[NCBI]
|
8.57915e-05
|
|
|
aortic aneurysm, familial thoracic 3
|
[NCBI]
|
8.57915e-05
|
|
|
malignant hyperthermia, susceptibility to, 5
|
[NCBI]
|
8.57915e-05
|
|
|
SCRA
|
[NCBI]
|
8.57915e-05
|
|
|
spondyloepimetaphyseal dysplasia, type ii
|
[NCBI]
|
8.57915e-05
|
|
|
myopathy, spheroid body
|
[NCBI]
|
8.57915e-05
|
|
|
bruck syndrome 2
|
[NCBI]
|
8.57915e-05
|
|
|
MCOP3
|
[NCBI]
|
8.57915e-05
|
|
|
cataract, crystalline aculeiform
|
[NCBI]
|
8.57915e-05
|
|
|
stocco dos santos x-linked mental retardation syndrome
|
[NCBI]
|
8.57915e-05
|
|
|
SCA16
|
[NCBI]
|
8.57915e-05
|
|
|
DFNA23
|
[NCBI]
|
8.57915e-05
|
|
|
MCOPS5
|
[NCBI]
|
8.57915e-05
|
|
|
body length, mouse, human homolog
|
[NCBI]
|
8.57915e-05
|
|
|
DFNB49
|
[NCBI]
|
8.57915e-05
|
|
|
DMAT
|
[NCBI]
|
8.57915e-05
|
|
|
MCPHA
|
[NCBI]
|
8.57915e-05
|
|
|
MRX93
|
[NCBI]
|
8.57915e-05
|
|
|
bor-duane hydrocephalus contiguous gene syndrome
|
[NCBI]
|
8.57915e-05
|
|
|
CCA3
|
[NCBI]
|
8.57915e-05
|
|
|
LCK
|
[NCBI]
|
8.49169e-05
|
|
|
PJS
|
[NCBI]
|
8.45835e-05
|
|
|
NFNS
|
[NCBI]
|
8.2869e-05
|
|
|
AHR
|
[NCBI]
|
8.2705e-05
|
|
|
diaphragmatic hernia, congenital
|
[NCBI]
|
8.2419e-05
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
8.20232e-05
|
|
|
ALD
|
[NCBI]
|
8.182e-05
|
|
|
DFNA12
|
[NCBI]
|
8.16232e-05
|
|
|
ASS
|
[NCBI]
|
8.13158e-05
|
|
|
OCRL
|
[NCBI]
|
8.10087e-05
|
|
|
OFD1
|
[NCBI]
|
8.09816e-05
|
|
|
obesity
|
[NCBI]
|
8.08646e-05
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
8.04286e-05
|
|
|
LRP5
|
[NCBI]
|
8.01535e-05
|
|
|
MDM1
|
[NCBI]
|
8.01491e-05
|
|
|
MMP17
|
[NCBI]
|
7.98594e-05
|
|
|
ZNF200
|
[NCBI]
|
7.98594e-05
|
|
|
LARS
|
[NCBI]
|
7.98594e-05
|
|
|
leptin, serum levels of
|
[NCBI]
|
7.9614e-05
|
|
|
x inactivation, familial skewed, 2
|
[NCBI]
|
7.9614e-05
|
|
|
MTM1
|
[NCBI]
|
7.9251e-05
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
7.91648e-05
|
|
|
thiourea tasting
|
[NCBI]
|
7.84445e-05
|
|
|
EPD
|
[NCBI]
|
7.8107e-05
|
|
|
FRA16A
|
[NCBI]
|
7.76077e-05
|
|
|
ARVD1
|
[NCBI]
|
7.76077e-05
|
|
|
SRA2
|
[NCBI]
|
7.71788e-05
|
|
|
DGAT1
|
[NCBI]
|
7.68578e-05
|
|
|
MS4A2
|
[NCBI]
|
7.68578e-05
|
|
|
breast cancer
|
[NCBI]
|
7.67869e-05
|
|
|
APOE
|
[NCBI]
|
7.67038e-05
|
|
|
SCA7
|
[NCBI]
|
7.6508e-05
|
|
|
GSR
|
[NCBI]
|
7.61086e-05
|
|
|
TF
|
[NCBI]
|
7.6026e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 3
|
[NCBI]
|
7.59729e-05
|
|
|
PEE4
|
[NCBI]
|
7.59729e-05
|
|
|
ARMD10
|
[NCBI]
|
7.59729e-05
|
|
|
carcinoid tumors, intestinal
|
[NCBI]
|
7.59729e-05
|
|
|
ARTS
|
[NCBI]
|
7.59729e-05
|
|
|
ACFD
|
[NCBI]
|
7.59729e-05
|
|
|
CMD3A
|
[NCBI]
|
7.59729e-05
|
|
|
factor x deficiency
|
[NCBI]
|
7.59318e-05
|
|
|
CTSC
|
[NCBI]
|
7.59318e-05
|
|
|
KFSD
|
[NCBI]
|
7.56257e-05
|
|
|
USH3
|
[NCBI]
|
7.56257e-05
|
|
|
denys-drash syndrome
|
[NCBI]
|
7.56257e-05
|
|
|
BHC
|
[NCBI]
|
7.52971e-05
|
|
|
MCPH1
|
[NCBI]
|
7.52971e-05
|
|
|
RMRP
|
[NCBI]
|
7.52951e-05
|
|
|
DYT1
|
[NCBI]
|
7.5099e-05
|
|
|
MRXS13
|
[NCBI]
|
7.44983e-05
|
|
|
LYZ
|
[NCBI]
|
7.39518e-05
|
|
|
APOC1
|
[NCBI]
|
7.38821e-05
|
|
|
PPY
|
[NCBI]
|
7.38821e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
7.37924e-05
|
|
|
VDR
|
[NCBI]
|
7.36031e-05
|
|
|
SPD1
|
[NCBI]
|
7.30758e-05
|
|
|
ISS
|
[NCBI]
|
7.30758e-05
|
|
|
JME
|
[NCBI]
|
7.30758e-05
|
|
|
BWS
|
[NCBI]
|
7.2722e-05
|
|
|
IDH1
|
[NCBI]
|
7.25931e-05
|
|
|
ADD1
|
[NCBI]
|
7.25931e-05
|
|
|
ADHD
|
[NCBI]
|
7.22446e-05
|
|
|
XLP1
|
[NCBI]
|
7.20119e-05
|
|
|
alzheimer disease 2
|
[NCBI]
|
7.16672e-05
|
|
|
ALS2
|
[NCBI]
|
7.16672e-05
|
|
|
NRG1
|
[NCBI]
|
7.1611e-05
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
7.139e-05
|
|
|
PHP
|
[NCBI]
|
7.139e-05
|
|
|
PSORS4
|
[NCBI]
|
7.139e-05
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
7.139e-05
|
|
|
TPH2
|
[NCBI]
|
7.11682e-05
|
|
|
HCRTR2
|
[NCBI]
|
7.11682e-05
|
|
|
IKBKAP
|
[NCBI]
|
7.11682e-05
|
|
|
SFTPA1
|
[NCBI]
|
7.11682e-05
|
|
|
CALCR
|
[NCBI]
|
7.11682e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
7.10026e-05
|
|
|
MYH7
|
[NCBI]
|
7.07845e-05
|
|
|
PPCD1
|
[NCBI]
|
7.07652e-05
|
|
|
GSTP1
|
[NCBI]
|
7.06978e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
7.05439e-05
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
7.048519e-05
|
|
|
SLC6A14
|
[NCBI]
|
7.0232e-05
|
|
|
EFHC1
|
[NCBI]
|
7.0232e-05
|
|
|
HARS
|
[NCBI]
|
7.0232e-05
|
|
|
TNNC2
|
[NCBI]
|
7.0232e-05
|
|
|
leprosy, susceptibility to, 2
|
[NCBI]
|
6.98296e-05
|
|
|
VAMAS1
|
[NCBI]
|
6.98296e-05
|
|
|
AIS1
|
[NCBI]
|
6.98296e-05
|
|
|
ependymoma, familial
|
[NCBI]
|
6.98296e-05
|
|
|
syndactyly, type iii
|
[NCBI]
|
6.98296e-05
|
|
|
SCA13
|
[NCBI]
|
6.98296e-05
|
|
|
GIST
|
[NCBI]
|
6.93077e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
6.92487e-05
|
|
|
ATRX
|
[NCBI]
|
6.92419e-05
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
6.91173e-05
|
|
|
JBTS1
|
[NCBI]
|
6.90655e-05
|
|
|
PLP1
|
[NCBI]
|
6.89105e-05
|
|
|
CMDD
|
[NCBI]
|
6.86606e-05
|
|
|
DAR
|
[NCBI]
|
6.85548e-05
|
|
|
NM
|
[NCBI]
|
6.81715e-05
|
|
|
hyperglycerolemia
|
[NCBI]
|
6.79899e-05
|
|
|
FTL
|
[NCBI]
|
6.79814e-05
|
|
|
MDLS
|
[NCBI]
|
6.79602e-05
|
|
|
LGMD2D
|
[NCBI]
|
6.78883e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
6.78412e-05
|
|
|
NF2
|
[NCBI]
|
6.76856e-05
|
|
|
PRX
|
[NCBI]
|
6.75804e-05
|
|
|
CTNS
|
[NCBI]
|
6.74755e-05
|
|
|
SGSH
|
[NCBI]
|
6.74661e-05
|
|
|
BTK
|
[NCBI]
|
6.7238e-05
|
|
|
BTBD9
|
[NCBI]
|
6.7117e-05
|
|
|
PALS
|
[NCBI]
|
6.68067e-05
|
|
|
PRKCSH
|
[NCBI]
|
6.67783e-05
|
|
|
g30 gene
|
[NCBI]
|
6.67783e-05
|
|
|
TGM5
|
[NCBI]
|
6.67783e-05
|
|
|
GANC
|
[NCBI]
|
6.67783e-05
|
|
|
GABRA5
|
[NCBI]
|
6.67783e-05
|
|
|
CAT
|
[NCBI]
|
6.65201e-05
|
|
|
DRD5
|
[NCBI]
|
6.63713e-05
|
|
|
AK1
|
[NCBI]
|
6.62325e-05
|
|
|
NDP
|
[NCBI]
|
6.60436e-05
|
|
|
RPGR
|
[NCBI]
|
6.58495e-05
|
|
|
MODY1
|
[NCBI]
|
6.56216e-05
|
|
|
STGD3
|
[NCBI]
|
6.56216e-05
|
|
|
lymphedema, hereditary, ii
|
[NCBI]
|
6.54319e-05
|
|
|
AH
|
[NCBI]
|
6.54319e-05
|
|
|
pseudodiastrophic dysplasia
|
[NCBI]
|
6.54319e-05
|
|
|
trismus-pseudocamptodactyly syndrome
|
[NCBI]
|
6.54319e-05
|
|
|
CTNS
|
[NCBI]
|
6.5354e-05
|
|
|
LYST
|
[NCBI]
|
6.52481e-05
|
|
|
DFNB67
|
[NCBI]
|
6.49107e-05
|
|
|
EDM5
|
[NCBI]
|
6.49107e-05
|
|
|
myotubular myopathy with abnormal genital development
|
[NCBI]
|
6.49107e-05
|
|
|
GUD
|
[NCBI]
|
6.49107e-05
|
|
|
ADCAD1
|
[NCBI]
|
6.49107e-05
|
|
|
MODY4
|
[NCBI]
|
6.49107e-05
|
|
|
FEB4
|
[NCBI]
|
6.49107e-05
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
6.49107e-05
|
|
|
chondrosarcoma
|
[NCBI]
|
6.49107e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2f
|
[NCBI]
|
6.49107e-05
|
|
|
LORD
|
[NCBI]
|
6.49107e-05
|
|
|
aminoacylase 1 deficiency
|
[NCBI]
|
6.49107e-05
|
|
|
HJMD
|
[NCBI]
|
6.49107e-05
|
|
|
SLEB2
|
[NCBI]
|
6.49107e-05
|
|
|
EV
|
[NCBI]
|
6.47222e-05
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
6.47021e-05
|
|
|
XDH
|
[NCBI]
|
6.46234e-05
|
|
|
SMN1
|
[NCBI]
|
6.46075e-05
|
|
|
PLG
|
[NCBI]
|
6.45798e-05
|
|
|
glioma of brain, familial
|
[NCBI]
|
6.42351e-05
|
|
|
ATP1A2
|
[NCBI]
|
6.42308e-05
|
|
|
SLC11A1
|
[NCBI]
|
6.41731e-05
|
|
|
TGD
|
[NCBI]
|
6.38878e-05
|
|
|
membrane-associated protein 17
|
[NCBI]
|
6.36633e-05
|
|
|
CCM2
|
[NCBI]
|
6.36633e-05
|
|
|
STRC
|
[NCBI]
|
6.36633e-05
|
|
|
CDKAL1
|
[NCBI]
|
6.36633e-05
|
|
|
GABRA3
|
[NCBI]
|
6.36633e-05
|
|
|
PRDM2
|
[NCBI]
|
6.36633e-05
|
|
|
CDR1
|
[NCBI]
|
6.36633e-05
|
|
|
NYX
|
[NCBI]
|
6.36633e-05
|
|
|
RPE
|
[NCBI]
|
6.36633e-05
|
|
|
EXT2
|
[NCBI]
|
6.32183e-05
|
|
|
CORD2
|
[NCBI]
|
6.27768e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
6.27268e-05
|
|
|
CAST
|
[NCBI]
|
6.2233e-05
|
|
|
scapuloperoneal syndrome, neurogenic, kaeser type
|
[NCBI]
|
6.20623e-05
|
|
|
BDE
|
[NCBI]
|
6.20623e-05
|
|
|
chromosome 17q21.31 microdeletion syndrome
|
[NCBI]
|
6.20253e-05
|
|
|
LGMD2C
|
[NCBI]
|
6.19792e-05
|
|
|
THY1
|
[NCBI]
|
6.13429e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
6.12064e-05
|
|
|
CLEC16A
|
[NCBI]
|
6.10333e-05
|
|
|
MALAT1
|
[NCBI]
|
6.10333e-05
|
|
|
PLA2G1B
|
[NCBI]
|
6.10333e-05
|
|
|
GNRH1
|
[NCBI]
|
6.07959e-05
|
|
|
APS2
|
[NCBI]
|
6.06395e-05
|
|
|
GLC3A
|
[NCBI]
|
6.0442e-05
|
|
|
ETM1
|
[NCBI]
|
6.0442e-05
|
|
|
HSAN1
|
[NCBI]
|
6.0442e-05
|
|
|
PRKCG
|
[NCBI]
|
6.03283e-05
|
|
|
CMD1A
|
[NCBI]
|
6.0262e-05
|
|
|
PTHLH
|
[NCBI]
|
6.01313e-05
|
|
|
FRAP1
|
[NCBI]
|
5.99404e-05
|
|
|
ACTC1
|
[NCBI]
|
5.94382e-05
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
5.92811e-05
|
|
|
OCA2
|
[NCBI]
|
5.91035e-05
|
|
|
HLA-F
|
[NCBI]
|
5.89103e-05
|
|
|
fanconi renotubular syndrome
|
[NCBI]
|
5.89075e-05
|
|
|
PRTS
|
[NCBI]
|
5.87674e-05
|
|
|
LAH
|
[NCBI]
|
5.87674e-05
|
|
|
CFEOM2
|
[NCBI]
|
5.87674e-05
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
5.87674e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
5.87674e-05
|
|
|
LCA5
|
[NCBI]
|
5.87674e-05
|
|
|
alpha-b crystallinopathy
|
[NCBI]
|
5.87674e-05
|
|
|
SPD2
|
[NCBI]
|
5.87674e-05
|
|
|
FSGS2
|
[NCBI]
|
5.87674e-05
|
|
|
EBN2
|
[NCBI]
|
5.87674e-05
|
|
|
MRX30
|
[NCBI]
|
5.87674e-05
|
|
|
MCOP2
|
[NCBI]
|
5.87674e-05
|
|
|
SCN2B
|
[NCBI]
|
5.86597e-05
|
|
|
CRYBB3
|
[NCBI]
|
5.86597e-05
|
|
|
TCP1
|
[NCBI]
|
5.86597e-05
|
|
|
PRKAR2B
|
[NCBI]
|
5.86597e-05
|
|
|
LMX1B
|
[NCBI]
|
5.86011e-05
|
|
|
CACNA1S
|
[NCBI]
|
5.85678e-05
|
|
|
LBSL
|
[NCBI]
|
5.8029e-05
|
|
|
SCA10
|
[NCBI]
|
5.78762e-05
|
|
|
FHM2
|
[NCBI]
|
5.75132e-05
|
|
|
JH
|
[NCBI]
|
5.74022e-05
|
|
|
CCA1
|
[NCBI]
|
5.70761e-05
|
|
|
FOXL2
|
[NCBI]
|
5.70639e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
5.68264e-05
|
|
|
XIST
|
[NCBI]
|
5.67107e-05
|
|
|
NSDHL
|
[NCBI]
|
5.65367e-05
|
|
|
PCD
|
[NCBI]
|
5.64301e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
5.61547e-05
|
|
|
G6PD
|
[NCBI]
|
5.60169e-05
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
5.52976e-05
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
5.51913e-05
|
|
|
MYOC
|
[NCBI]
|
5.51429e-05
|
|
|
ITGB1
|
[NCBI]
|
5.46615e-05
|
|
|
CAMK4
|
[NCBI]
|
5.46194e-05
|
|
|
ARIX
|
[NCBI]
|
5.46194e-05
|
|
|
IGF2BP2
|
[NCBI]
|
5.46194e-05
|
|
|
COL4A2
|
[NCBI]
|
5.46194e-05
|
|
|
ATP2C1
|
[NCBI]
|
5.46194e-05
|
|
|
CAPN10
|
[NCBI]
|
5.45958e-05
|
|
|
CACP
|
[NCBI]
|
5.43697e-05
|
|
|
PGL3
|
[NCBI]
|
5.43697e-05
|
|
|
porencephaly, familial
|
[NCBI]
|
5.43697e-05
|
|
|
ED3
|
[NCBI]
|
5.43697e-05
|
|
|
POF2A
|
[NCBI]
|
5.43697e-05
|
|
|
DFNB6
|
[NCBI]
|
5.43697e-05
|
|
|
AVSD2
|
[NCBI]
|
5.43697e-05
|
|
|
KRT1
|
[NCBI]
|
5.38812e-05
|
|
|
IL10
|
[NCBI]
|
5.32963e-05
|
|
|
CYP1B1
|
[NCBI]
|
5.31397e-05
|
|
|
CA3
|
[NCBI]
|
5.30128e-05
|
|
|
FANCE
|
[NCBI]
|
5.28416e-05
|
|
|
LQT1
|
[NCBI]
|
5.2803e-05
|
|
|
PARK6
|
[NCBI]
|
5.27753e-05
|
|
|
dent disease 1
|
[NCBI]
|
5.25919e-05
|
|
|
hydrolethalus syndrome 1
|
[NCBI]
|
5.240988e-05
|
|
|
fabry disease
|
[NCBI]
|
5.23922e-05
|
|
|
OPA1
|
[NCBI]
|
5.20143e-05
|
|
|
CORD6
|
[NCBI]
|
5.18857e-05
|
|
|
SPG7
|
[NCBI]
|
5.18857e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 2
|
[NCBI]
|
5.18857e-05
|
|
|
antisense igf2r
|
[NCBI]
|
5.18857e-05
|
|
|
ASAT
|
[NCBI]
|
5.18857e-05
|
|
|
HPA1
|
[NCBI]
|
5.18857e-05
|
|
|
leber congenital amaurosis, type iii
|
[NCBI]
|
5.18857e-05
|
|
|
complement component 4, partial deficiency of
|
[NCBI]
|
5.18857e-05
|
|
|
ETS1
|
[NCBI]
|
5.18251e-05
|
|
|
CRYAA
|
[NCBI]
|
5.17597e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
5.17571e-05
|
|
|
cystinuria
|
[NCBI]
|
5.17417e-05
|
|
|
EIG
|
[NCBI]
|
5.13731e-05
|
|
|
CVID
|
[NCBI]
|
5.13156e-05
|
|
|
AK3
|
[NCBI]
|
5.13143e-05
|
|
|
PTGFR
|
[NCBI]
|
5.1235e-05
|
|
|
GLRA2
|
[NCBI]
|
5.1235e-05
|
|
|
PSG4
|
[NCBI]
|
5.1235e-05
|
|
|
CLCN4
|
[NCBI]
|
5.1235e-05
|
|
|
PPP1R2
|
[NCBI]
|
5.1235e-05
|
|
|
PSG7
|
[NCBI]
|
5.1235e-05
|
|
|
PSG9
|
[NCBI]
|
5.1235e-05
|
|
|
ISL1
|
[NCBI]
|
5.1235e-05
|
|
|
PSG5
|
[NCBI]
|
5.1235e-05
|
|
|
PTPRG
|
[NCBI]
|
5.1235e-05
|
|
|
CHRNG
|
[NCBI]
|
5.1235e-05
|
|
|
PSG10
|
[NCBI]
|
5.1235e-05
|
|
|
PSG8
|
[NCBI]
|
5.1235e-05
|
|
|
PSG11
|
[NCBI]
|
5.1235e-05
|
|
|
CPA1
|
[NCBI]
|
5.1235e-05
|
|
|
PSG6
|
[NCBI]
|
5.1235e-05
|
|
|
ATP10A
|
[NCBI]
|
5.1235e-05
|
|
|
uniparental disomy, paternal, chromosome 14
|
[NCBI]
|
5.10001e-05
|
|
|
ATCAY
|
[NCBI]
|
5.10001e-05
|
|
|
CNA2
|
[NCBI]
|
5.10001e-05
|
|
|
glaucoma, normal tension, susceptibility to
|
[NCBI]
|
5.10001e-05
|
|
|
intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked
|
[NCBI]
|
5.10001e-05
|
|
|
naxos disease
|
[NCBI]
|
5.10001e-05
|
|
|
RNPEPL1
|
[NCBI]
|
5.06564e-05
|
|
|
HIST1H3J
|
[NCBI]
|
5.06564e-05
|
|
|
CYP4F22
|
[NCBI]
|
5.06564e-05
|
|
|
HIST1H2BL
|
[NCBI]
|
5.06564e-05
|
|
|
HIST1H2AK
|
[NCBI]
|
5.06564e-05
|
|
|
HIST1H4K
|
[NCBI]
|
5.06564e-05
|
|
|
HIST1H2BN
|
[NCBI]
|
5.06564e-05
|
|
|
INE1
|
[NCBI]
|
5.06564e-05
|
|
|
SLC9A5
|
[NCBI]
|
5.06564e-05
|
|
|
ADAM20
|
[NCBI]
|
5.06564e-05
|
|
|
TARS
|
[NCBI]
|
5.06564e-05
|
|
|
narcolepsy candidate region gene 1a
|
[NCBI]
|
5.06564e-05
|
|
|
MIC6
|
[NCBI]
|
5.06564e-05
|
|
|
SERF2
|
[NCBI]
|
5.06564e-05
|
|
|
SPRR3
|
[NCBI]
|
5.06564e-05
|
|
|
INE2
|
[NCBI]
|
5.06564e-05
|
|
|
mental retardation, x-linked, south african type
|
[NCBI]
|
5.06564e-05
|
|
|
PPKB
|
[NCBI]
|
5.06564e-05
|
|
|
ST11
|
[NCBI]
|
5.06564e-05
|
|
|
amyloid beta a4 precursor protein-like 1
|
[NCBI]
|
5.06564e-05
|
|
|
ovarian cancer-associated gene 2
|
[NCBI]
|
5.06564e-05
|
|
|
MDF1
|
[NCBI]
|
5.06564e-05
|
|
|
tissue-specific extinguisher 3
|
[NCBI]
|
5.06564e-05
|
|
|
OR1F1
|
[NCBI]
|
5.06564e-05
|
|
|
x123 gene
|
[NCBI]
|
5.06564e-05
|
|
|
ADAM21
|
[NCBI]
|
5.06564e-05
|
|
|
NOMO3
|
[NCBI]
|
5.06564e-05
|
|
|
DIRC2
|
[NCBI]
|
5.06564e-05
|
|
|
transmembrane 7 superfamily, member 3
|
[NCBI]
|
5.06564e-05
|
|
|
HIST1H2BM
|
[NCBI]
|
5.06564e-05
|
|
|
TGM7
|
[NCBI]
|
5.06564e-05
|
|
|
HSPA3
|
[NCBI]
|
5.06564e-05
|
|
|
EML1
|
[NCBI]
|
5.06564e-05
|
|
|
twirler mutation, murine, human homolog of
|
[NCBI]
|
5.06564e-05
|
|
|
ZNF205
|
[NCBI]
|
5.06564e-05
|
|
|
ATP5E
|
[NCBI]
|
5.06564e-05
|
|
|
HIST1H3H
|
[NCBI]
|
5.06564e-05
|
|
|
NCAM2
|
[NCBI]
|
5.06564e-05
|
|
|
LY6G6D
|
[NCBI]
|
5.06564e-05
|
|
|
CTXN
|
[NCBI]
|
5.06564e-05
|
|
|
HIST1H2AJ
|
[NCBI]
|
5.06564e-05
|
|
|
MIAT
|
[NCBI]
|
5.06564e-05
|
|
|
HIST1H2AI
|
[NCBI]
|
5.06564e-05
|
|
|
PSACH
|
[NCBI]
|
5.0537e-05
|
|
|
COL1A1
|
[NCBI]
|
5.02717e-05
|
|
|
ATM
|
[NCBI]
|
5.02632e-05
|
|
|
COL3A1
|
[NCBI]
|
5.02014e-05
|
|
|
CLN2
|
[NCBI]
|
4.99759e-05
|
|
|
bethlem myopathy
|
[NCBI]
|
4.99759e-05
|
|
|
LAMB2
|
[NCBI]
|
4.98539e-05
|
|
|
DNASE2
|
[NCBI]
|
4.98539e-05
|
|
|
SLC3A1
|
[NCBI]
|
4.98314e-05
|
|
|
SCN1A
|
[NCBI]
|
4.98004e-05
|
|
|
ARHGEF6
|
[NCBI]
|
4.97077e-05
|
|
|
GDNF
|
[NCBI]
|
4.96326e-05
|
|
|
CD
|
[NCBI]
|
4.94399e-05
|
|
|
CACNA1A
|
[NCBI]
|
4.94162e-05
|
|
|
EXT1
|
[NCBI]
|
4.91877e-05
|
|
|
LEP
|
[NCBI]
|
4.8808e-05
|
|
|
GZMB
|
[NCBI]
|
4.86846e-05
|
|
|
OPA1
|
[NCBI]
|
4.85715e-05
|
|
|
HEPOD
|
[NCBI]
|
4.84717e-05
|
|
|
EEC1
|
[NCBI]
|
4.8405834e-05
|
|
|
TFPI
|
[NCBI]
|
4.83328e-05
|
|
|
ST7
|
[NCBI]
|
4.83266e-05
|
|
|
PSG2
|
[NCBI]
|
4.83266e-05
|
|
|
GNAI1
|
[NCBI]
|
4.83266e-05
|
|
|
ARD1A
|
[NCBI]
|
4.83266e-05
|
|
|
PGM2
|
[NCBI]
|
4.83266e-05
|
|
|
CCKBR
|
[NCBI]
|
4.83266e-05
|
|
|
BTN1A1
|
[NCBI]
|
4.83266e-05
|
|
|
ANTXR2
|
[NCBI]
|
4.83266e-05
|
|
|
BCAT1
|
[NCBI]
|
4.83266e-05
|
|
|
KNO
|
[NCBI]
|
4.83099e-05
|
|
|
ALS4
|
[NCBI]
|
4.83099e-05
|
|
|
POAG
|
[NCBI]
|
4.80741e-05
|
|
|
ARX
|
[NCBI]
|
4.80266e-05
|
|
|
alopecia areata 1
|
[NCBI]
|
4.774485e-05
|
|
|
LDHB
|
[NCBI]
|
4.75028e-05
|
|
|
PFIC2
|
[NCBI]
|
4.7488e-05
|
|
|
DFNA10
|
[NCBI]
|
4.7488e-05
|
|
|
MKS3
|
[NCBI]
|
4.7488e-05
|
|
|
NPHP4
|
[NCBI]
|
4.7488e-05
|
|
|
dentinogenesis imperfecta, shields type iii
|
[NCBI]
|
4.7488e-05
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
4.7488e-05
|
|
|
neurofibromatosis, familial spinal
|
[NCBI]
|
4.7488e-05
|
|
|
DFNA13
|
[NCBI]
|
4.7488e-05
|
|
|
LI2
|
[NCBI]
|
4.7488e-05
|
|
|
CMH3
|
[NCBI]
|
4.7488e-05
|
|
|
CDHS
|
[NCBI]
|
4.7488e-05
|
|
|
IBM2
|
[NCBI]
|
4.74536e-05
|
|
|
MAPT
|
[NCBI]
|
4.71565e-05
|
|
|
CCND1
|
[NCBI]
|
4.71522e-05
|
|
|
PRH2
|
[NCBI]
|
4.71168e-05
|
|
|
IDH2
|
[NCBI]
|
4.71168e-05
|
|
|
BBS4
|
[NCBI]
|
4.69898e-05
|
|
|
CHRNA7
|
[NCBI]
|
4.69898e-05
|
|
|
LMAN1
|
[NCBI]
|
4.69898e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
4.69895e-05
|
|
|
NOG
|
[NCBI]
|
4.68281e-05
|
|
|
AMCN
|
[NCBI]
|
4.66599e-05
|
|
|
diabetes insipidus, neurohypophyseal type
|
[NCBI]
|
4.64983e-05
|
|
|
WHS
|
[NCBI]
|
4.643107e-05
|
|
|
CDC42
|
[NCBI]
|
4.63699e-05
|
|
|
NIDDM2
|
[NCBI]
|
4.6102734e-05
|
|
|
spinal muscular atrophy, proximal, adult, autosomal dominant
|
[NCBI]
|
4.61025e-05
|
|
|
MUC1
|
[NCBI]
|
4.57949e-05
|
|
|
MAS
|
[NCBI]
|
4.57887e-05
|
|
|
PSG3
|
[NCBI]
|
4.578e-05
|
|
|
APBA1
|
[NCBI]
|
4.578e-05
|
|
|
TSPY
|
[NCBI]
|
4.578e-05
|
|
|
EYA4
|
[NCBI]
|
4.578e-05
|
|
|
TACSTD2
|
[NCBI]
|
4.578e-05
|
|
|
IFNGR1
|
[NCBI]
|
4.57793e-05
|
|
|
FABP2
|
[NCBI]
|
4.5729e-05
|
|
|
GEFS+
|
[NCBI]
|
4.51656e-05
|
|
|
RBP3
|
[NCBI]
|
4.51049e-05
|
|
|
TS
|
[NCBI]
|
4.508356e-05
|
|
|
CNTF
|
[NCBI]
|
4.4983e-05
|
|
|
NP
|
[NCBI]
|
4.49327e-05
|
|
|
DISC1
|
[NCBI]
|
4.46674e-05
|
|
|
ETV6
|
[NCBI]
|
4.46674e-05
|
|
|
VANGL2
|
[NCBI]
|
4.45928e-05
|
|
|
APH
|
[NCBI]
|
4.45928e-05
|
|
|
PSEN2
|
[NCBI]
|
4.43899e-05
|
|
|
EWSR1
|
[NCBI]
|
4.42967e-05
|
|
|
RET
|
[NCBI]
|
4.42709e-05
|
|
|
SPG11
|
[NCBI]
|
4.42561e-05
|
|
|
MPZ
|
[NCBI]
|
4.41766e-05
|
|
|
DFNB7
|
[NCBI]
|
4.41184e-05
|
|
|
SPG13
|
[NCBI]
|
4.41184e-05
|
|
|
ARVD2
|
[NCBI]
|
4.41184e-05
|
|
|
CMD1E
|
[NCBI]
|
4.41184e-05
|
|
|
PVOD
|
[NCBI]
|
4.41184e-05
|
|
|
myopathy, centronuclear, autosomal dominant
|
[NCBI]
|
4.41184e-05
|
|
|
MM
|
[NCBI]
|
4.38272e-05
|
|
|
oca2 gene
|
[NCBI]
|
4.36677e-05
|
|
|
ORW2
|
[NCBI]
|
4.36614e-05
|
|
|
CD3G
|
[NCBI]
|
4.35179e-05
|
|
|
VAV1
|
[NCBI]
|
4.35179e-05
|
|
|
CCNB1
|
[NCBI]
|
4.35179e-05
|
|
|
HTR1B
|
[NCBI]
|
4.35179e-05
|
|
|
bartter syndrome, antenatal, type 1
|
[NCBI]
|
4.32627e-05
|
|
|
DI
|
[NCBI]
|
4.32627e-05
|
|
|
TGFBR2
|
[NCBI]
|
4.31678e-05
|
|
|
MSH6
|
[NCBI]
|
4.31678e-05
|
|
|
DYSF
|
[NCBI]
|
4.3151e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
4.30815e-05
|
|
|
pseudohyperkalemia, familial, 1, due to red cell leak
|
[NCBI]
|
4.28589e-05
|
|
|
blood group, p system
|
[NCBI]
|
4.28265e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
4.28265e-05
|
|
|
menkes disease
|
[NCBI]
|
4.27554e-05
|
|
|
monosomy 7 of bone marrow
|
[NCBI]
|
4.268996e-05
|
|
|
SMAD4
|
[NCBI]
|
4.26627e-05
|
|
|
EDM2
|
[NCBI]
|
4.25918e-05
|
|
|
vohwinkel syndrome, variant form
|
[NCBI]
|
4.25918e-05
|
|
|
RP7
|
[NCBI]
|
4.25918e-05
|
|
|
RTADR
|
[NCBI]
|
4.25918e-05
|
|
|
watson syndrome
|
[NCBI]
|
4.25918e-05
|
|
|
DFNB2
|
[NCBI]
|
4.25918e-05
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
4.25918e-05
|
|
|
HCHOLA3
|
[NCBI]
|
4.25918e-05
|
|
|
NAIC
|
[NCBI]
|
4.25918e-05
|
|
|
MRX54
|
[NCBI]
|
4.25918e-05
|
|
|
hypophosphatemic rickets, x-linked recessive
|
[NCBI]
|
4.25918e-05
|
|
|
TFE3
|
[NCBI]
|
4.25597e-05
|
|
|
OR13G1
|
[NCBI]
|
4.24799e-05
|
|
|
myeloid leukemia-related gene
|
[NCBI]
|
4.24799e-05
|
|
|
TM7SF2
|
[NCBI]
|
4.24799e-05
|
|
|
ATP6V1E
|
[NCBI]
|
4.24799e-05
|
|
|
ZNF79
|
[NCBI]
|
4.24799e-05
|
|
|
IL2
|
[NCBI]
|
4.24523e-05
|
|
|
IGHMBP2
|
[NCBI]
|
4.24515e-05
|
|
|
GOT2
|
[NCBI]
|
4.24515e-05
|
|
|
CXORF5
|
[NCBI]
|
4.24515e-05
|
|
|
IL1A
|
[NCBI]
|
4.22017e-05
|
|
|
HNF4A
|
[NCBI]
|
4.21335e-05
|
|
|
INSR
|
[NCBI]
|
4.18034e-05
|
|
|
MTRNR1
|
[NCBI]
|
4.17568e-05
|
|
|
EN2
|
[NCBI]
|
4.16764e-05
|
|
|
OFC1
|
[NCBI]
|
4.158752e-05
|
|
|
SUZ12
|
[NCBI]
|
4.14852e-05
|
|
|
MEG3
|
[NCBI]
|
4.14848e-05
|
|
|
HMS
|
[NCBI]
|
4.14282e-05
|
|
|
vater association
|
[NCBI]
|
4.14282e-05
|
|
|
SCA5
|
[NCBI]
|
4.14282e-05
|
|
|
AN1
|
[NCBI]
|
4.14282e-05
|
|
|
PFHB1A
|
[NCBI]
|
4.134768e-05
|
|
|
HLA-B
|
[NCBI]
|
4.12698e-05
|
|
|
HRPT1
|
[NCBI]
|
4.11766e-05
|
|
|
MYMY1
|
[NCBI]
|
4.10275e-05
|
|
|
CNC1
|
[NCBI]
|
4.09765e-05
|
|
|
MYO15A
|
[NCBI]
|
4.06086e-05
|
|
|
SEPT9
|
[NCBI]
|
4.05185e-05
|
|
|
MAOB
|
[NCBI]
|
4.04251e-05
|
|
|
HPS
|
[NCBI]
|
4.02233e-05
|
|
|
SAA1
|
[NCBI]
|
3.9955e-05
|
|
|
AHO
|
[NCBI]
|
3.97989e-05
|
|
|
alkaptonuria
|
[NCBI]
|
3.97432e-05
|
|
|
MATN3
|
[NCBI]
|
3.96419e-05
|
|
|
COL6A3
|
[NCBI]
|
3.96419e-05
|
|
|
SPN
|
[NCBI]
|
3.96419e-05
|
|
|
HHEX
|
[NCBI]
|
3.96419e-05
|
|
|
MSR1
|
[NCBI]
|
3.96352e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
3.94536e-05
|
|
|
IL8
|
[NCBI]
|
3.92576e-05
|
|
|
DFNB8
|
[NCBI]
|
3.92222e-05
|
|
|
CCM2
|
[NCBI]
|
3.92222e-05
|
|
|
RP17
|
[NCBI]
|
3.92222e-05
|
|
|
minicore myopathy with external ophthalmoplegia
|
[NCBI]
|
3.92222e-05
|
|
|
MCOPS2
|
[NCBI]
|
3.92208e-05
|
|
|
vitiligo
|
[NCBI]
|
3.92208e-05
|
|
|
char syndrome
|
[NCBI]
|
3.92208e-05
|
|
|
ear wax, wet/dry
|
[NCBI]
|
3.92208e-05
|
|
|
SMS
|
[NCBI]
|
3.919927e-05
|
|
|
CLN3
|
[NCBI]
|
3.90828e-05
|
|
|
PPH1
|
[NCBI]
|
3.88924e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii
|
[NCBI]
|
3.8865e-05
|
|
|
3-@methylglutaconic aciduria, type iii
|
[NCBI]
|
3.8865e-05
|
|
|
XRCC2
|
[NCBI]
|
3.87586e-05
|
|
|
C5R1
|
[NCBI]
|
3.87586e-05
|
|
|
MSX2
|
[NCBI]
|
3.87586e-05
|
|
|
NCF2
|
[NCBI]
|
3.87586e-05
|
|
|
FANCD2
|
[NCBI]
|
3.87586e-05
|
|
|
PIM1
|
[NCBI]
|
3.79572e-05
|
|
|
FYN
|
[NCBI]
|
3.79572e-05
|
|
|
HGD
|
[NCBI]
|
3.79572e-05
|
|
|
SHOX
|
[NCBI]
|
3.78264e-05
|
|
|
SLC26A4
|
[NCBI]
|
3.78235e-05
|
|
|
CTGF
|
[NCBI]
|
3.75091e-05
|
|
|
CLPED1
|
[NCBI]
|
3.73744e-05
|
|
|
INAD1
|
[NCBI]
|
3.73744e-05
|
|
|
emanuel syndrome
|
[NCBI]
|
3.73744e-05
|
|
|
CMT2D
|
[NCBI]
|
3.73744e-05
|
|
|
MCOLN1
|
[NCBI]
|
3.72196e-05
|
|
|
COL9A1
|
[NCBI]
|
3.72196e-05
|
|
|
SCN2A
|
[NCBI]
|
3.71449e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
3.69875e-05
|
|
|
GAPDH
|
[NCBI]
|
3.69031e-05
|
|
|
EDMD
|
[NCBI]
|
3.68413e-05
|
|
|
BMD
|
[NCBI]
|
3.66276e-05
|
|
|
FSGS1
|
[NCBI]
|
3.6532e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
3.6532e-05
|
|
|
ACO1
|
[NCBI]
|
3.64073e-05
|
|
|
BGN
|
[NCBI]
|
3.63378e-05
|
|
|
PEPD
|
[NCBI]
|
3.62936e-05
|
|
|
RECQL2
|
[NCBI]
|
3.62935e-05
|
|
|
ABO
|
[NCBI]
|
3.62935e-05
|
|
|
DMD
|
[NCBI]
|
3.59414e-05
|
|
|
SFTPC
|
[NCBI]
|
3.59027e-05
|
|
|
CMT4D
|
[NCBI]
|
3.580826e-05
|
|
|
DA1
|
[NCBI]
|
3.580826e-05
|
|
|
NYS1
|
[NCBI]
|
3.580826e-05
|
|
|
PFIC1
|
[NCBI]
|
3.57994e-05
|
|
|
JUP
|
[NCBI]
|
3.57249e-05
|
|
|
NEFH
|
[NCBI]
|
3.57249e-05
|
|
|
PF4
|
[NCBI]
|
3.56264e-05
|
|
|
DFNB10
|
[NCBI]
|
3.54954e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2b1
|
[NCBI]
|
3.54954e-05
|
|
|
LGMD2F
|
[NCBI]
|
3.54954e-05
|
|
|
DFNA4
|
[NCBI]
|
3.54954e-05
|
|
|
HDL1
|
[NCBI]
|
3.54954e-05
|
|
|
oguchi disease
|
[NCBI]
|
3.54954e-05
|
|
|
cataract, lamellar
|
[NCBI]
|
3.54954e-05
|
|
|
ACLS
|
[NCBI]
|
3.531163e-05
|
|
|
SPRR2B
|
[NCBI]
|
3.51141e-05
|
|
|
HIST1H3I
|
[NCBI]
|
3.51141e-05
|
|
|
FTSJ2
|
[NCBI]
|
3.51141e-05
|
|
|
LIPB
|
[NCBI]
|
3.51141e-05
|
|
|
HIST1H4I
|
[NCBI]
|
3.51141e-05
|
|
|
MRPS12
|
[NCBI]
|
3.51141e-05
|
|
|
HNRPF
|
[NCBI]
|
3.51141e-05
|
|
|
arkadia, mouse, homolog of
|
[NCBI]
|
3.51141e-05
|
|
|
PTPN23
|
[NCBI]
|
3.51141e-05
|
|
|
HIST1H2AL
|
[NCBI]
|
3.51141e-05
|
|
|
MTRF1
|
[NCBI]
|
3.51141e-05
|
|
|
TRP2
|
[NCBI]
|
3.51141e-05
|
|
|
POLQ
|
[NCBI]
|
3.51141e-05
|
|
|
pseudoautosomal gtp-binding protein-like
|
[NCBI]
|
3.51141e-05
|
|
|
RHBG
|
[NCBI]
|
3.51141e-05
|
|
|
LRCH1
|
[NCBI]
|
3.51141e-05
|
|
|
SMARCC2
|
[NCBI]
|
3.51141e-05
|
|
|
RAB5C
|
[NCBI]
|
3.51141e-05
|
|
|
respiratory rhythmicity in sleep
|
[NCBI]
|
3.51141e-05
|
|
|
HIST2H2AC
|
[NCBI]
|
3.51141e-05
|
|
|
DGKE
|
[NCBI]
|
3.51141e-05
|
|
|
ZNF195
|
[NCBI]
|
3.51141e-05
|
|
|
USP11
|
[NCBI]
|
3.51141e-05
|
|
|
TOR2A
|
[NCBI]
|
3.51141e-05
|
|
|
rgs16-interacting membrane protein
|
[NCBI]
|
3.51141e-05
|
|
|
MEX3C
|
[NCBI]
|
3.51141e-05
|
|
|
NEK6
|
[NCBI]
|
3.51141e-05
|
|
|
TRL1
|
[NCBI]
|
3.51141e-05
|
|
|
SERF1A
|
[NCBI]
|
3.51141e-05
|
|
|
STAC
|
[NCBI]
|
3.51141e-05
|
|
|
HIVEP1
|
[NCBI]
|
3.51141e-05
|
|
|
SMARCD2
|
[NCBI]
|
3.51141e-05
|
|
|
MASTL
|
[NCBI]
|
3.51141e-05
|
|
|
ZP1
|
[NCBI]
|
3.51141e-05
|
|
|
NOMO1
|
[NCBI]
|
3.51141e-05
|
|
|
SMARCD1
|
[NCBI]
|
3.51141e-05
|
|
|
NEURL
|
[NCBI]
|
3.51141e-05
|
|
|
MMP24
|
[NCBI]
|
3.51141e-05
|
|
|
TRT2
|
[NCBI]
|
3.51141e-05
|
|
|
ZC3H12D
|
[NCBI]
|
3.51141e-05
|
|
|
CAPZB
|
[NCBI]
|
3.51141e-05
|
|
|
NDUFA9
|
[NCBI]
|
3.51141e-05
|
|
|
NGFG
|
[NCBI]
|
3.51141e-05
|
|
|
HIST1H2AM
|
[NCBI]
|
3.51141e-05
|
|
|
HIST3H3
|
[NCBI]
|
3.51141e-05
|
|
|
GABRG1
|
[NCBI]
|
3.51141e-05
|
|
|
IFNB3
|
[NCBI]
|
3.51141e-05
|
|
|
HIST1H4J
|
[NCBI]
|
3.51141e-05
|
|
|
SMARCC1
|
[NCBI]
|
3.51141e-05
|
|
|
MTNR1B
|
[NCBI]
|
3.51141e-05
|
|
|
GSPT2
|
[NCBI]
|
3.51141e-05
|
|
|
OVOL1
|
[NCBI]
|
3.51141e-05
|
|
|
SPAG1
|
[NCBI]
|
3.51141e-05
|
|
|
ZNF214
|
[NCBI]
|
3.51141e-05
|
|
|
HNRPH2
|
[NCBI]
|
3.51141e-05
|
|
|
HYLS1
|
[NCBI]
|
3.51141e-05
|
|
|
progesterone-induced blocking factor 1
|
[NCBI]
|
3.51141e-05
|
|
|
TP250
|
[NCBI]
|
3.51141e-05
|
|
|
CRTAC1
|
[NCBI]
|
3.51141e-05
|
|
|
MYO3A
|
[NCBI]
|
3.51141e-05
|
|
|
CNTN3
|
[NCBI]
|
3.51141e-05
|
|
|
ORAOV1
|
[NCBI]
|
3.51141e-05
|
|
|
KIF25
|
[NCBI]
|
3.51141e-05
|
|
|
MMP23B
|
[NCBI]
|
3.51141e-05
|
|
|
KIAA0179
|
[NCBI]
|
3.51141e-05
|
|
|
OTOA
|
[NCBI]
|
3.51141e-05
|
|
|
FETUB
|
[NCBI]
|
3.51141e-05
|
|
|
HIST1H2BO
|
[NCBI]
|
3.51141e-05
|
|
|
NOMO2
|
[NCBI]
|
3.51141e-05
|
|
|
RRP1
|
[NCBI]
|
3.51141e-05
|
|
|
leucyl-trna synthetase, mitochondrial
|
[NCBI]
|
3.51141e-05
|
|
|
MRX49
|
[NCBI]
|
3.51141e-05
|
|
|
TWISTNB
|
[NCBI]
|
3.51141e-05
|
|
|
PMS2L1
|
[NCBI]
|
3.51141e-05
|
|
|
TBL2
|
[NCBI]
|
3.51141e-05
|
|
|
IER5
|
[NCBI]
|
3.51141e-05
|
|
|
MRRF
|
[NCBI]
|
3.51141e-05
|
|
|
ZNF215
|
[NCBI]
|
3.51141e-05
|
|
|
KCNQ1DN
|
[NCBI]
|
3.51141e-05
|
|
|
MMP23A
|
[NCBI]
|
3.51141e-05
|
|
|
dis3, s. pombe, homolog of
|
[NCBI]
|
3.51141e-05
|
|
|
TRP1
|
[NCBI]
|
3.51141e-05
|
|
|
RGS6
|
[NCBI]
|
3.51141e-05
|
|
|
PAPOLA
|
[NCBI]
|
3.51141e-05
|
|
|
LGALS4
|
[NCBI]
|
3.51141e-05
|
|
|
RARS1
|
[NCBI]
|
3.51141e-05
|
|
|
HIST1H4L
|
[NCBI]
|
3.51141e-05
|
|
|
TOR1B
|
[NCBI]
|
3.51141e-05
|
|
|
g6b protein
|
[NCBI]
|
3.51141e-05
|
|
|
GPR35
|
[NCBI]
|
3.51141e-05
|
|
|
AHCY
|
[NCBI]
|
3.50904e-05
|
|
|
BMPR2
|
[NCBI]
|
3.49739e-05
|
|
|
MYBPC3
|
[NCBI]
|
3.49739e-05
|
|
|
ENAM
|
[NCBI]
|
3.49739e-05
|
|
|
DURS1
|
[NCBI]
|
3.495842e-05
|
|
|
FY
|
[NCBI]
|
3.48328e-05
|
|
|
DRPLA
|
[NCBI]
|
3.47677e-05
|
|
|
alcohol dependence
|
[NCBI]
|
3.46685e-05
|
|
|
FRAXE
|
[NCBI]
|
3.4664e-05
|
|
|
GRN
|
[NCBI]
|
3.44984e-05
|
|
|
CD14
|
[NCBI]
|
3.44979e-05
|
|
|
IRID1
|
[NCBI]
|
3.446598e-05
|
|
|
GINGF
|
[NCBI]
|
3.446598e-05
|
|
|
SMAX1
|
[NCBI]
|
3.43762e-05
|
|
|
CMT4B1
|
[NCBI]
|
3.43246e-05
|
|
|
OPLL
|
[NCBI]
|
3.43246e-05
|
|
|
PRKCA
|
[NCBI]
|
3.42761e-05
|
|
|
CRYBB2
|
[NCBI]
|
3.42761e-05
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
3.42331e-05
|
|
|
fucosidosis
|
[NCBI]
|
3.41734e-05
|
|
|
COH1
|
[NCBI]
|
3.414596e-05
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
3.41191e-05
|
|
|
PLA2G7
|
[NCBI]
|
3.39427e-05
|
|
|
NIDDM
|
[NCBI]
|
3.39097e-05
|
|
|
PQBP1
|
[NCBI]
|
3.38626e-05
|
|
|
SPG3A
|
[NCBI]
|
3.36866e-05
|
|
|
SGCA
|
[NCBI]
|
3.36416e-05
|
|
|
ATF1
|
[NCBI]
|
3.36416e-05
|
|
|
PLA2G2A
|
[NCBI]
|
3.36416e-05
|
|
|
FST
|
[NCBI]
|
3.36416e-05
|
|
|
CRYBA1
|
[NCBI]
|
3.3625e-05
|
|
|
TINU
|
[NCBI]
|
3.35059e-05
|
|
|
PCCA
|
[NCBI]
|
3.34208e-05
|
|
|
CMH
|
[NCBI]
|
3.321769e-05
|
|
|
VIL2
|
[NCBI]
|
3.30491e-05
|
|
|
SLC45A2
|
[NCBI]
|
3.29905e-05
|
|
|
ABCA4
|
[NCBI]
|
3.28313e-05
|
|
|
ESR1
|
[NCBI]
|
3.28156e-05
|
|
|
ichthyosis, bullous type
|
[NCBI]
|
3.28052e-05
|
|
|
DSS
|
[NCBI]
|
3.28052e-05
|
|
|
SPMM
|
[NCBI]
|
3.28052e-05
|
|
|
thyroxine-binding globulin of serum
|
[NCBI]
|
3.25412e-05
|
|
|
HMN2A
|
[NCBI]
|
3.24782e-05
|
|
|
MB
|
[NCBI]
|
3.24335e-05
|
|
|
MEF2A
|
[NCBI]
|
3.2398e-05
|
|
|
GNB3
|
[NCBI]
|
3.2398e-05
|
|
|
C5
|
[NCBI]
|
3.23808e-05
|
|
|
DARS2
|
[NCBI]
|
3.23698e-05
|
|
|
NDUFA10
|
[NCBI]
|
3.23698e-05
|
|
|
OAS3
|
[NCBI]
|
3.23698e-05
|
|
|
SPP1
|
[NCBI]
|
3.23258e-05
|
|
|
BCNS
|
[NCBI]
|
3.231587e-05
|
|
|
ATP6V0C
|
[NCBI]
|
3.20723e-05
|
|
|
C11ORF5
|
[NCBI]
|
3.20723e-05
|
|
|
SEA
|
[NCBI]
|
3.20723e-05
|
|
|
HOXB1
|
[NCBI]
|
3.20723e-05
|
|
|
deleted in endometrial carcinoma
|
[NCBI]
|
3.20723e-05
|
|
|
CPSF2
|
[NCBI]
|
3.20723e-05
|
|
|
LCA5
|
[NCBI]
|
3.20723e-05
|
|
|
MHA
|
[NCBI]
|
3.188e-05
|
|
|
GCG
|
[NCBI]
|
3.18428e-05
|
|
|
GJA3
|
[NCBI]
|
3.17883e-05
|
|
|
JK
|
[NCBI]
|
3.17883e-05
|
|
|
FMR1
|
[NCBI]
|
3.15096e-05
|
|
|
ABCC8
|
[NCBI]
|
3.14362e-05
|
|
|
alzheimer disease 8
|
[NCBI]
|
3.14231e-05
|
|
|
CGB
|
[NCBI]
|
3.12331e-05
|
|
|
SPG7
|
[NCBI]
|
3.12331e-05
|
|
|
ENO1
|
[NCBI]
|
3.12156e-05
|
|
|
IL9
|
[NCBI]
|
3.12156e-05
|
|
|
GUCY2D
|
[NCBI]
|
3.12156e-05
|
|
|
schwannomatosis
|
[NCBI]
|
3.091206e-05
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
3.091206e-05
|
|
|
mucolipidosis iv
|
[NCBI]
|
3.07938e-05
|
|
|
HBZ
|
[NCBI]
|
3.07112e-05
|
|
|
NEFL
|
[NCBI]
|
3.07112e-05
|
|
|
FOXC1
|
[NCBI]
|
3.07112e-05
|
|
|
L1CAM
|
[NCBI]
|
3.06099e-05
|
|
|
chondrodysplasia, grebe type
|
[NCBI]
|
3.05978e-05
|
|
|
IBM3
|
[NCBI]
|
3.05978e-05
|
|
|
mal de meleda
|
[NCBI]
|
3.05978e-05
|
|
|
MRX9
|
[NCBI]
|
3.05978e-05
|
|
|
PGM3
|
[NCBI]
|
3.01385e-05
|
|
|
PTPN22
|
[NCBI]
|
3.01385e-05
|
|
|
PBC
|
[NCBI]
|
3.01363e-05
|
|
|
DMBT1
|
[NCBI]
|
3.01207e-05
|
|
|
MNG1
|
[NCBI]
|
3.0054134e-05
|
|
|
CLN6
|
[NCBI]
|
2.9851e-05
|
|
|
STHAG3
|
[NCBI]
|
2.9851e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
2.9851e-05
|
|
|
NEM2
|
[NCBI]
|
2.9851e-05
|
|
|
FHL2
|
[NCBI]
|
2.9851e-05
|
|
|
XRN
|
[NCBI]
|
2.9851e-05
|
|
|
SQT1
|
[NCBI]
|
2.9851e-05
|
|
|
RMD
|
[NCBI]
|
2.98387e-05
|
|
|
IFNG
|
[NCBI]
|
2.97781e-05
|
|
|
gastroesophageal reflux
|
[NCBI]
|
2.95917e-05
|
|
|
VUR1
|
[NCBI]
|
2.957419e-05
|
|
|
KSS
|
[NCBI]
|
2.94535e-05
|
|
|
ARHGEF10
|
[NCBI]
|
2.9328e-05
|
|
|
STOX1
|
[NCBI]
|
2.9328e-05
|
|
|
SCN3A
|
[NCBI]
|
2.9328e-05
|
|
|
PTPRH
|
[NCBI]
|
2.9328e-05
|
|
|
ZNF21
|
[NCBI]
|
2.9328e-05
|
|
|
STX5A
|
[NCBI]
|
2.9328e-05
|
|
|
lymphocyte cytosol polypeptide, 20-kd
|
[NCBI]
|
2.9328e-05
|
|
|
CHST5
|
[NCBI]
|
2.9328e-05
|
|
|
DDX4
|
[NCBI]
|
2.9328e-05
|
|
|
SHROOM2
|
[NCBI]
|
2.9328e-05
|
|
|
CCNF
|
[NCBI]
|
2.9328e-05
|
|
|
REQ
|
[NCBI]
|
2.9328e-05
|
|
|
MDFI
|
[NCBI]
|
2.9328e-05
|
|
|
GUCY1B2
|
[NCBI]
|
2.9328e-05
|
|
|
HIST1H3E
|
[NCBI]
|
2.9328e-05
|
|
|
DNAJB6
|
[NCBI]
|
2.9328e-05
|
|
|
selenophosphate synthetase 2
|
[NCBI]
|
2.9328e-05
|
|
|
CDH16
|
[NCBI]
|
2.9328e-05
|
|
|
DNASE1L2
|
[NCBI]
|
2.9328e-05
|
|
|
LYL1
|
[NCBI]
|
2.9328e-05
|
|
|
RRH
|
[NCBI]
|
2.9328e-05
|
|
|
CER1
|
[NCBI]
|
2.9328e-05
|
|
|
AMBN
|
[NCBI]
|
2.9328e-05
|
|
|
MYH4
|
[NCBI]
|
2.9328e-05
|
|
|
TPBG
|
[NCBI]
|
2.9328e-05
|
|
|
MN1
|
[NCBI]
|
2.9328e-05
|
|
|
MFAP2
|
[NCBI]
|
2.9328e-05
|
|
|
LHFPL5
|
[NCBI]
|
2.9328e-05
|
|
|
protein inhibitor of activated stat3
|
[NCBI]
|
2.9328e-05
|
|
|
TSSC4
|
[NCBI]
|
2.9328e-05
|
|
|
INA
|
[NCBI]
|
2.9328e-05
|
|
|
GPR65
|
[NCBI]
|
2.9328e-05
|
|
|
GUCY2C
|
[NCBI]
|
2.9328e-05
|
|
|
RGS13
|
[NCBI]
|
2.9328e-05
|
|
|
SYN3
|
[NCBI]
|
2.9328e-05
|
|
|
PYGB
|
[NCBI]
|
2.9328e-05
|
|
|
ZNF239
|
[NCBI]
|
2.9328e-05
|
|
|
AADAC
|
[NCBI]
|
2.9328e-05
|
|
|
HIST1H2BD
|
[NCBI]
|
2.9328e-05
|
|
|
GRM8
|
[NCBI]
|
2.9328e-05
|
|
|
ZNF169
|
[NCBI]
|
2.9328e-05
|
|
|
CHL1
|
[NCBI]
|
2.9328e-05
|
|
|
STATH
|
[NCBI]
|
2.9328e-05
|
|
|
CHAF1B
|
[NCBI]
|
2.9328e-05
|
|
|
GNAIH
|
[NCBI]
|
2.9328e-05
|
|
|
SUCLA2
|
[NCBI]
|
2.9328e-05
|
|
|
ASCC3L1
|
[NCBI]
|
2.9328e-05
|
|
|
ATP6V0A4
|
[NCBI]
|
2.9328e-05
|
|
|
SULT4A1
|
[NCBI]
|
2.9328e-05
|
|
|
SNRPA
|
[NCBI]
|
2.9328e-05
|
|
|
CPSF1
|
[NCBI]
|
2.9328e-05
|
|
|
B3GAT2
|
[NCBI]
|
2.9328e-05
|
|
|
OTOG
|
[NCBI]
|
2.9328e-05
|
|
|
PBX3
|
[NCBI]
|
2.9328e-05
|
|
|
LIMD1
|
[NCBI]
|
2.9328e-05
|
|
|
DPH1
|
[NCBI]
|
2.9328e-05
|
|
|
ATP1AL1
|
[NCBI]
|
2.9328e-05
|
|
|
P2RX5
|
[NCBI]
|
2.9328e-05
|
|
|
GCNT1
|
[NCBI]
|
2.9328e-05
|
|
|
HIST1H2BB
|
[NCBI]
|
2.9328e-05
|
|
|
SMARCD3
|
[NCBI]
|
2.9328e-05
|
|
|
CYP2F1
|
[NCBI]
|
2.9328e-05
|
|
|
HMG20B
|
[NCBI]
|
2.9328e-05
|
|
|
HIST1H2AB
|
[NCBI]
|
2.9328e-05
|
|
|
CD33
|
[NCBI]
|
2.9328e-05
|
|
|
FXYD3
|
[NCBI]
|
2.9328e-05
|
|
|
TULP3
|
[NCBI]
|
2.9328e-05
|
|
|
BICD1
|
[NCBI]
|
2.9328e-05
|
|
|
SPRR1B
|
[NCBI]
|
2.9328e-05
|
|
|
HIST1H3B
|
[NCBI]
|
2.9328e-05
|
|
|
RBM10
|
[NCBI]
|
2.9328e-05
|
|
|
HIST1H2AE
|
[NCBI]
|
2.9328e-05
|
|
|
EDG6
|
[NCBI]
|
2.9328e-05
|
|
|
CACNG1
|
[NCBI]
|
2.9328e-05
|
|
|
MUC3B
|
[NCBI]
|
2.9328e-05
|
|
|
MDGA1
|
[NCBI]
|
2.9328e-05
|
|
|
NAP1L1
|
[NCBI]
|
2.9328e-05
|
|
|
androgen-induced prostate proliferative shutoff-associated protein
|
[NCBI]
|
2.9328e-05
|
|
|
SARM1
|
[NCBI]
|
2.9328e-05
|
|
|
SMTN
|
[NCBI]
|
2.9328e-05
|
|
|
CSN1
|
[NCBI]
|
2.9328e-05
|
|
|
BEX2
|
[NCBI]
|
2.9328e-05
|
|
|
PDCD10
|
[NCBI]
|
2.9328e-05
|
|
|
ESA4
|
[NCBI]
|
2.9328e-05
|
|
|
MIRN27B
|
[NCBI]
|
2.9328e-05
|
|
|
GABRG3
|
[NCBI]
|
2.9328e-05
|
|
|
TIMM8B
|
[NCBI]
|
2.9328e-05
|
|
|
SPRR2A
|
[NCBI]
|
2.9328e-05
|
|
|
FOXA3
|
[NCBI]
|
2.9328e-05
|
|
|
HIST1H2BG
|
[NCBI]
|
2.9328e-05
|
|
|
GBA
|
[NCBI]
|
2.93113e-05
|
|
|
neural tube defects
|
[NCBI]
|
2.91513e-05
|
|
|
POF1
|
[NCBI]
|
2.91513e-05
|
|
|
MYB
|
[NCBI]
|
2.91281e-05
|
|
|
SFTPB
|
[NCBI]
|
2.91066e-05
|
|
|
NEB
|
[NCBI]
|
2.91066e-05
|
|
|
orotic aciduria i
|
[NCBI]
|
2.91052e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
2.898866e-05
|
|
|
CMT4B2
|
[NCBI]
|
2.87514e-05
|
|
|
SYM1
|
[NCBI]
|
2.87514e-05
|
|
|
NPHP3
|
[NCBI]
|
2.87514e-05
|
|
|
BL
|
[NCBI]
|
2.87474e-05
|
|
|
PRDM16
|
[NCBI]
|
2.86899e-05
|
|
|
GALK1
|
[NCBI]
|
2.86412e-05
|
|
|
HHT
|
[NCBI]
|
2.84898e-05
|
|
|
ABCC1
|
[NCBI]
|
2.84854e-05
|
|
|
CRMO
|
[NCBI]
|
2.84748e-05
|
|
|
HOKPP
|
[NCBI]
|
2.84748e-05
|
|
|
DFNB1
|
[NCBI]
|
2.83948e-05
|
|
|
GIP
|
[NCBI]
|
2.83466e-05
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
2.83416e-05
|
|
|
COL1A2
|
[NCBI]
|
2.81544e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
2.81544e-05
|
|
|
RXRA
|
[NCBI]
|
2.81314e-05
|
|
|
PYGM
|
[NCBI]
|
2.81314e-05
|
|
|
CLCN5
|
[NCBI]
|
2.81314e-05
|
|
|
MTAP
|
[NCBI]
|
2.81255e-05
|
|
|
FCMD
|
[NCBI]
|
2.790149e-05
|
|
|
LCT
|
[NCBI]
|
2.78723e-05
|
|
|
AGT
|
[NCBI]
|
2.78176e-05
|
|
|
CHRNA1
|
[NCBI]
|
2.76905e-05
|
|
|
TCOF1
|
[NCBI]
|
2.76559e-05
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
2.76436e-05
|
|
|
ODG2
|
[NCBI]
|
2.76436e-05
|
|
|
MOBP
|
[NCBI]
|
2.7566e-05
|
|
|
TMEM67
|
[NCBI]
|
2.7566e-05
|
|
|
CD48
|
[NCBI]
|
2.7566e-05
|
|
|
FXN
|
[NCBI]
|
2.75601e-05
|
|
|
deafness, congenital, with keratopachydermia and constrictions of fingers and toes
|
[NCBI]
|
2.74461e-05
|
|
|
ITGA9
|
[NCBI]
|
2.73776e-05
|
|
|
TBX18
|
[NCBI]
|
2.73776e-05
|
|
|
FIGN
|
[NCBI]
|
2.73776e-05
|
|
|
FAU
|
[NCBI]
|
2.73776e-05
|
|
|
DPP6
|
[NCBI]
|
2.73776e-05
|
|
|
ST5
|
[NCBI]
|
2.73776e-05
|
|
|
GRID1
|
[NCBI]
|
2.73776e-05
|
|
|
DCC
|
[NCBI]
|
2.73492e-05
|
|
|
DSP
|
[NCBI]
|
2.72717e-05
|
|
|
hypoparathyroidism, sensorineural deafness, and renal disease
|
[NCBI]
|
2.718526e-05
|
|
|
epstein syndrome
|
[NCBI]
|
2.718526e-05
|
|
|
AN2
|
[NCBI]
|
2.680829e-05
|
|
|
CDSN
|
[NCBI]
|
2.6755e-05
|
|
|
WFS1
|
[NCBI]
|
2.67496e-05
|
|
|
GCK
|
[NCBI]
|
2.67e-05
|
|
|
GATA3
|
[NCBI]
|
2.63308e-05
|
|
|
IRF1
|
[NCBI]
|
2.63141e-05
|
|
|
MFN2
|
[NCBI]
|
2.63141e-05
|
|
|
RHO
|
[NCBI]
|
2.62901e-05
|
|
|
phenylketonuria ii
|
[NCBI]
|
2.59619e-05
|
|
|
CTSB
|
[NCBI]
|
2.59324e-05
|
|
|
PLAT
|
[NCBI]
|
2.59324e-05
|
|
|
TK1
|
[NCBI]
|
2.58953e-05
|
|
|
SLSN1
|
[NCBI]
|
2.584298e-05
|
|
|
BDC
|
[NCBI]
|
2.584298e-05
|
|
|
osteogenic sarcoma
|
[NCBI]
|
2.57972e-05
|
|
|
CRS1
|
[NCBI]
|
2.575776e-05
|
|
|
PPP5C
|
[NCBI]
|
2.56156e-05
|
|
|
TLE3
|
[NCBI]
|
2.56156e-05
|
|
|
AOC2
|
[NCBI]
|
2.56156e-05
|
|
|
SPTBN2
|
[NCBI]
|
2.56156e-05
|
|
|
TAL2
|
[NCBI]
|
2.56156e-05
|
|
|
LIPH
|
[NCBI]
|
2.56156e-05
|
|
|
MYBBP1A
|
[NCBI]
|
2.56156e-05
|
|
|
NONO
|
[NCBI]
|
2.56156e-05
|
|
|
PSMC1
|
[NCBI]
|
2.56156e-05
|
|
|
SLC5A3
|
[NCBI]
|
2.56156e-05
|
|
|
TRSP
|
[NCBI]
|
2.56156e-05
|
|
|
NBR1
|
[NCBI]
|
2.56156e-05
|
|
|
SOX21
|
[NCBI]
|
2.56156e-05
|
|
|
NT5E
|
[NCBI]
|
2.56156e-05
|
|
|
SOSTDC1
|
[NCBI]
|
2.56156e-05
|
|
|
ZNF35
|
[NCBI]
|
2.56156e-05
|
|
|
antigen defined by monoclonal antibody f10.44.2
|
[NCBI]
|
2.56156e-05
|
|
|
FGL2
|
[NCBI]
|
2.56156e-05
|
|
|
CACNB1
|
[NCBI]
|
2.56156e-05
|
|
|
PRPF8
|
[NCBI]
|
2.56156e-05
|
|
|
PLCD1
|
[NCBI]
|
2.56156e-05
|
|
|
GRINA
|
[NCBI]
|
2.56156e-05
|
|
|
LRP1B
|
[NCBI]
|
2.56156e-05
|
|
|
PFN2
|
[NCBI]
|
2.56156e-05
|
|
|
MINPP1
|
[NCBI]
|
2.56156e-05
|
|
|
EXTL1
|
[NCBI]
|
2.56156e-05
|
|
|
ANGPTL2
|
[NCBI]
|
2.56156e-05
|
|
|
ZNF185
|
[NCBI]
|
2.56156e-05
|
|
|
SSTR4
|
[NCBI]
|
2.56156e-05
|
|
|
PSME3
|
[NCBI]
|
2.56156e-05
|
|
|
CTNNA3
|
[NCBI]
|
2.56156e-05
|
|
|
PRY
|
[NCBI]
|
2.56156e-05
|
|
|
IK
|
[NCBI]
|
2.56156e-05
|
|
|
CIAPIN1
|
[NCBI]
|
2.56156e-05
|
|
|
PALM
|
[NCBI]
|
2.56156e-05
|
|
|
KCNK6
|
[NCBI]
|
2.56156e-05
|
|
|
C1QTNF5
|
[NCBI]
|
2.56156e-05
|
|
|
PLEKHG4
|
[NCBI]
|
2.56156e-05
|
|
|
CHGB
|
[NCBI]
|
2.56156e-05
|
|
|
KLF12
|
[NCBI]
|
2.56156e-05
|
|
|
COX6A1
|
[NCBI]
|
2.56156e-05
|
|
|
TNNI1
|
[NCBI]
|
2.56156e-05
|
|
|
FEZF2
|
[NCBI]
|
2.56156e-05
|
|
|
TCAP
|
[NCBI]
|
2.56156e-05
|
|
|
MYL1
|
[NCBI]
|
2.56156e-05
|
|
|
HSPCB
|
[NCBI]
|
2.56156e-05
|
|
|
AFM
|
[NCBI]
|
2.56156e-05
|
|
|
CRADD
|
[NCBI]
|
2.56156e-05
|
|
|
SOX1
|
[NCBI]
|
2.56156e-05
|
|
|
RP9
|
[NCBI]
|
2.56156e-05
|
|
|
STRA6
|
[NCBI]
|
2.56156e-05
|
|
|
LRMP
|
[NCBI]
|
2.56156e-05
|
|
|
MYOM2
|
[NCBI]
|
2.56156e-05
|
|
|
NEF3
|
[NCBI]
|
2.56156e-05
|
|
|
PCM1
|
[NCBI]
|
2.56156e-05
|
|
|
TRPM6
|
[NCBI]
|
2.56156e-05
|
|
|
UTY
|
[NCBI]
|
2.56156e-05
|
|
|
CH25H
|
[NCBI]
|
2.56156e-05
|
|
|
PRKCI
|
[NCBI]
|
2.56156e-05
|
|
|
MAGEB2
|
[NCBI]
|
2.56156e-05
|
|
|
RPL28
|
[NCBI]
|
2.56156e-05
|
|
|
RPL12
|
[NCBI]
|
2.56156e-05
|
|
|
INPP1
|
[NCBI]
|
2.56156e-05
|
|
|
PTPRJ
|
[NCBI]
|
2.56156e-05
|
|
|
ATP1B2
|
[NCBI]
|
2.56156e-05
|
|
|
RNU3
|
[NCBI]
|
2.56156e-05
|
|
|
GABRB1
|
[NCBI]
|
2.56156e-05
|
|
|
XPR1
|
[NCBI]
|
2.56156e-05
|
|
|
EMD
|
[NCBI]
|
2.54969e-05
|
|
|
COL4A1
|
[NCBI]
|
2.54969e-05
|
|
|
SANDO
|
[NCBI]
|
2.52387e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
2.50068e-05
|
|
|
PI
|
[NCBI]
|
2.50029e-05
|
|
|
SAI1
|
[NCBI]
|
2.48189e-05
|
|
|
HK1
|
[NCBI]
|
2.47023e-05
|
|
|
CDKN1C
|
[NCBI]
|
2.46864e-05
|
|
|
ALUNC
|
[NCBI]
|
2.468368e-05
|
|
|
CMT2B
|
[NCBI]
|
2.468368e-05
|
|
|
CDH1
|
[NCBI]
|
2.44381e-05
|
|
|
A2M
|
[NCBI]
|
2.43228e-05
|
|
|
PLCG2
|
[NCBI]
|
2.43202e-05
|
|
|
VIPR2
|
[NCBI]
|
2.43202e-05
|
|
|
OAS2
|
[NCBI]
|
2.43202e-05
|
|
|
SLC12A1
|
[NCBI]
|
2.43202e-05
|
|
|
SOX18
|
[NCBI]
|
2.43202e-05
|
|
|
HSPE1
|
[NCBI]
|
2.43202e-05
|
|
|
PSMB10
|
[NCBI]
|
2.43202e-05
|
|
|
FGF4
|
[NCBI]
|
2.43066e-05
|
|
|
CDB1
|
[NCBI]
|
2.423106e-05
|
|
|
CZP1
|
[NCBI]
|
2.423106e-05
|
|
|
ankyloblepharon-ectodermal defects-cleft lip/palate
|
[NCBI]
|
2.423106e-05
|
|
|
ACE
|
[NCBI]
|
2.42148e-05
|
|
|
ABCC11
|
[NCBI]
|
2.41836e-05
|
|
|
DCDC2
|
[NCBI]
|
2.41836e-05
|
|
|
DBC1
|
[NCBI]
|
2.41836e-05
|
|
|
PTPN2
|
[NCBI]
|
2.41836e-05
|
|
|
MCC
|
[NCBI]
|
2.41836e-05
|
|
|
KCNC3
|
[NCBI]
|
2.41836e-05
|
|
|
CD63
|
[NCBI]
|
2.41836e-05
|
|
|
SENP2
|
[NCBI]
|
2.41836e-05
|
|
|
ELA1
|
[NCBI]
|
2.41836e-05
|
|
|
MARK2
|
[NCBI]
|
2.41836e-05
|
|
|
PXE
|
[NCBI]
|
2.40634e-05
|
|
|
FGFR4
|
[NCBI]
|
2.39929e-05
|
|
|
GLO1
|
[NCBI]
|
2.3944e-05
|
|
|
GALC
|
[NCBI]
|
2.3944e-05
|
|
|
chromosome 18q deletion syndrome
|
[NCBI]
|
2.367674e-05
|
|
|
ACCPN
|
[NCBI]
|
2.367674e-05
|
|
|
crouzon syndrome
|
[NCBI]
|
2.367674e-05
|
|
|
XPC
|
[NCBI]
|
2.36661e-05
|
|
|
PAX2
|
[NCBI]
|
2.35972e-05
|
|
|
PAX3
|
[NCBI]
|
2.359283e-05
|
|
|
IL4R
|
[NCBI]
|
2.35659e-05
|
|
|
CRYAB
|
[NCBI]
|
2.35659e-05
|
|
|
LDHA
|
[NCBI]
|
2.34518e-05
|
|
|
elliptocytosis, rhesus-unlinked type
|
[NCBI]
|
2.33923e-05
|
|
|
FTC
|
[NCBI]
|
2.33923e-05
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
2.33056e-05
|
|
|
SC
|
[NCBI]
|
2.32445e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
2.32445e-05
|
|
|
CTSK
|
[NCBI]
|
2.32191e-05
|
|
|
GJA8
|
[NCBI]
|
2.32041e-05
|
|
|
DGI1
|
[NCBI]
|
2.288878e-05
|
|
|
CMT2A2
|
[NCBI]
|
2.288878e-05
|
|
|
BDA1
|
[NCBI]
|
2.288878e-05
|
|
|
WS3
|
[NCBI]
|
2.288878e-05
|
|
|
CEBPD
|
[NCBI]
|
2.28882e-05
|
|
|
PPIF
|
[NCBI]
|
2.28882e-05
|
|
|
CA9
|
[NCBI]
|
2.28882e-05
|
|
|
TSPAN32
|
[NCBI]
|
2.28882e-05
|
|
|
SLC25A19
|
[NCBI]
|
2.28882e-05
|
|
|
BEX1
|
[NCBI]
|
2.28882e-05
|
|
|
GRM2
|
[NCBI]
|
2.28882e-05
|
|
|
MAP3K13
|
[NCBI]
|
2.28882e-05
|
|
|
FANCF
|
[NCBI]
|
2.28882e-05
|
|
|
GLMN
|
[NCBI]
|
2.28882e-05
|
|
|
FGF13
|
[NCBI]
|
2.28882e-05
|
|
|
JARID1A
|
[NCBI]
|
2.28882e-05
|
|
|
SQLE
|
[NCBI]
|
2.28882e-05
|
|
|
NBEA
|
[NCBI]
|
2.28882e-05
|
|
|
RCN2
|
[NCBI]
|
2.28882e-05
|
|
|
TAAR5
|
[NCBI]
|
2.28882e-05
|
|
|
CSMD1
|
[NCBI]
|
2.28882e-05
|
|
|
ACLY
|
[NCBI]
|
2.28882e-05
|
|
|
ABCA12
|
[NCBI]
|
2.28882e-05
|
|
|
ACTR1A
|
[NCBI]
|
2.28882e-05
|
|
|
SAA4
|
[NCBI]
|
2.28882e-05
|
|
|
MCAM
|
[NCBI]
|
2.28882e-05
|
|
|
EPIM
|
[NCBI]
|
2.28882e-05
|
|
|
CPA4
|
[NCBI]
|
2.28882e-05
|
|
|
MX1
|
[NCBI]
|
2.28882e-05
|
|
|
homeobox protein, pepp subfamily, 2
|
[NCBI]
|
2.28882e-05
|
|
|
TJP2
|
[NCBI]
|
2.28882e-05
|
|
|
MASP2
|
[NCBI]
|
2.28882e-05
|
|
|
MEF2D
|
[NCBI]
|
2.28882e-05
|
|
|
IRAK3
|
[NCBI]
|
2.28882e-05
|
|
|
RAP1GDS1
|
[NCBI]
|
2.28882e-05
|
|
|
HRC
|
[NCBI]
|
2.28882e-05
|
|
|
RPL9
|
[NCBI]
|
2.28882e-05
|
|
|
FXYD2
|
[NCBI]
|
2.28882e-05
|
|
|
TNFRSF7
|
[NCBI]
|
2.28882e-05
|
|
|
NBL1
|
[NCBI]
|
2.28882e-05
|
|
|
BCAT2
|
[NCBI]
|
2.28882e-05
|
|
|
SPRR1A
|
[NCBI]
|
2.28882e-05
|
|
|
AK2
|
[NCBI]
|
2.28882e-05
|
|
|
DPAGT1
|
[NCBI]
|
2.28882e-05
|
|
|
PPP1R11
|
[NCBI]
|
2.28882e-05
|
|
|
ATG16L1
|
[NCBI]
|
2.28882e-05
|
|
|
ABCD3
|
[NCBI]
|
2.28882e-05
|
|
|
EDARADD
|
[NCBI]
|
2.28882e-05
|
|
|
KCNB1
|
[NCBI]
|
2.28882e-05
|
|
|
PIP5K1B
|
[NCBI]
|
2.28882e-05
|
|
|
GRM4
|
[NCBI]
|
2.28882e-05
|
|
|
HIST1H4F
|
[NCBI]
|
2.28882e-05
|
|
|
HMGN1
|
[NCBI]
|
2.28882e-05
|
|
|
MNAT1
|
[NCBI]
|
2.28882e-05
|
|
|
CAV2
|
[NCBI]
|
2.28882e-05
|
|
|
NINJ1
|
[NCBI]
|
2.28882e-05
|
|
|
JUND
|
[NCBI]
|
2.28882e-05
|
|
|
THRA
|
[NCBI]
|
2.28576e-05
|
|
|
paget disease, juvenile
|
[NCBI]
|
2.279354e-05
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
2.265045e-05
|
|
|
POLR2A
|
[NCBI]
|
2.25253e-05
|
|
|
TNNT2
|
[NCBI]
|
2.25253e-05
|
|
|
MUT
|
[NCBI]
|
2.25253e-05
|
|
|
AR
|
[NCBI]
|
2.225757e-05
|
|
|
CEACAM1
|
[NCBI]
|
2.19698e-05
|
|
|
POLRMT
|
[NCBI]
|
2.18676e-05
|
|
|
CA6
|
[NCBI]
|
2.18676e-05
|
|
|
HSPA6
|
[NCBI]
|
2.18676e-05
|
|
|
SLC25A12
|
[NCBI]
|
2.18676e-05
|
|
|
CLN6
|
[NCBI]
|
2.18676e-05
|
|
|
INSRR
|
[NCBI]
|
2.18676e-05
|
|
|
FBP1
|
[NCBI]
|
2.18676e-05
|
|
|
LFNG
|
[NCBI]
|
2.18605e-05
|
|
|
alzheimer disease 4
|
[NCBI]
|
2.182616e-05
|
|
|
CSNB2A
|
[NCBI]
|
2.182616e-05
|
|
|
DFNA2
|
[NCBI]
|
2.182616e-05
|
|
|
PCDH8
|
[NCBI]
|
2.17615e-05
|
|
|
GPC5
|
[NCBI]
|
2.17615e-05
|
|
|
MLH3
|
[NCBI]
|
2.17615e-05
|
|
|
NIPA1
|
[NCBI]
|
2.17615e-05
|
|
|
SH2B3
|
[NCBI]
|
2.17615e-05
|
|
|
S100A6
|
[NCBI]
|
2.17615e-05
|
|
|
MIC2Y
|
[NCBI]
|
2.17615e-05
|
|
|
g72 gene
|
[NCBI]
|
2.17615e-05
|
|
|
CHS
|
[NCBI]
|
2.173147e-05
|
|
|
SFD
|
[NCBI]
|
2.172948e-05
|
|
|
XPF
|
[NCBI]
|
2.172948e-05
|
|
|
LGMD2H
|
[NCBI]
|
2.172948e-05
|
|
|
C1NH
|
[NCBI]
|
2.15549e-05
|
|
|
SLC25A4
|
[NCBI]
|
2.15549e-05
|
|
|
CALCA
|
[NCBI]
|
2.15549e-05
|
|
|
IDE
|
[NCBI]
|
2.150426e-05
|
|
|
DMC
|
[NCBI]
|
2.13981e-05
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
2.13981e-05
|
|
|
NPC1
|
[NCBI]
|
2.12091e-05
|
|
|
EMILIN1
|
[NCBI]
|
2.102862e-05
|
|
|
FOXI1
|
[NCBI]
|
2.102862e-05
|
|
|
SLC7A8
|
[NCBI]
|
2.102862e-05
|
|
|
PITX2
|
[NCBI]
|
2.097871e-05
|
|
|
NOS2A
|
[NCBI]
|
2.09289e-05
|
|
|
CAPN1
|
[NCBI]
|
2.083646e-05
|
|
|
NHS
|
[NCBI]
|
2.083646e-05
|
|
|
MEOX1
|
[NCBI]
|
2.083646e-05
|
|
|
DIAPH2
|
[NCBI]
|
2.083646e-05
|
|
|
WNT2
|
[NCBI]
|
2.083646e-05
|
|
|
SPCH1
|
[NCBI]
|
2.077051e-05
|
|
|
CDC2L2
|
[NCBI]
|
2.07409e-05
|
|
|
C1QBP
|
[NCBI]
|
2.07409e-05
|
|
|
HSN2
|
[NCBI]
|
2.07409e-05
|
|
|
MAD1L1
|
[NCBI]
|
2.07409e-05
|
|
|
SYN2
|
[NCBI]
|
2.07409e-05
|
|
|
SOAT2
|
[NCBI]
|
2.07409e-05
|
|
|
TUBAL1
|
[NCBI]
|
2.07409e-05
|
|
|
GABRA2
|
[NCBI]
|
2.07409e-05
|
|
|
SYT3
|
[NCBI]
|
2.07409e-05
|
|
|
CHE2
|
[NCBI]
|
2.07409e-05
|
|
|
DNAH9
|
[NCBI]
|
2.07409e-05
|
|
|
NUP214
|
[NCBI]
|
2.07409e-05
|
|
|
SLC7A1
|
[NCBI]
|
2.07409e-05
|
|
|
HTR7
|
[NCBI]
|
2.07409e-05
|
|
|
ENO2
|
[NCBI]
|
2.07409e-05
|
|
|
DLX3
|
[NCBI]
|
2.07409e-05
|
|
|
SLC22A7
|
[NCBI]
|
2.07409e-05
|
|
|
ATOX1
|
[NCBI]
|
2.07409e-05
|
|
|
ATP1B1
|
[NCBI]
|
2.07409e-05
|
|
|
ATP1A3
|
[NCBI]
|
2.07409e-05
|
|
|
bsnd gene
|
[NCBI]
|
2.07409e-05
|
|
|
LALBA
|
[NCBI]
|
2.07409e-05
|
|
|
DLG5
|
[NCBI]
|
2.07409e-05
|
|
|
GPRK2L
|
[NCBI]
|
2.07409e-05
|
|
|
TYRO3
|
[NCBI]
|
2.07409e-05
|
|
|
COL19A1
|
[NCBI]
|
2.07409e-05
|
|
|
TEAD1
|
[NCBI]
|
2.07409e-05
|
|
|
MFRP
|
[NCBI]
|
2.07409e-05
|
|
|
ovary-, testis-, and epididymis-expressed gene
|
[NCBI]
|
2.07409e-05
|
|
|
SULT2A1
|
[NCBI]
|
2.07409e-05
|
|
|
TBX19
|
[NCBI]
|
2.07409e-05
|
|
|
PMS1
|
[NCBI]
|
2.07409e-05
|
|
|
HMCN1
|
[NCBI]
|
2.07409e-05
|
|
|
CDY1
|
[NCBI]
|
2.07409e-05
|
|
|
FUCA2
|
[NCBI]
|
2.07409e-05
|
|
|
PKD2L1
|
[NCBI]
|
2.07409e-05
|
|
|
ZNF384
|
[NCBI]
|
2.07409e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase/delta-isomerase, type i
|
[NCBI]
|
2.07409e-05
|
|
|
P2RY6
|
[NCBI]
|
2.07409e-05
|
|
|
TBXAS1
|
[NCBI]
|
2.07409e-05
|
|
|
IMPA2
|
[NCBI]
|
2.07409e-05
|
|
|
KIF11
|
[NCBI]
|
2.07409e-05
|
|
|
BMP3
|
[NCBI]
|
2.07409e-05
|
|
|
RNPS1
|
[NCBI]
|
2.07409e-05
|
|
|
E4F1
|
[NCBI]
|
2.07409e-05
|
|
|
ED2
|
[NCBI]
|
2.072254e-05
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
2.072254e-05
|
|
|
TSC2
|
[NCBI]
|
2.061963e-05
|
|
|
ERCC2
|
[NCBI]
|
2.05967e-05
|
|
|
BOS1
|
[NCBI]
|
2.048388e-05
|
|
|
DHS
|
[NCBI]
|
2.048248e-05
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
2.046289e-05
|
|
|
DHFR
|
[NCBI]
|
2.034573e-05
|
|
|
RBP4
|
[NCBI]
|
2.032731e-05
|
|
|
KCNJ11
|
[NCBI]
|
2.032731e-05
|
|
|
campomelic dysplasia
|
[NCBI]
|
2.011491e-05
|
|
|
CSTB
|
[NCBI]
|
2.005529e-05
|
|
|
CDKN1B
|
[NCBI]
|
2.002051e-05
|
|
|
TNFRSF8
|
[NCBI]
|
1.990192e-05
|
|
|
CTCFL
|
[NCBI]
|
1.990192e-05
|
|
|
RTN3
|
[NCBI]
|
1.990192e-05
|
|
|
GABRA4
|
[NCBI]
|
1.990192e-05
|
|
|
CHST6
|
[NCBI]
|
1.990192e-05
|
|
|
SYNJ1
|
[NCBI]
|
1.990192e-05
|
|
|
LUM
|
[NCBI]
|
1.990192e-05
|
|
|
P2RY1
|
[NCBI]
|
1.990192e-05
|
|
|
EBS2
|
[NCBI]
|
1.983196e-05
|
|
|
ATLD
|
[NCBI]
|
1.983196e-05
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
1.983196e-05
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
1.983196e-05
|
|
|
PKD3
|
[NCBI]
|
1.983196e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
1.983196e-05
|
|
|
ARAF1
|
[NCBI]
|
1.981586e-05
|
|
|
RPS25
|
[NCBI]
|
1.981586e-05
|
|
|
MUC3A
|
[NCBI]
|
1.981586e-05
|
|
|
CTNNA2
|
[NCBI]
|
1.981586e-05
|
|
|
SUFU
|
[NCBI]
|
1.981586e-05
|
|
|
DYX1C1
|
[NCBI]
|
1.981586e-05
|
|
|
C1QG
|
[NCBI]
|
1.981586e-05
|
|
|
HSPB8
|
[NCBI]
|
1.981586e-05
|
|
|
XCE
|
[NCBI]
|
1.981586e-05
|
|
|
SLURP1
|
[NCBI]
|
1.981586e-05
|
|
|
P2RY14
|
[NCBI]
|
1.981586e-05
|
|
|
RENBP
|
[NCBI]
|
1.981586e-05
|
|
|
IL1RAPL1
|
[NCBI]
|
1.981586e-05
|
|
|
NPHP4
|
[NCBI]
|
1.981586e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
1.979311e-05
|
|
|
CASR
|
[NCBI]
|
1.973696e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
1.972258e-05
|
|
|
PSEN1
|
[NCBI]
|
1.956184e-05
|
|
|
gastric cancer
|
[NCBI]
|
1.939802e-05
|
|
|
DFNA6
|
[NCBI]
|
1.932458e-05
|
|
|
SACS
|
[NCBI]
|
1.932458e-05
|
|
|
MLH1
|
[NCBI]
|
1.920939e-05
|
|
|
DRD4
|
[NCBI]
|
1.920201e-05
|
|
|
MARCKS
|
[NCBI]
|
1.919128e-05
|
|
|
MN
|
[NCBI]
|
1.919128e-05
|
|
|
DDX6
|
[NCBI]
|
1.903424e-05
|
|
|
TAS2R16
|
[NCBI]
|
1.903424e-05
|
|
|
USP9Y
|
[NCBI]
|
1.903424e-05
|
|
|
KIF1B
|
[NCBI]
|
1.903424e-05
|
|
|
VNN1
|
[NCBI]
|
1.897688e-05
|
|
|
TPM2
|
[NCBI]
|
1.897688e-05
|
|
|
HIPK3
|
[NCBI]
|
1.897688e-05
|
|
|
MEIS2
|
[NCBI]
|
1.897688e-05
|
|
|
FBXW4
|
[NCBI]
|
1.897688e-05
|
|
|
SLC25A5
|
[NCBI]
|
1.897688e-05
|
|
|
CTRB1
|
[NCBI]
|
1.897688e-05
|
|
|
CRYBA4
|
[NCBI]
|
1.897688e-05
|
|
|
TTID
|
[NCBI]
|
1.897688e-05
|
|
|
EMP3
|
[NCBI]
|
1.897688e-05
|
|
|
ITM2A
|
[NCBI]
|
1.897688e-05
|
|
|
CDH11
|
[NCBI]
|
1.897688e-05
|
|
|
CACNA2D1
|
[NCBI]
|
1.897688e-05
|
|
|
PCNT1
|
[NCBI]
|
1.897688e-05
|
|
|
PTPRN
|
[NCBI]
|
1.897688e-05
|
|
|
RAB1
|
[NCBI]
|
1.897688e-05
|
|
|
DBY
|
[NCBI]
|
1.897688e-05
|
|
|
SLC30A8
|
[NCBI]
|
1.897688e-05
|
|
|
PRB2
|
[NCBI]
|
1.897688e-05
|
|
|
PDE6G
|
[NCBI]
|
1.897688e-05
|
|
|
EMP2
|
[NCBI]
|
1.897688e-05
|
|
|
KHSRP
|
[NCBI]
|
1.897688e-05
|
|
|
PCDH11X
|
[NCBI]
|
1.897688e-05
|
|
|
TRA1
|
[NCBI]
|
1.897688e-05
|
|
|
GPX2
|
[NCBI]
|
1.897688e-05
|
|
|
CYP2B6
|
[NCBI]
|
1.897688e-05
|
|
|
C1QB
|
[NCBI]
|
1.897688e-05
|
|
|
TRPM2
|
[NCBI]
|
1.897688e-05
|
|
|
HAND1
|
[NCBI]
|
1.897688e-05
|
|
|
POU2F1
|
[NCBI]
|
1.897688e-05
|
|
|
LIPE
|
[NCBI]
|
1.897688e-05
|
|
|
IL5RA
|
[NCBI]
|
1.897688e-05
|
|
|
DLX5
|
[NCBI]
|
1.897688e-05
|
|
|
DYNC2H1
|
[NCBI]
|
1.897688e-05
|
|
|
P2RY2
|
[NCBI]
|
1.897688e-05
|
|
|
HSF4
|
[NCBI]
|
1.897688e-05
|
|
|
TCF8
|
[NCBI]
|
1.897688e-05
|
|
|
FNTA
|
[NCBI]
|
1.897688e-05
|
|
|
TBX22
|
[NCBI]
|
1.897688e-05
|
|
|
LST1
|
[NCBI]
|
1.897688e-05
|
|
|
PCDH11Y
|
[NCBI]
|
1.897688e-05
|
|
|
GLP1R
|
[NCBI]
|
1.897688e-05
|
|
|
GTF2I
|
[NCBI]
|
1.897688e-05
|
|
|
GADD45G
|
[NCBI]
|
1.897688e-05
|
|
|
TNNT1
|
[NCBI]
|
1.897688e-05
|
|
|
IL1R1
|
[NCBI]
|
1.897688e-05
|
|
|
HIST1H1B
|
[NCBI]
|
1.897688e-05
|
|
|
KCNA5
|
[NCBI]
|
1.897688e-05
|
|
|
KLRA1
|
[NCBI]
|
1.897688e-05
|
|
|
SART3
|
[NCBI]
|
1.897688e-05
|
|
|
PRKDC
|
[NCBI]
|
1.889551e-05
|
|
|
THRB
|
[NCBI]
|
1.855009e-05
|
|
|
PARK2
|
[NCBI]
|
1.852807e-05
|
|
|
CDL1
|
[NCBI]
|
1.848968e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
1.847857e-05
|
|
|
COMT
|
[NCBI]
|
1.840096e-05
|
|
|
GSN
|
[NCBI]
|
1.838043e-05
|
|
|
LRRK2
|
[NCBI]
|
1.838003e-05
|
|
|
GCPS
|
[NCBI]
|
1.835735e-05
|
|
|
CDGG1
|
[NCBI]
|
1.831764e-05
|
|
|
CMT2A1
|
[NCBI]
|
1.831764e-05
|
|
|
mulibrey nanism
|
[NCBI]
|
1.831764e-05
|
|
|
OPPG
|
[NCBI]
|
1.831764e-05
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
1.831764e-05
|
|
|
ADHR
|
[NCBI]
|
1.830171e-05
|
|
|
CD83
|
[NCBI]
|
1.826692e-05
|
|
|
PDLIM3
|
[NCBI]
|
1.826692e-05
|
|
|
PCMT1
|
[NCBI]
|
1.826692e-05
|
|
|
FBLN5
|
[NCBI]
|
1.826692e-05
|
|
|
HAGH
|
[NCBI]
|
1.826692e-05
|
|
|
PFKP
|
[NCBI]
|
1.819526e-05
|
|
|
CCHCR1
|
[NCBI]
|
1.819526e-05
|
|
|
RXRG
|
[NCBI]
|
1.819526e-05
|
|
|
ROM1
|
[NCBI]
|
1.819526e-05
|
|
|
CLN8
|
[NCBI]
|
1.815644e-05
|
|
|
glycogen storage disease ic
|
[NCBI]
|
1.815644e-05
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
1.815644e-05
|
|
|
LGMD2E
|
[NCBI]
|
1.815644e-05
|
|
|
RARA
|
[NCBI]
|
1.813628e-05
|
|
|
CFH
|
[NCBI]
|
1.812076e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
1.790041e-05
|
|
|
TYRP1
|
[NCBI]
|
1.787219e-05
|
|
|
ALMS1
|
[NCBI]
|
1.776862e-05
|
|
|
CRAT
|
[NCBI]
|
1.765346e-05
|
|
|
ICAM1
|
[NCBI]
|
1.763632e-05
|
|
|
ABCC6
|
[NCBI]
|
1.761728e-05
|
|
|
ACP1
|
[NCBI]
|
1.761728e-05
|
|
|
INS
|
[NCBI]
|
1.7616e-05
|
|
|
SACS
|
[NCBI]
|
1.752085e-05
|
|
|
ERCC4
|
[NCBI]
|
1.752085e-05
|
|
|
HOXC8
|
[NCBI]
|
1.752085e-05
|
|
|
RNU2
|
[NCBI]
|
1.74853e-05
|
|
|
TBL1X
|
[NCBI]
|
1.74853e-05
|
|
|
KPNA2
|
[NCBI]
|
1.74853e-05
|
|
|
IL10RB
|
[NCBI]
|
1.74853e-05
|
|
|
SLC2A5
|
[NCBI]
|
1.74853e-05
|
|
|
VKORC1
|
[NCBI]
|
1.74853e-05
|
|
|
CLDN14
|
[NCBI]
|
1.74853e-05
|
|
|
BMPR1B
|
[NCBI]
|
1.74853e-05
|
|
|
COL4A6
|
[NCBI]
|
1.74853e-05
|
|
|
IFNAR2
|
[NCBI]
|
1.74853e-05
|
|
|
RAB3A
|
[NCBI]
|
1.74853e-05
|
|
|
IRGM
|
[NCBI]
|
1.74853e-05
|
|
|
SLC9A1
|
[NCBI]
|
1.74853e-05
|
|
|
HSPA2
|
[NCBI]
|
1.74853e-05
|
|
|
HIST2H2AA
|
[NCBI]
|
1.74853e-05
|
|
|
FOXG1
|
[NCBI]
|
1.74853e-05
|
|
|
FLNC
|
[NCBI]
|
1.74853e-05
|
|
|
EPB72
|
[NCBI]
|
1.74853e-05
|
|
|
EMP1
|
[NCBI]
|
1.74853e-05
|
|
|
BLVRA
|
[NCBI]
|
1.74853e-05
|
|
|
CD86
|
[NCBI]
|
1.74853e-05
|
|
|
GPR154
|
[NCBI]
|
1.74853e-05
|
|
|
CCL4L1
|
[NCBI]
|
1.74853e-05
|
|
|
RPL7A
|
[NCBI]
|
1.74853e-05
|
|
|
FCER2
|
[NCBI]
|
1.74853e-05
|
|
|
TAPBP
|
[NCBI]
|
1.74853e-05
|
|
|
GSTA2
|
[NCBI]
|
1.74853e-05
|
|
|
tl antigen
|
[NCBI]
|
1.74853e-05
|
|
|
HMMR
|
[NCBI]
|
1.74853e-05
|
|
|
CBLB
|
[NCBI]
|
1.74853e-05
|
|
|
SLC25A13
|
[NCBI]
|
1.74853e-05
|
|
|
SMC1A
|
[NCBI]
|
1.74853e-05
|
|
|
BCS1L
|
[NCBI]
|
1.74853e-05
|
|
|
CYP2A6
|
[NCBI]
|
1.740828e-05
|
|
|
CMT4A
|
[NCBI]
|
1.733038e-05
|
|
|
PMDS
|
[NCBI]
|
1.733038e-05
|
|
|
sertoli cell-only syndrome, y-linked
|
[NCBI]
|
1.733038e-05
|
|
|
STAR
|
[NCBI]
|
1.722412e-05
|
|
|
FANCC
|
[NCBI]
|
1.713312e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
1.706418e-05
|
|
|
FPLD2
|
[NCBI]
|
1.704184e-05
|
|
|
SDS
|
[NCBI]
|
1.702932e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
1.699095e-05
|
|
|
SNCA
|
[NCBI]
|
1.697128e-05
|
|
|
LMBR1
|
[NCBI]
|
1.692964e-05
|
|
|
FN1
|
[NCBI]
|
1.690717e-05
|
|
|
MICA
|
[NCBI]
|
1.689725e-05
|
|
|
NT5C
|
[NCBI]
|
1.687184e-05
|
|
|
ENTPD1
|
[NCBI]
|
1.687184e-05
|
|
|
PROM1
|
[NCBI]
|
1.687184e-05
|
|
|
PODXL
|
[NCBI]
|
1.687184e-05
|
|
|
glycogen storage disease vi
|
[NCBI]
|
1.687184e-05
|
|
|
BFLS
|
[NCBI]
|
1.685273e-05
|
|
|
JBS
|
[NCBI]
|
1.685273e-05
|
|
|
TSHR
|
[NCBI]
|
1.683427e-05
|
|
|
MODY3
|
[NCBI]
|
1.681416e-05
|
|
|
gracile syndrome
|
[NCBI]
|
1.681416e-05
|
|
|
MIRN16-1
|
[NCBI]
|
1.681089e-05
|
|
|
SIPA1
|
[NCBI]
|
1.681089e-05
|
|
|
DFNA5
|
[NCBI]
|
1.681089e-05
|
|
|
KRT12
|
[NCBI]
|
1.681089e-05
|
|
|
PGAM1
|
[NCBI]
|
1.681089e-05
|
|
|
GNAL
|
[NCBI]
|
1.681089e-05
|
|
|
HOXD3
|
[NCBI]
|
1.681089e-05
|
|
|
FGA
|
[NCBI]
|
1.679106e-05
|
|
|
erythermalgia, primary
|
[NCBI]
|
1.673557e-05
|
|
|
NOD2
|
[NCBI]
|
1.666713e-05
|
|
|
FTD
|
[NCBI]
|
1.6463361e-05
|
|
|
JAG1
|
[NCBI]
|
1.644859e-05
|
|
|
ADRB2
|
[NCBI]
|
1.644859e-05
|
|
|
factor v deficiency
|
[NCBI]
|
1.638662e-05
|
|
|
ACPP
|
[NCBI]
|
1.633819e-05
|
|
|
GCGR
|
[NCBI]
|
1.633327e-05
|
|
|
GABRD
|
[NCBI]
|
1.633327e-05
|
|
|
XPD
|
[NCBI]
|
1.632344e-05
|
|
|
HYPX
|
[NCBI]
|
1.62974e-05
|
|
|
TOC
|
[NCBI]
|
1.62974e-05
|
|
|
GRHL3
|
[NCBI]
|
1.621968e-05
|
|
|
HEMB
|
[NCBI]
|
1.620385e-05
|
|
|
GCLM
|
[NCBI]
|
1.619743e-05
|
|
|
FOXA1
|
[NCBI]
|
1.619743e-05
|
|
|
CRLF1
|
[NCBI]
|
1.619743e-05
|
|
|
SSTR1
|
[NCBI]
|
1.619743e-05
|
|
|
NRG2
|
[NCBI]
|
1.619743e-05
|
|
|
ADRA1B
|
[NCBI]
|
1.619743e-05
|
|
|
SYT7
|
[NCBI]
|
1.619743e-05
|
|
|
NTS
|
[NCBI]
|
1.619743e-05
|
|
|
ABCA2
|
[NCBI]
|
1.619743e-05
|
|
|
INSL4
|
[NCBI]
|
1.619743e-05
|
|
|
LMO7
|
[NCBI]
|
1.619743e-05
|
|
|
MYLK
|
[NCBI]
|
1.619743e-05
|
|
|
CHRND
|
[NCBI]
|
1.619743e-05
|
|
|
HIST1H3C
|
[NCBI]
|
1.619743e-05
|
|
|
BAZ1B
|
[NCBI]
|
1.619743e-05
|
|
|
ACVR1C
|
[NCBI]
|
1.619743e-05
|
|
|
FRZB
|
[NCBI]
|
1.619743e-05
|
|
|
RPL5
|
[NCBI]
|
1.619743e-05
|
|
|
GAB2
|
[NCBI]
|
1.619743e-05
|
|
|
COL9A2
|
[NCBI]
|
1.619743e-05
|
|
|
AHI1
|
[NCBI]
|
1.619743e-05
|
|
|
CDC2L1
|
[NCBI]
|
1.619743e-05
|
|
|
SEMA5A
|
[NCBI]
|
1.619743e-05
|
|
|
PDGFA
|
[NCBI]
|
1.619743e-05
|
|
|
LIG1
|
[NCBI]
|
1.619743e-05
|
|
|
SMARCA2
|
[NCBI]
|
1.619743e-05
|
|
|
TEK
|
[NCBI]
|
1.619743e-05
|
|
|
GTF2IRD1
|
[NCBI]
|
1.619743e-05
|
|
|
HCH
|
[NCBI]
|
1.614178e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
1.604954e-05
|
|
|
PTPRC
|
[NCBI]
|
1.602816e-05
|
|
|
PARK2
|
[NCBI]
|
1.578382e-05
|
|
|
SOD2
|
[NCBI]
|
1.566189e-05
|
|
|
SLC2A8
|
[NCBI]
|
1.565886e-05
|
|
|
FDX1
|
[NCBI]
|
1.565886e-05
|
|
|
LTB4R
|
[NCBI]
|
1.565886e-05
|
|
|
hemojuvelin
|
[NCBI]
|
1.565886e-05
|
|
|
HGPS
|
[NCBI]
|
1.563587e-05
|
|
|
RP1
|
[NCBI]
|
1.560622e-05
|
|
|
SCN1B
|
[NCBI]
|
1.560622e-05
|
|
|
WNT4
|
[NCBI]
|
1.560622e-05
|
|
|
CCNC
|
[NCBI]
|
1.560622e-05
|
|
|
SNCG
|
[NCBI]
|
1.560622e-05
|
|
|
TNNI2
|
[NCBI]
|
1.560622e-05
|
|
|
ERBB3
|
[NCBI]
|
1.560622e-05
|
|
|
XRCC1
|
[NCBI]
|
1.560622e-05
|
|
|
TUB
|
[NCBI]
|
1.560622e-05
|
|
|
CNGB3
|
[NCBI]
|
1.560622e-05
|
|
|
ANKH
|
[NCBI]
|
1.560622e-05
|
|
|
ATP7B
|
[NCBI]
|
1.557536e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
1.552283e-05
|
|
|
liddle syndrome
|
[NCBI]
|
1.552283e-05
|
|
|
ACHM2
|
[NCBI]
|
1.544535e-05
|
|
|
XPV
|
[NCBI]
|
1.539329e-05
|
|
|
complement component c1r deficiency
|
[NCBI]
|
1.518012e-05
|
|
|
SLC1A5
|
[NCBI]
|
1.50815e-05
|
|
|
PLAGL1
|
[NCBI]
|
1.50815e-05
|
|
|
TYK2
|
[NCBI]
|
1.506765e-05
|
|
|
NCOR1
|
[NCBI]
|
1.506765e-05
|
|
|
AGC1
|
[NCBI]
|
1.506765e-05
|
|
|
RXRB
|
[NCBI]
|
1.506765e-05
|
|
|
CDH3
|
[NCBI]
|
1.506765e-05
|
|
|
FZD4
|
[NCBI]
|
1.506765e-05
|
|
|
ING1
|
[NCBI]
|
1.506765e-05
|
|
|
PLCB3
|
[NCBI]
|
1.506765e-05
|
|
|
HTN3
|
[NCBI]
|
1.506765e-05
|
|
|
EDAR
|
[NCBI]
|
1.506765e-05
|
|
|
CLDN16
|
[NCBI]
|
1.506765e-05
|
|
|
PHKA1
|
[NCBI]
|
1.506765e-05
|
|
|
SLC19A2
|
[NCBI]
|
1.506765e-05
|
|
|
LITAF
|
[NCBI]
|
1.506765e-05
|
|
|
HTRA1
|
[NCBI]
|
1.506765e-05
|
|
|
PRKG1
|
[NCBI]
|
1.506765e-05
|
|
|
GCNT2
|
[NCBI]
|
1.506765e-05
|
|
|
SYT2
|
[NCBI]
|
1.506765e-05
|
|
|
ANXA7
|
[NCBI]
|
1.506765e-05
|
|
|
WHSC1
|
[NCBI]
|
1.506765e-05
|
|
|
OXTR
|
[NCBI]
|
1.506765e-05
|
|
|
JUNB
|
[NCBI]
|
1.506765e-05
|
|
|
RPS4X
|
[NCBI]
|
1.506765e-05
|
|
|
HAL
|
[NCBI]
|
1.506765e-05
|
|
|
ZIC2
|
[NCBI]
|
1.506765e-05
|
|
|
RB1CC1
|
[NCBI]
|
1.506765e-05
|
|
|
TTC10
|
[NCBI]
|
1.506765e-05
|
|
|
RAMP2
|
[NCBI]
|
1.506765e-05
|
|
|
GRID2
|
[NCBI]
|
1.506765e-05
|
|
|
CD
|
[NCBI]
|
1.502982e-05
|
|
|
ARMD1
|
[NCBI]
|
1.49932e-05
|
|
|
SOX9
|
[NCBI]
|
1.495914e-05
|
|
|
CPI
|
[NCBI]
|
1.483401e-05
|
|
|
PDHA1
|
[NCBI]
|
1.477625e-05
|
|
|
PNMT
|
[NCBI]
|
1.477341e-05
|
|
|
CTLA4
|
[NCBI]
|
1.475601e-05
|
|
|
NCIE1
|
[NCBI]
|
1.464792e-05
|
|
|
OMP
|
[NCBI]
|
1.464562e-05
|
|
|
TFAP2B
|
[NCBI]
|
1.46111e-05
|
|
|
DIO1
|
[NCBI]
|
1.458891e-05
|
|
|
BMP6
|
[NCBI]
|
1.458891e-05
|
|
|
AMT
|
[NCBI]
|
1.458891e-05
|
|
|
ADSS
|
[NCBI]
|
1.458891e-05
|
|
|
CD151
|
[NCBI]
|
1.458891e-05
|
|
|
Ss
|
[NCBI]
|
1.458891e-05
|
|
|
NCAM1
|
[NCBI]
|
1.458891e-05
|
|
|
ATRX
|
[NCBI]
|
1.458403e-05
|
|
|
DAZ
|
[NCBI]
|
1.45619e-05
|
|
|
HOXA1
|
[NCBI]
|
1.454293e-05
|
|
|
SGCG
|
[NCBI]
|
1.454293e-05
|
|
|
CLDN3
|
[NCBI]
|
1.454293e-05
|
|
|
KERA
|
[NCBI]
|
1.454293e-05
|
|
|
GLI
|
[NCBI]
|
1.454293e-05
|
|
|
AMN
|
[NCBI]
|
1.454293e-05
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
1.4281039e-05
|
|
|
NS1
|
[NCBI]
|
1.427517e-05
|
|
|
CSF2
|
[NCBI]
|
1.424266e-05
|
|
|
MTC
|
[NCBI]
|
1.423399e-05
|
|
|
CDA
|
[NCBI]
|
1.423399e-05
|
|
|
LIS1
|
[NCBI]
|
1.423399e-05
|
|
|
FOLH1
|
[NCBI]
|
1.420653e-05
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
1.418055e-05
|
|
|
ENG
|
[NCBI]
|
1.416875e-05
|
|
|
SCNN1G
|
[NCBI]
|
1.415908e-05
|
|
|
TRMA
|
[NCBI]
|
1.412971e-05
|
|
|
HPS1
|
[NCBI]
|
1.407253e-05
|
|
|
FMN
|
[NCBI]
|
1.407253e-05
|
|
|
XRCC5
|
[NCBI]
|
1.407253e-05
|
|
|
RAB7
|
[NCBI]
|
1.407253e-05
|
|
|
NXF1
|
[NCBI]
|
1.406419e-05
|
|
|
CSN2
|
[NCBI]
|
1.406419e-05
|
|
|
NEUROD1
|
[NCBI]
|
1.406419e-05
|
|
|
SAA2
|
[NCBI]
|
1.406419e-05
|
|
|
TLX1
|
[NCBI]
|
1.406419e-05
|
|
|
PRM1
|
[NCBI]
|
1.406419e-05
|
|
|
STXBP1
|
[NCBI]
|
1.406419e-05
|
|
|
OAS1
|
[NCBI]
|
1.406419e-05
|
|
|
ALPI
|
[NCBI]
|
1.406419e-05
|
|
|
PLEC1
|
[NCBI]
|
1.406419e-05
|
|
|
FGF6
|
[NCBI]
|
1.406419e-05
|
|
|
ATP2B2
|
[NCBI]
|
1.406419e-05
|
|
|
PDPK1
|
[NCBI]
|
1.406419e-05
|
|
|
CCL4
|
[NCBI]
|
1.406419e-05
|
|
|
AAAS
|
[NCBI]
|
1.406419e-05
|
|
|
NR2E3
|
[NCBI]
|
1.406419e-05
|
|
|
HK2
|
[NCBI]
|
1.406419e-05
|
|
|
C1QA
|
[NCBI]
|
1.406419e-05
|
|
|
CD80
|
[NCBI]
|
1.406419e-05
|
|
|
HSAN2
|
[NCBI]
|
1.400561e-05
|
|
|
LPA
|
[NCBI]
|
1.400413e-05
|
|
|
HDC
|
[NCBI]
|
1.393003e-05
|
|
|
OCP
|
[NCBI]
|
1.392246e-05
|
|
|
POLG
|
[NCBI]
|
1.380788e-05
|
|
|
CYP2E
|
[NCBI]
|
1.376997e-05
|
|
|
MOS
|
[NCBI]
|
1.37327e-05
|
|
|
TLR4
|
[NCBI]
|
1.36545e-05
|
|
|
NDRG1
|
[NCBI]
|
1.364738e-05
|
|
|
GRIA3
|
[NCBI]
|
1.363436e-05
|
|
|
CTSS
|
[NCBI]
|
1.363436e-05
|
|
|
GMPR
|
[NCBI]
|
1.363436e-05
|
|
|
TOP2A
|
[NCBI]
|
1.363436e-05
|
|
|
LRP6
|
[NCBI]
|
1.363436e-05
|
|
|
TSC1
|
[NCBI]
|
1.361428e-05
|
|
|
ERCC8
|
[NCBI]
|
1.359379e-05
|
|
|
DAPK1
|
[NCBI]
|
1.359379e-05
|
|
|
ZNF148
|
[NCBI]
|
1.359379e-05
|
|
|
CCNA2
|
[NCBI]
|
1.359379e-05
|
|
|
POU3F4
|
[NCBI]
|
1.359379e-05
|
|
|
CTLN2
|
[NCBI]
|
1.359053e-05
|
|
|
CBBM
|
[NCBI]
|
1.357995e-05
|
|
|
DNAH11
|
[NCBI]
|
1.344495e-05
|
|
|
CIPA
|
[NCBI]
|
1.341721e-05
|
|
|
ALB
|
[NCBI]
|
1.338631e-05
|
|
|
ADM
|
[NCBI]
|
1.328578e-05
|
|
|
HOXB5
|
[NCBI]
|
1.326049e-05
|
|
|
RELN
|
[NCBI]
|
1.326005e-05
|
|
|
SLC17A5
|
[NCBI]
|
1.324525e-05
|
|
|
SORD
|
[NCBI]
|
1.324525e-05
|
|
|
THC2
|
[NCBI]
|
1.322705e-05
|
|
|
EDM1
|
[NCBI]
|
1.322705e-05
|
|
|
FTNS
|
[NCBI]
|
1.322705e-05
|
|
|
PAK3
|
[NCBI]
|
1.316864e-05
|
|
|
MYH1
|
[NCBI]
|
1.316396e-05
|
|
|
LTK
|
[NCBI]
|
1.316396e-05
|
|
|
GTF2H1
|
[NCBI]
|
1.316396e-05
|
|
|
CX3CL1
|
[NCBI]
|
1.316396e-05
|
|
|
RARB
|
[NCBI]
|
1.316396e-05
|
|
|
CDKN2B
|
[NCBI]
|
1.316396e-05
|
|
|
PAX9
|
[NCBI]
|
1.316396e-05
|
|
|
ADH3
|
[NCBI]
|
1.316396e-05
|
|
|
PTGDS
|
[NCBI]
|
1.316396e-05
|
|
|
SLC6A2
|
[NCBI]
|
1.316396e-05
|
|
|
RYR3
|
[NCBI]
|
1.316396e-05
|
|
|
KCNQ4
|
[NCBI]
|
1.316396e-05
|
|
|
AL-A1
|
[NCBI]
|
1.316396e-05
|
|
|
OTSC1
|
[NCBI]
|
1.312915e-05
|
|
|
C4A
|
[NCBI]
|
1.31137e-05
|
|
|
TCF7L2
|
[NCBI]
|
1.308069e-05
|
|
|
MAP2
|
[NCBI]
|
1.30326e-05
|
|
|
lymphedema-distichiasis syndrome
|
[NCBI]
|
1.300214e-05
|
|
|
factor vii deficiency
|
[NCBI]
|
1.292333e-05
|
|
|
APRT
|
[NCBI]
|
1.286809e-05
|
|
|
ATS
|
[NCBI]
|
1.286162e-05
|
|
|
BBS
|
[NCBI]
|
1.279795e-05
|
|
|
XG
|
[NCBI]
|
1.278175e-05
|
|
|
ABCB1
|
[NCBI]
|
1.277948e-05
|
|
|
CD1A
|
[NCBI]
|
1.277485e-05
|
|
|
CKM
|
[NCBI]
|
1.277485e-05
|
|
|
B4GALT1
|
[NCBI]
|
1.277485e-05
|
|
|
IVL
|
[NCBI]
|
1.277485e-05
|
|
|
CALML3
|
[NCBI]
|
1.277485e-05
|
|
|
ACCN3
|
[NCBI]
|
1.277485e-05
|
|
|
PRKCE
|
[NCBI]
|
1.277485e-05
|
|
|
MERTK
|
[NCBI]
|
1.277485e-05
|
|
|
SIX1
|
[NCBI]
|
1.273881e-05
|
|
|
SIX3
|
[NCBI]
|
1.273881e-05
|
|
|
EMX2
|
[NCBI]
|
1.273881e-05
|
|
|
SOX3
|
[NCBI]
|
1.273881e-05
|
|
|
MAD2L1
|
[NCBI]
|
1.273881e-05
|
|
|
WAS
|
[NCBI]
|
1.256941e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
1.252961e-05
|
|
|
SLS
|
[NCBI]
|
1.248391e-05
|
|
|
AMH
|
[NCBI]
|
1.244041e-05
|
|
|
ABCA1
|
[NCBI]
|
1.243638e-05
|
|
|
SAG
|
[NCBI]
|
1.242018e-05
|
|
|
BPES
|
[NCBI]
|
1.2369197e-05
|
|
|
SKI
|
[NCBI]
|
1.235192e-05
|
|
|
FCGR2A
|
[NCBI]
|
1.235192e-05
|
|
|
KRT18
|
[NCBI]
|
1.23497e-05
|
|
|
ASCL1
|
[NCBI]
|
1.23497e-05
|
|
|
WWOX
|
[NCBI]
|
1.23497e-05
|
|
|
USP7
|
[NCBI]
|
1.23497e-05
|
|
|
GDF11
|
[NCBI]
|
1.23497e-05
|
|
|
EZH2
|
[NCBI]
|
1.23497e-05
|
|
|
LCN1
|
[NCBI]
|
1.23497e-05
|
|
|
BLNK
|
[NCBI]
|
1.23497e-05
|
|
|
SELL
|
[NCBI]
|
1.23497e-05
|
|
|
KLK1
|
[NCBI]
|
1.23497e-05
|
|
|
CNTFR
|
[NCBI]
|
1.23497e-05
|
|
|
IGSF4
|
[NCBI]
|
1.23497e-05
|
|
|
G22P1
|
[NCBI]
|
1.23497e-05
|
|
|
MEF2C
|
[NCBI]
|
1.23497e-05
|
|
|
PAPSS2
|
[NCBI]
|
1.23497e-05
|
|
|
KRT15
|
[NCBI]
|
1.23497e-05
|
|
|
PKM2
|
[NCBI]
|
1.23497e-05
|
|
|
PSG1
|
[NCBI]
|
1.23497e-05
|
|
|
EA1
|
[NCBI]
|
1.234896e-05
|
|
|
BHD
|
[NCBI]
|
1.234896e-05
|
|
|
PPAC
|
[NCBI]
|
1.233009e-05
|
|
|
DCT
|
[NCBI]
|
1.213964e-05
|
|
|
ITPA
|
[NCBI]
|
1.209502e-05
|
|
|
ARH
|
[NCBI]
|
1.201431e-05
|
|
|
autoimmune disease
|
[NCBI]
|
1.201431e-05
|
|
|
ANXA2
|
[NCBI]
|
1.199503e-05
|
|
|
COL6A2
|
[NCBI]
|
1.199503e-05
|
|
|
DPP4
|
[NCBI]
|
1.199503e-05
|
|
|
CCL27
|
[NCBI]
|
1.199503e-05
|
|
|
LGI1
|
[NCBI]
|
1.199503e-05
|
|
|
OLIG2
|
[NCBI]
|
1.199503e-05
|
|
|
CTNNA1
|
[NCBI]
|
1.199503e-05
|
|
|
FLI1
|
[NCBI]
|
1.196281e-05
|
|
|
TCIRG1
|
[NCBI]
|
1.196281e-05
|
|
|
TRAPPC2
|
[NCBI]
|
1.196281e-05
|
|
|
MYF6
|
[NCBI]
|
1.196281e-05
|
|
|
MAP1B
|
[NCBI]
|
1.176863e-05
|
|
|
ALAD
|
[NCBI]
|
1.1684e-05
|
|
|
krabbe disease
|
[NCBI]
|
1.168338e-05
|
|
|
GRM1
|
[NCBI]
|
1.166987e-05
|
|
|
plasmin inhibitor deficiency
|
[NCBI]
|
1.166987e-05
|
|
|
ART4
|
[NCBI]
|
1.166987e-05
|
|
|
LDLR
|
[NCBI]
|
1.163238e-05
|
|
|
CACNA1F
|
[NCBI]
|
1.16087e-05
|
|
|
HSPG2
|
[NCBI]
|
1.16087e-05
|
|
|
ETS2
|
[NCBI]
|
1.16087e-05
|
|
|
MEST
|
[NCBI]
|
1.160814e-05
|
|
|
LAMR1
|
[NCBI]
|
1.160814e-05
|
|
|
PVRL1
|
[NCBI]
|
1.160814e-05
|
|
|
SDHC
|
[NCBI]
|
1.160814e-05
|
|
|
CDK5R1
|
[NCBI]
|
1.160814e-05
|
|
|
ONECUT1
|
[NCBI]
|
1.160814e-05
|
|
|
alsin
|
[NCBI]
|
1.160814e-05
|
|
|
GABBR1
|
[NCBI]
|
1.160814e-05
|
|
|
CYP3A5
|
[NCBI]
|
1.160814e-05
|
|
|
PLAG1
|
[NCBI]
|
1.160814e-05
|
|
|
esophageal cancer
|
[NCBI]
|
1.158127e-05
|
|
|
SERPINA6
|
[NCBI]
|
1.154315e-05
|
|
|
CML
|
[NCBI]
|
1.150335e-05
|
|
|
GHR
|
[NCBI]
|
1.140208e-05
|
|
|
FLNA
|
[NCBI]
|
1.131155e-05
|
|
|
ATXN2
|
[NCBI]
|
1.128298e-05
|
|
|
TPM1
|
[NCBI]
|
1.128298e-05
|
|
|
ACAT1
|
[NCBI]
|
1.128298e-05
|
|
|
GOT1
|
[NCBI]
|
1.128298e-05
|
|
|
PEPA
|
[NCBI]
|
1.128298e-05
|
|
|
NQO1
|
[NCBI]
|
1.128298e-05
|
|
|
DRD1
|
[NCBI]
|
1.128298e-05
|
|
|
PDE4D
|
[NCBI]
|
1.128298e-05
|
|
|
EFNB1
|
[NCBI]
|
1.125403e-05
|
|
|
MTMR2
|
[NCBI]
|
1.125403e-05
|
|
|
TECTA
|
[NCBI]
|
1.125403e-05
|
|
|
DCTN1
|
[NCBI]
|
1.125403e-05
|
|
|
KRT10
|
[NCBI]
|
1.125403e-05
|
|
|
SORBS1
|
[NCBI]
|
1.125403e-05
|
|
|
HSPD1
|
[NCBI]
|
1.125403e-05
|
|
|
SMARCB1
|
[NCBI]
|
1.125403e-05
|
|
|
FOXE1
|
[NCBI]
|
1.125403e-05
|
|
|
PRLR
|
[NCBI]
|
1.123055e-05
|
|
|
TYR
|
[NCBI]
|
1.121982e-05
|
|
|
FH
|
[NCBI]
|
1.117384e-05
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
1.115787e-05
|
|
|
LGMD1B
|
[NCBI]
|
1.113622e-05
|
|
|
AGS1
|
[NCBI]
|
1.113622e-05
|
|
|
HHC1
|
[NCBI]
|
1.112891e-05
|
|
|
FIH
|
[NCBI]
|
1.110722e-05
|
|
|
WFS1
|
[NCBI]
|
1.110722e-05
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
1.108895e-05
|
|
|
HOMG
|
[NCBI]
|
1.108895e-05
|
|
|
PVR
|
[NCBI]
|
1.105508e-05
|
|
|
galactosemia
|
[NCBI]
|
1.103918e-05
|
|
|
GALT
|
[NCBI]
|
1.102259e-05
|
|
|
SCDO1
|
[NCBI]
|
1.0983009e-05
|
|
|
LDS
|
[NCBI]
|
1.097488e-05
|
|
|
TBG
|
[NCBI]
|
1.095438e-05
|
|
|
PCSK9
|
[NCBI]
|
1.092887e-05
|
|
|
PFKL
|
[NCBI]
|
1.092887e-05
|
|
|
PRH1
|
[NCBI]
|
1.092887e-05
|
|
|
SALL1
|
[NCBI]
|
1.092887e-05
|
|
|
BID
|
[NCBI]
|
1.092887e-05
|
|
|
TNNI3
|
[NCBI]
|
1.092887e-05
|
|
|
RNR1
|
[NCBI]
|
1.092887e-05
|
|
|
CGA
|
[NCBI]
|
1.092887e-05
|
|
|
CCKAR
|
[NCBI]
|
1.092832e-05
|
|
|
FOXP2
|
[NCBI]
|
1.092832e-05
|
|
|
TP53
|
[NCBI]
|
1.09156e-05
|
|
|
PFM
|
[NCBI]
|
1.090922e-05
|
|
|
RTT
|
[NCBI]
|
1.088185e-05
|
|
|
MSH2
|
[NCBI]
|
1.087478e-05
|
|
|
CDK5
|
[NCBI]
|
1.086641e-05
|
|
|
GH1
|
[NCBI]
|
1.08576e-05
|
|
|
IL4
|
[NCBI]
|
1.08576e-05
|
|
|
DBA
|
[NCBI]
|
1.084038e-05
|
|
|
PSAP
|
[NCBI]
|
1.076766e-05
|
|
|
ITGB2
|
[NCBI]
|
1.073654e-05
|
|
|
MPI
|
[NCBI]
|
1.070613e-05
|
|
|
MTP
|
[NCBI]
|
1.070613e-05
|
|
|
DAO
|
[NCBI]
|
1.066905e-05
|
|
|
LU
|
[NCBI]
|
1.062926e-05
|
|
|
DSCR1
|
[NCBI]
|
1.062926e-05
|
|
|
PKHD1
|
[NCBI]
|
1.060316e-05
|
|
|
JARID1D
|
[NCBI]
|
1.060316e-05
|
|
|
LOR
|
[NCBI]
|
1.060316e-05
|
|
|
INVS
|
[NCBI]
|
1.060316e-05
|
|
|
NTRK3
|
[NCBI]
|
1.060316e-05
|
|
|
LPL
|
[NCBI]
|
1.051003e-05
|
|
|
RAF1
|
[NCBI]
|
1.044369e-05
|
|
|
HRAS
|
[NCBI]
|
1.03875e-05
|
|
|
RDT
|
[NCBI]
|
1.037329e-05
|
|
|
chromosome 5q deletion syndrome
|
[NCBI]
|
1.036853e-05
|
|
|
GALR1
|
[NCBI]
|
1.035202e-05
|
|
|
MMP7
|
[NCBI]
|
1.030355e-05
|
|
|
CCNH
|
[NCBI]
|
1.030355e-05
|
|
|
PDC
|
[NCBI]
|
1.030355e-05
|
|
|
KCNQ2
|
[NCBI]
|
1.030355e-05
|
|
|
APOA2
|
[NCBI]
|
1.030355e-05
|
|
|
AGL
|
[NCBI]
|
1.030355e-05
|
|
|
TAP1
|
[NCBI]
|
1.030355e-05
|
|
|
SLC1A3
|
[NCBI]
|
1.030355e-05
|
|
|
SDC1
|
[NCBI]
|
1.030355e-05
|
|
|
SDHB
|
[NCBI]
|
1.030355e-05
|
|
|
CNP
|
[NCBI]
|
1.030355e-05
|
|
|
MTND4L
|
[NCBI]
|
1.030355e-05
|
|
|
PPP1R12A
|
[NCBI]
|
1.030355e-05
|
|
|
ME2
|
[NCBI]
|
1.030355e-05
|
|
|
FOXA2
|
[NCBI]
|
1.030355e-05
|
|
|
HEPH
|
[NCBI]
|
1.030355e-05
|
|
|
ELAC2
|
[NCBI]
|
1.030229e-05
|
|
|
CD99
|
[NCBI]
|
1.030229e-05
|
|
|
FGFR2
|
[NCBI]
|
1.022872e-05
|
|
|
SLC6A4
|
[NCBI]
|
1.02148e-05
|
|
|
LCAT
|
[NCBI]
|
1.015049e-05
|
|
|
ALGS1
|
[NCBI]
|
1.013545e-05
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
1.009679e-05
|
|
|
S100A8
|
[NCBI]
|
1.009449e-05
|
|
|
FSHB
|
[NCBI]
|
1.009449e-05
|
|
|
TBX21
|
[NCBI]
|
1.002631e-05
|
|
|
PDCD1
|
[NCBI]
|
1.002631e-05
|
|
|
NTF3
|
[NCBI]
|
1.002631e-05
|
|
|
PGK2
|
[NCBI]
|
1.002631e-05
|
|
|
PAX1
|
[NCBI]
|
1.002334e-05
|
|
|
ROR2
|
[NCBI]
|
1.002334e-05
|
|
|
SLC26A2
|
[NCBI]
|
1.000268e-05
|
|
|
THBD
|
[NCBI]
|
1.000268e-05
|
|
|
RAPSN
|
[NCBI]
|
1.000268e-05
|
|
|
BEST1
|
[NCBI]
|
1.000268e-05
|
|
|
MAP1A
|
[NCBI]
|
9.8545e-06
|
|
|
RP
|
[NCBI]
|
9.84381e-06
|
|
|
GNRHR
|
[NCBI]
|
9.79675e-06
|
|
|
PFC
|
[NCBI]
|
9.76878e-06
|
|
|
GDI1
|
[NCBI]
|
9.76386e-06
|
|
|
faciogenital dysplasia
|
[NCBI]
|
9.76051e-06
|
|
|
BMPR1A
|
[NCBI]
|
9.72544e-06
|
|
|
LEF1
|
[NCBI]
|
9.72544e-06
|
|
|
MAPK9
|
[NCBI]
|
9.72544e-06
|
|
|
HLA-DPA1
|
[NCBI]
|
9.72544e-06
|
|
|
TERF1
|
[NCBI]
|
9.72544e-06
|
|
|
COL18A1
|
[NCBI]
|
9.72544e-06
|
|
|
IRF6
|
[NCBI]
|
9.72544e-06
|
|
|
RALGDS
|
[NCBI]
|
9.72544e-06
|
|
|
CYP2C9
|
[NCBI]
|
9.72544e-06
|
|
|
CMPK1
|
[NCBI]
|
9.72373e-06
|
|
|
TBX1
|
[NCBI]
|
9.72373e-06
|
|
|
SOX2
|
[NCBI]
|
9.72373e-06
|
|
|
KCNQ1OT1
|
[NCBI]
|
9.72373e-06
|
|
|
VED
|
[NCBI]
|
9.69648e-06
|
|
|
MCDC1
|
[NCBI]
|
9.66313e-06
|
|
|
DM2
|
[NCBI]
|
9.59562e-06
|
|
|
UGDH
|
[NCBI]
|
9.46791e-06
|
|
|
NCF1
|
[NCBI]
|
9.46791e-06
|
|
|
CNR1
|
[NCBI]
|
9.46791e-06
|
|
|
CLDN11
|
[NCBI]
|
9.46791e-06
|
|
|
ADIPOR1
|
[NCBI]
|
9.46791e-06
|
|
|
MFS
|
[NCBI]
|
9.35479e-06
|
|
|
SCIDX1
|
[NCBI]
|
9.33885e-06
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
9.3291e-06
|
|
|
LMS
|
[NCBI]
|
9.3291e-06
|
|
|
SHH
|
[NCBI]
|
9.28932e-06
|
|
|
PGK1
|
[NCBI]
|
9.28785e-06
|
|
|
LAMP2
|
[NCBI]
|
9.22792e-06
|
|
|
CDS
|
[NCBI]
|
9.20392e-06
|
|
|
ARMD4
|
[NCBI]
|
9.20392e-06
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
9.20392e-06
|
|
|
DDR1
|
[NCBI]
|
9.18896e-06
|
|
|
NR5A2
|
[NCBI]
|
9.18896e-06
|
|
|
CSH1
|
[NCBI]
|
9.18896e-06
|
|
|
C7
|
[NCBI]
|
9.18896e-06
|
|
|
MYOD1
|
[NCBI]
|
9.18896e-06
|
|
|
RTN4
|
[NCBI]
|
9.18896e-06
|
|
|
CYP11A1
|
[NCBI]
|
9.18896e-06
|
|
|
SPG2
|
[NCBI]
|
9.10808e-06
|
|
|
NPC1
|
[NCBI]
|
9.05138e-06
|
|
|
neuraminidase deficiency
|
[NCBI]
|
9.003719e-06
|
|
|
ATXN7
|
[NCBI]
|
8.94897e-06
|
|
|
KEL
|
[NCBI]
|
8.94897e-06
|
|
|
UCHL1
|
[NCBI]
|
8.92948e-06
|
|
|
PAPPA
|
[NCBI]
|
8.92948e-06
|
|
|
LTF
|
[NCBI]
|
8.92948e-06
|
|
|
TSHB
|
[NCBI]
|
8.92948e-06
|
|
|
ALDOA
|
[NCBI]
|
8.92948e-06
|
|
|
GLRA1
|
[NCBI]
|
8.92948e-06
|
|
|
TLR2
|
[NCBI]
|
8.79707e-06
|
|
|
PANK2
|
[NCBI]
|
8.79341e-06
|
|
|
CLN3
|
[NCBI]
|
8.7836e-06
|
|
|
SLC16A2
|
[NCBI]
|
8.72466e-06
|
|
|
SCNN1A
|
[NCBI]
|
8.72466e-06
|
|
|
SCNN1B
|
[NCBI]
|
8.72466e-06
|
|
|
APS1
|
[NCBI]
|
8.69027e-06
|
|
|
PFKM
|
[NCBI]
|
8.68949e-06
|
|
|
IL16
|
[NCBI]
|
8.68949e-06
|
|
|
TPM3
|
[NCBI]
|
8.68949e-06
|
|
|
NRIP1
|
[NCBI]
|
8.68949e-06
|
|
|
CBL
|
[NCBI]
|
8.68949e-06
|
|
|
SURF1
|
[NCBI]
|
8.68949e-06
|
|
|
TCF3
|
[NCBI]
|
8.68949e-06
|
|
|
SPTA1
|
[NCBI]
|
8.5805e-06
|
|
|
PPARG
|
[NCBI]
|
8.54225e-06
|
|
|
MAN2B1
|
[NCBI]
|
8.51446e-06
|
|
|
MYO6
|
[NCBI]
|
8.51446e-06
|
|
|
VCAM1
|
[NCBI]
|
8.46518e-06
|
|
|
TAL1
|
[NCBI]
|
8.46518e-06
|
|
|
ACTA1
|
[NCBI]
|
8.46518e-06
|
|
|
Ge
|
[NCBI]
|
8.46518e-06
|
|
|
HIGM1
|
[NCBI]
|
8.46271e-06
|
|
|
NR4A3
|
[NCBI]
|
8.46103e-06
|
|
|
COL11A2
|
[NCBI]
|
8.44743e-06
|
|
|
KCNE1
|
[NCBI]
|
8.44743e-06
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
8.43623e-06
|
|
|
ITGB3
|
[NCBI]
|
8.26796e-06
|
|
|
HSD17B4
|
[NCBI]
|
8.25498e-06
|
|
|
EPB42
|
[NCBI]
|
8.25498e-06
|
|
|
BIRC1
|
[NCBI]
|
8.24569e-06
|
|
|
G6PT1
|
[NCBI]
|
8.22312e-06
|
|
|
CEBPB
|
[NCBI]
|
8.22312e-06
|
|
|
XRCC9
|
[NCBI]
|
8.22312e-06
|
|
|
ADRB3
|
[NCBI]
|
8.22312e-06
|
|
|
PHOX2B
|
[NCBI]
|
8.22104e-06
|
|
|
MME
|
[NCBI]
|
8.22104e-06
|
|
|
WS1
|
[NCBI]
|
8.203477e-06
|
|
|
HHF2
|
[NCBI]
|
8.12321e-06
|
|
|
GJB1
|
[NCBI]
|
8.07858e-06
|
|
|
DHRD
|
[NCBI]
|
8.06865e-06
|
|
|
ERCC1
|
[NCBI]
|
8.04952e-06
|
|
|
PGD
|
[NCBI]
|
7.99673e-06
|
|
|
AMC
|
[NCBI]
|
7.9924e-06
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
7.89459e-06
|
|
|
PEE1
|
[NCBI]
|
7.887308e-06
|
|
|
G6PC2
|
[NCBI]
|
7.87171e-06
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
7.81548e-06
|
|
|
CHRNA4
|
[NCBI]
|
7.78653e-06
|
|
|
WNK1
|
[NCBI]
|
7.78653e-06
|
|
|
BMP1
|
[NCBI]
|
7.78653e-06
|
|
|
GCCD1
|
[NCBI]
|
7.7781e-06
|
|
|
APP
|
[NCBI]
|
7.768e-06
|
|
|
GSD
|
[NCBI]
|
7.76418e-06
|
|
|
alexander disease
|
[NCBI]
|
7.76418e-06
|
|
|
MSS
|
[NCBI]
|
7.75417e-06
|
|
|
HOXD13
|
[NCBI]
|
7.58522e-06
|
|
|
EBP
|
[NCBI]
|
7.58522e-06
|
|
|
ALMS
|
[NCBI]
|
7.579343e-06
|
|
|
NRL
|
[NCBI]
|
7.57433e-06
|
|
|
TBX5
|
[NCBI]
|
7.57433e-06
|
|
|
SLC2A1
|
[NCBI]
|
7.57433e-06
|
|
|
SLC6A3
|
[NCBI]
|
7.55557e-06
|
|
|
bladder cancer
|
[NCBI]
|
7.55407e-06
|
|
|
COMP
|
[NCBI]
|
7.52328e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
7.48965e-06
|
|
|
POMC
|
[NCBI]
|
7.46106e-06
|
|
|
SPR
|
[NCBI]
|
7.45441e-06
|
|
|
GCCR
|
[NCBI]
|
7.41892e-06
|
|
|
EDMD2
|
[NCBI]
|
7.41665e-06
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
7.41665e-06
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
7.40326e-06
|
|
|
CA2
|
[NCBI]
|
7.40326e-06
|
|
|
NNMT
|
[NCBI]
|
7.40326e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
7.40326e-06
|
|
|
CCNE1
|
[NCBI]
|
7.40326e-06
|
|
|
LCP1
|
[NCBI]
|
7.40326e-06
|
|
|
HSPCA
|
[NCBI]
|
7.37689e-06
|
|
|
HIP1
|
[NCBI]
|
7.37689e-06
|
|
|
NME1
|
[NCBI]
|
7.37689e-06
|
|
|
MYH6
|
[NCBI]
|
7.37689e-06
|
|
|
apert syndrome
|
[NCBI]
|
7.3448044e-06
|
|
|
TMOD
|
[NCBI]
|
7.22802e-06
|
|
|
CUBN
|
[NCBI]
|
7.19106e-06
|
|
|
GJB6
|
[NCBI]
|
7.19106e-06
|
|
|
FUS
|
[NCBI]
|
7.17758e-06
|
|
|
SYP
|
[NCBI]
|
7.17758e-06
|
|
|
SRF
|
[NCBI]
|
7.1691e-06
|
|
|
TGFB1
|
[NCBI]
|
7.15943e-06
|
|
|
ILK
|
[NCBI]
|
7.15469e-06
|
|
|
pancreatic carcinoma
|
[NCBI]
|
7.10507e-06
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
7.03989e-06
|
|
|
DSPP
|
[NCBI]
|
7.02995e-06
|
|
|
XK
|
[NCBI]
|
7.01582e-06
|
|
|
myotonia congenita, autosomal dominant
|
[NCBI]
|
7.01041e-06
|
|
|
MITF
|
[NCBI]
|
7.00443e-06
|
|
|
hartnup disorder
|
[NCBI]
|
6.99688e-06
|
|
|
NBIA1
|
[NCBI]
|
6.99688e-06
|
|
|
MC2R
|
[NCBI]
|
6.99175e-06
|
|
|
HLA-DQB1
|
[NCBI]
|
6.99175e-06
|
|
|
FOXC2
|
[NCBI]
|
6.99175e-06
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
6.99175e-06
|
|
|
ATR
|
[NCBI]
|
6.99005e-06
|
|
|
JAK2
|
[NCBI]
|
6.95034e-06
|
|
|
TG
|
[NCBI]
|
6.88843e-06
|
|
|
CPT2
|
[NCBI]
|
6.85029e-06
|
|
|
HOS
|
[NCBI]
|
6.81879e-06
|
|
|
PLOD1
|
[NCBI]
|
6.81651e-06
|
|
|
MRE11A
|
[NCBI]
|
6.80422e-06
|
|
|
hurler syndrome
|
[NCBI]
|
6.74244e-06
|
|
|
complement component 7 deficiency
|
[NCBI]
|
6.73536e-06
|
|
|
NRAS
|
[NCBI]
|
6.68624e-06
|
|
|
EFE
|
[NCBI]
|
6.673879e-06
|
|
|
UBTF
|
[NCBI]
|
6.65898e-06
|
|
|
MPL
|
[NCBI]
|
6.65098e-06
|
|
|
DLK1
|
[NCBI]
|
6.65098e-06
|
|
|
RPS6KA5
|
[NCBI]
|
6.62898e-06
|
|
|
RHD
|
[NCBI]
|
6.62898e-06
|
|
|
TGFBI
|
[NCBI]
|
6.62746e-06
|
|
|
CDH23
|
[NCBI]
|
6.62746e-06
|
|
|
EDA
|
[NCBI]
|
6.62746e-06
|
|
|
FGFR3
|
[NCBI]
|
6.58281e-06
|
|
|
von willebrand disease
|
[NCBI]
|
6.55575e-06
|
|
|
OXT
|
[NCBI]
|
6.54462e-06
|
|
|
CHM
|
[NCBI]
|
6.53706e-06
|
|
|
IL1RN
|
[NCBI]
|
6.49438e-06
|
|
|
HSPA1A
|
[NCBI]
|
6.46345e-06
|
|
|
CA1
|
[NCBI]
|
6.46345e-06
|
|
|
NKX2E
|
[NCBI]
|
6.46064e-06
|
|
|
HNF1B
|
[NCBI]
|
6.45222e-06
|
|
|
NUP98
|
[NCBI]
|
6.45222e-06
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
6.44707e-06
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
6.44707e-06
|
|
|
EEC3
|
[NCBI]
|
6.40848e-06
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
6.40848e-06
|
|
|
ARSA
|
[NCBI]
|
6.38849e-06
|
|
|
aHUS
|
[NCBI]
|
6.32587e-06
|
|
|
ALK
|
[NCBI]
|
6.31966e-06
|
|
|
DCK
|
[NCBI]
|
6.31113e-06
|
|
|
MAPK8
|
[NCBI]
|
6.28669e-06
|
|
|
PMM2
|
[NCBI]
|
6.28669e-06
|
|
|
MTND3
|
[NCBI]
|
6.28669e-06
|
|
|
EGR2
|
[NCBI]
|
6.2854e-06
|
|
|
EVC
|
[NCBI]
|
6.260535e-06
|
|
|
AIC
|
[NCBI]
|
6.21761e-06
|
|
|
RPE65
|
[NCBI]
|
6.1585e-06
|
|
|
HTR2A
|
[NCBI]
|
6.12773e-06
|
|
|
SGBS1
|
[NCBI]
|
6.1209098e-06
|
|
|
CLOCK
|
[NCBI]
|
6.11987e-06
|
|
|
VCP
|
[NCBI]
|
6.06331e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
6.03545e-06
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
6.01248e-06
|
|
|
PDS
|
[NCBI]
|
6.00352e-06
|
|
|
FMF
|
[NCBI]
|
5.999581e-06
|
|
|
GHRH
|
[NCBI]
|
5.96375e-06
|
|
|
SRD5A2
|
[NCBI]
|
5.96327e-06
|
|
|
PMS2
|
[NCBI]
|
5.9622e-06
|
|
|
camurati-engelmann disease
|
[NCBI]
|
5.8939e-06
|
|
|
SHEP2
|
[NCBI]
|
5.8939e-06
|
|
|
FTLDU
|
[NCBI]
|
5.8939e-06
|
|
|
IL3
|
[NCBI]
|
5.82231e-06
|
|
|
FKRP
|
[NCBI]
|
5.81492e-06
|
|
|
MTCO3
|
[NCBI]
|
5.81492e-06
|
|
|
HLA-DRB1
|
[NCBI]
|
5.81492e-06
|
|
|
HYPP
|
[NCBI]
|
5.71118e-06
|
|
|
KCNA1
|
[NCBI]
|
5.65725e-06
|
|
|
MTND2
|
[NCBI]
|
5.65725e-06
|
|
|
CACNA1C
|
[NCBI]
|
5.65725e-06
|
|
|
SP7
|
[NCBI]
|
5.65725e-06
|
|
|
MYC
|
[NCBI]
|
5.52338e-06
|
|
|
DAG1
|
[NCBI]
|
5.51653e-06
|
|
|
ADH2
|
[NCBI]
|
5.50807e-06
|
|
|
CYP1A1
|
[NCBI]
|
5.50341e-06
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
5.457544e-06
|
|
|
ALS1
|
[NCBI]
|
5.44698e-06
|
|
|
CDG1A
|
[NCBI]
|
5.433546e-06
|
|
|
DDC
|
[NCBI]
|
5.42072e-06
|
|
|
PPID
|
[NCBI]
|
5.36735e-06
|
|
|
MYD88
|
[NCBI]
|
5.36735e-06
|
|
|
corneal dystrophy, crystalline, of schnyder
|
[NCBI]
|
5.324034e-06
|
|
|
centralopathic epilepsy
|
[NCBI]
|
5.324034e-06
|
|
|
MLP
|
[NCBI]
|
5.23372e-06
|
|
|
AHSG
|
[NCBI]
|
5.23372e-06
|
|
|
GSTM1
|
[NCBI]
|
5.23372e-06
|
|
|
CD4
|
[NCBI]
|
5.23372e-06
|
|
|
APOA1
|
[NCBI]
|
5.14977e-06
|
|
|
TP73L
|
[NCBI]
|
5.10564e-06
|
|
|
CHRNE
|
[NCBI]
|
5.09241e-06
|
|
|
TIMP3
|
[NCBI]
|
5.09241e-06
|
|
|
ITGA2B
|
[NCBI]
|
5.09241e-06
|
|
|
HMGA2
|
[NCBI]
|
5.09206e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
5.05457e-06
|
|
|
PMC
|
[NCBI]
|
5.05457e-06
|
|
|
SOD1
|
[NCBI]
|
4.96631e-06
|
|
|
PROP1
|
[NCBI]
|
4.96538e-06
|
|
|
MEFV
|
[NCBI]
|
4.87018e-06
|
|
|
TNFRSF6B
|
[NCBI]
|
4.84451e-06
|
|
|
IPF1
|
[NCBI]
|
4.8314e-06
|
|
|
TCRB
|
[NCBI]
|
4.8314e-06
|
|
|
MTHFR
|
[NCBI]
|
4.82894e-06
|
|
|
SST
|
[NCBI]
|
4.73187e-06
|
|
|
CFTR
|
[NCBI]
|
4.72222e-06
|
|
|
HLA-DQA1
|
[NCBI]
|
4.71053e-06
|
|
|
IGF2R
|
[NCBI]
|
4.71053e-06
|
|
|
PLTP
|
[NCBI]
|
4.60452e-06
|
|
|
WAS
|
[NCBI]
|
4.602651e-06
|
|
|
SLC3A2
|
[NCBI]
|
4.59541e-06
|
|
|
EDN3
|
[NCBI]
|
4.58353e-06
|
|
|
CAV3
|
[NCBI]
|
4.58353e-06
|
|
|
CAV1
|
[NCBI]
|
4.58339e-06
|
|
|
AREG
|
[NCBI]
|
4.58339e-06
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
4.552773e-06
|
|
|
MECP2
|
[NCBI]
|
4.48174e-06
|
|
|
COL4A5
|
[NCBI]
|
4.46266e-06
|
|
|
CBD
|
[NCBI]
|
4.41778e-06
|
|
|
GPX1
|
[NCBI]
|
4.41519e-06
|
|
|
PRG4
|
[NCBI]
|
4.41519e-06
|
|
|
ADK
|
[NCBI]
|
4.35857e-06
|
|
|
IL1B
|
[NCBI]
|
4.34754e-06
|
|
|
IFNB1
|
[NCBI]
|
4.34754e-06
|
|
|
PRODH
|
[NCBI]
|
4.34754e-06
|
|
|
propionic acidemia
|
[NCBI]
|
4.3319287e-06
|
|
|
PTEN
|
[NCBI]
|
4.3014e-06
|
|
|
HSPB1
|
[NCBI]
|
4.25393e-06
|
|
|
ACVRL1
|
[NCBI]
|
4.23784e-06
|
|
|
CD40LG
|
[NCBI]
|
4.23784e-06
|
|
|
DST
|
[NCBI]
|
4.23784e-06
|
|
|
GRIN1
|
[NCBI]
|
4.23784e-06
|
|
|
MET
|
[NCBI]
|
4.23281e-06
|
|
|
CAPN3
|
[NCBI]
|
4.23281e-06
|
|
|
ALPL
|
[NCBI]
|
4.23281e-06
|
|
|
ESCS
|
[NCBI]
|
4.22304e-06
|
|
|
CDK4
|
[NCBI]
|
4.19568e-06
|
|
|
FBS
|
[NCBI]
|
4.19264e-06
|
|
|
GDXY
|
[NCBI]
|
4.19008e-06
|
|
|
HBB
|
[NCBI]
|
4.14556e-06
|
|
|
GPC3
|
[NCBI]
|
4.1332e-06
|
|
|
BRRS
|
[NCBI]
|
4.12503e-06
|
|
|
MTND6
|
[NCBI]
|
4.12371e-06
|
|
|
RECQL3
|
[NCBI]
|
4.12371e-06
|
|
|
IRF3
|
[NCBI]
|
4.12311e-06
|
|
|
DCN
|
[NCBI]
|
4.12311e-06
|
|
|
TIMP1
|
[NCBI]
|
4.09474e-06
|
|
|
BACE1
|
[NCBI]
|
4.09474e-06
|
|
|
AQP1
|
[NCBI]
|
4.07661e-06
|
|
|
HEXA
|
[NCBI]
|
4.05418e-06
|
|
|
TERC
|
[NCBI]
|
4.01401e-06
|
|
|
WDM
|
[NCBI]
|
4.00034e-06
|
|
|
IBD5
|
[NCBI]
|
4.00034e-06
|
|
|
HLA-A
|
[NCBI]
|
3.99031e-06
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
3.9571291e-06
|
|
|
LI1
|
[NCBI]
|
3.95388e-06
|
|
|
FHIT
|
[NCBI]
|
3.94218e-06
|
|
|
KRT5
|
[NCBI]
|
3.90937e-06
|
|
|
MTND5
|
[NCBI]
|
3.90937e-06
|
|
|
HMBS
|
[NCBI]
|
3.89767e-06
|
|
|
PML
|
[NCBI]
|
3.80951e-06
|
|
|
FASN
|
[NCBI]
|
3.80951e-06
|
|
|
PAFAH1B1
|
[NCBI]
|
3.80558e-06
|
|
|
XPA
|
[NCBI]
|
3.76722e-06
|
|
|
IL12B
|
[NCBI]
|
3.71415e-06
|
|
|
SRY
|
[NCBI]
|
3.71174e-06
|
|
|
DNMT3B
|
[NCBI]
|
3.70572e-06
|
|
|
acromegaly
|
[NCBI]
|
3.686385e-06
|
|
|
CST3
|
[NCBI]
|
3.67651e-06
|
|
|
LPI
|
[NCBI]
|
3.65140295e-06
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
3.64506e-06
|
|
|
PROS1
|
[NCBI]
|
3.64135e-06
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
3.6100739e-06
|
|
|
PPOX
|
[NCBI]
|
3.60693e-06
|
|
|
SJS1
|
[NCBI]
|
3.592836e-06
|
|
|
HNF1A
|
[NCBI]
|
3.53336e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
3.48874e-06
|
|
|
GRPR
|
[NCBI]
|
3.43217e-06
|
|
|
BCL6
|
[NCBI]
|
3.42326e-06
|
|
|
FABP3
|
[NCBI]
|
3.42046e-06
|
|
|
PLOSL
|
[NCBI]
|
3.35331e-06
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
3.33884e-06
|
|
|
CTCF
|
[NCBI]
|
3.3279e-06
|
|
|
ACADM
|
[NCBI]
|
3.32423e-06
|
|
|
IL5
|
[NCBI]
|
3.26923e-06
|
|
|
PIGA
|
[NCBI]
|
3.23931e-06
|
|
|
GHRL
|
[NCBI]
|
3.23931e-06
|
|
|
AVPR2
|
[NCBI]
|
3.23679e-06
|
|
|
LEPR
|
[NCBI]
|
3.2194e-06
|
|
|
BGLAP
|
[NCBI]
|
3.17727e-06
|
|
|
ALDH2
|
[NCBI]
|
3.15143e-06
|
|
|
RAG1
|
[NCBI]
|
3.15143e-06
|
|
|
MDM2
|
[NCBI]
|
3.14971e-06
|
|
|
HDAC3
|
[NCBI]
|
3.14971e-06
|
|
|
NR6A1
|
[NCBI]
|
3.06643e-06
|
|
|
LTA
|
[NCBI]
|
3.06435e-06
|
|
|
JAK1
|
[NCBI]
|
3.06435e-06
|
|
|
AIRE
|
[NCBI]
|
3.02055e-06
|
|
|
MNGIE
|
[NCBI]
|
3.01579e-06
|
|
|
lung cancer
|
[NCBI]
|
3.008483e-06
|
|
|
IL13
|
[NCBI]
|
3.00014e-06
|
|
|
MTCO1
|
[NCBI]
|
2.98107e-06
|
|
|
complement component 2 deficiency
|
[NCBI]
|
2.9514e-06
|
|
|
SNRPN
|
[NCBI]
|
2.91864e-06
|
|
|
OPTN
|
[NCBI]
|
2.89972e-06
|
|
|
TACR1
|
[NCBI]
|
2.85733e-06
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
2.850227e-06
|
|
|
GK
|
[NCBI]
|
2.82518e-06
|
|
|
PHS
|
[NCBI]
|
2.8249156e-06
|
|
|
TERT
|
[NCBI]
|
2.7787e-06
|
|
|
LAD
|
[NCBI]
|
2.778038e-06
|
|
|
CYP3A4
|
[NCBI]
|
2.75222e-06
|
|
|
STK11
|
[NCBI]
|
2.74828e-06
|
|
|
NPS
|
[NCBI]
|
2.70255e-06
|
|
|
TPI1
|
[NCBI]
|
2.67087e-06
|
|
|
SLC2A4
|
[NCBI]
|
2.66811e-06
|
|
|
AGTR1
|
[NCBI]
|
2.6663e-06
|
|
|
ABCB11
|
[NCBI]
|
2.65472e-06
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
2.644729e-06
|
|
|
HAE
|
[NCBI]
|
2.631957316e-06
|
|
|
MCKD1
|
[NCBI]
|
2.61974e-06
|
|
|
FGG
|
[NCBI]
|
2.61549e-06
|
|
|
UCMD
|
[NCBI]
|
2.61099e-06
|
|
|
SCA17
|
[NCBI]
|
2.61099e-06
|
|
|
AGER
|
[NCBI]
|
2.59469e-06
|
|
|
EDNRB
|
[NCBI]
|
2.59334e-06
|
|
|
SMN2
|
[NCBI]
|
2.59239e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
2.571839e-06
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
2.559605e-06
|
|
|
CUTL1
|
[NCBI]
|
2.51943e-06
|
|
|
SDC2
|
[NCBI]
|
2.49762e-06
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
2.45479e-06
|
|
|
TNFRSF1B
|
[NCBI]
|
2.44958e-06
|
|
|
LIFR
|
[NCBI]
|
2.44899e-06
|
|
|
HIF1A
|
[NCBI]
|
2.44899e-06
|
|
|
GAA
|
[NCBI]
|
2.44899e-06
|
|
|
apc gene
|
[NCBI]
|
2.446745e-06
|
|
|
LCA1
|
[NCBI]
|
2.445143e-06
|
|
|
FGF2
|
[NCBI]
|
2.434322e-06
|
|
|
DJS
|
[NCBI]
|
2.4224198e-06
|
|
|
DBI
|
[NCBI]
|
2.42081e-06
|
|
|
PNPLA6
|
[NCBI]
|
2.405029e-06
|
|
|
PDYN
|
[NCBI]
|
2.39256e-06
|
|
|
EGR1
|
[NCBI]
|
2.37914e-06
|
|
|
AAA
|
[NCBI]
|
2.332475e-06
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
2.330295e-06
|
|
|
DES
|
[NCBI]
|
2.2573e-06
|
|
|
BRAF
|
[NCBI]
|
2.247977e-06
|
|
|
TFR2
|
[NCBI]
|
2.2451e-06
|
|
|
JPS
|
[NCBI]
|
2.215314e-06
|
|
|
HIDS
|
[NCBI]
|
2.195729e-06
|
|
|
MMP3
|
[NCBI]
|
2.18105e-06
|
|
|
HLA-DRA
|
[NCBI]
|
2.18105e-06
|
|
|
BLM
|
[NCBI]
|
2.179328e-06
|
|
|
PON1
|
[NCBI]
|
2.152263e-06
|
|
|
GUSB
|
[NCBI]
|
2.1517e-06
|
|
|
STAT5A
|
[NCBI]
|
2.138345e-06
|
|
|
MTCYB
|
[NCBI]
|
2.117047e-06
|
|
|
RHCE
|
[NCBI]
|
2.110637e-06
|
|
|
CP
|
[NCBI]
|
2.077203e-06
|
|
|
PSNP1
|
[NCBI]
|
2.074908e-06
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
2.074908e-06
|
|
|
TCRA
|
[NCBI]
|
2.061971e-06
|
|
|
GAMT
|
[NCBI]
|
2.061194e-06
|
|
|
SLC6A6
|
[NCBI]
|
2.055697e-06
|
|
|
GRIA1
|
[NCBI]
|
2.055697e-06
|
|
|
sotos syndrome
|
[NCBI]
|
2.021254e-06
|
|
|
STAT1
|
[NCBI]
|
1.997654e-06
|
|
|
CGL2
|
[NCBI]
|
1.994955e-06
|
|
|
RUNX1
|
[NCBI]
|
1.936571e-06
|
|
|
HEXB
|
[NCBI]
|
1.835124e-06
|
|
|
ZNF145
|
[NCBI]
|
1.821534e-06
|
|
|
UCP1
|
[NCBI]
|
1.795806e-06
|
|
|
FBN1
|
[NCBI]
|
1.788481e-06
|
|
|
MAOA
|
[NCBI]
|
1.788481e-06
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
1.7821756e-06
|
|
|
PMD
|
[NCBI]
|
1.767939e-06
|
|
|
SLPI
|
[NCBI]
|
1.723291e-06
|
|
|
VLDLR
|
[NCBI]
|
1.712254e-06
|
|
|
TNC
|
[NCBI]
|
1.708535e-06
|
|
|
TBP
|
[NCBI]
|
1.642901e-06
|
|
|
UMOD
|
[NCBI]
|
1.628012e-06
|
|
|
MAP3K5
|
[NCBI]
|
1.622666e-06
|
|
|
GJB2
|
[NCBI]
|
1.613912e-06
|
|
|
ERBB2
|
[NCBI]
|
1.60789e-06
|
|
|
TPT1
|
[NCBI]
|
1.558447e-06
|
|
|
COL7A1
|
[NCBI]
|
1.557685e-06
|
|
|
CGD
|
[NCBI]
|
1.526164e-06
|
|
|
walker-warburg syndrome
|
[NCBI]
|
1.486776e-06
|
|
|
MDC1A
|
[NCBI]
|
1.481554e-06
|
|
|
UOX
|
[NCBI]
|
1.481554e-06
|
|
|
MSTN
|
[NCBI]
|
1.460467e-06
|
|
|
PRF1
|
[NCBI]
|
1.460467e-06
|
|
|
RTS
|
[NCBI]
|
1.3971526e-06
|
|
|
PG
|
[NCBI]
|
1.394887e-06
|
|
|
porphyria variegata
|
[NCBI]
|
1.38794846e-06
|
|
|
histidinemia
|
[NCBI]
|
1.3813026e-06
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
1.35982e-06
|
|
|
MTS
|
[NCBI]
|
1.324337e-06
|
|
|
DKC
|
[NCBI]
|
1.30013105e-06
|
|
|
PGR
|
[NCBI]
|
1.294293e-06
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
1.286176e-06
|
|
|
CTSL
|
[NCBI]
|
1.243213e-06
|
|
|
pheochromocytoma
|
[NCBI]
|
1.222896e-06
|
|
|
HCRT
|
[NCBI]
|
1.205248e-06
|
|
|
CYP2D6
|
[NCBI]
|
1.194747e-06
|
|
|
IGHG1
|
[NCBI]
|
1.194747e-06
|
|
|
MTND1
|
[NCBI]
|
1.194747e-06
|
|
|
SH2D1A
|
[NCBI]
|
1.194278e-06
|
|
|
EPOR
|
[NCBI]
|
1.189722e-06
|
|
|
FGF23
|
[NCBI]
|
1.134296e-06
|
|
|
CCD
|
[NCBI]
|
1.088756e-06
|
|
|
EVA
|
[NCBI]
|
1.073307e-06
|
|
|
MAG
|
[NCBI]
|
1.042631e-06
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
1.0404939e-06
|
|
|
sialuria, finnish type
|
[NCBI]
|
1.0404939e-06
|
|
|
CHAC
|
[NCBI]
|
1.025788633e-06
|
|
|
HBG2
|
[NCBI]
|
1.005204e-06
|
|
|
IFNA1
|
[NCBI]
|
9.84427e-07
|
|
|
CFB
|
[NCBI]
|
9.71518e-07
|
|
|
SMA3
|
[NCBI]
|
9.63014e-07
|
|
|
STL1
|
[NCBI]
|
9.6208405e-07
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
9.44908e-07
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
9.43704e-07
|
|
|
KIT
|
[NCBI]
|
9.28349e-07
|
|
|
TFRC
|
[NCBI]
|
9.28349e-07
|
|
|
WT1
|
[NCBI]
|
8.69181e-07
|
|
|
OTC
|
[NCBI]
|
8.60582e-07
|
|
|
LFS1
|
[NCBI]
|
8.47553e-07
|
|
|
DRD
|
[NCBI]
|
7.972502e-07
|
|
|
C3
|
[NCBI]
|
7.95835e-07
|
|
|
FGFR1
|
[NCBI]
|
7.87714e-07
|
|
|
glycogen storage disease iii
|
[NCBI]
|
7.79456633e-07
|
|
|
KCNH2
|
[NCBI]
|
7.49211e-07
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
7.36937e-07
|
|
|
PCI
|
[NCBI]
|
7.28623e-07
|
|
|
melanoma, uveal
|
[NCBI]
|
7.170527e-07
|
|
|
GSC
|
[NCBI]
|
6.55871e-07
|
|
|
BMP4
|
[NCBI]
|
6.52321e-07
|
|
|
phenylketonuria
|
[NCBI]
|
6.129822e-07
|
|
|
TPO
|
[NCBI]
|
6.071951e-07
|
|
|
ADA
|
[NCBI]
|
6.03093e-07
|
|
|
SLC2A2
|
[NCBI]
|
5.9796e-07
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
5.874729e-07
|
|
|
glycogen storage disease ib
|
[NCBI]
|
5.874729e-07
|
|
|
BCL2
|
[NCBI]
|
5.71689e-07
|
|
|
MTND4
|
[NCBI]
|
5.69701e-07
|
|
|
IGF1
|
[NCBI]
|
5.68431e-07
|
|
|
FCAS
|
[NCBI]
|
5.62261e-07
|
|
|
PRNP
|
[NCBI]
|
5.51553e-07
|
|
|
B2M
|
[NCBI]
|
5.341183e-07
|
|
|
NOS3
|
[NCBI]
|
5.18973e-07
|
|
|
PC
|
[NCBI]
|
5.18313e-07
|
|
|
ENPEP
|
[NCBI]
|
4.97978e-07
|
|
|
IRS1
|
[NCBI]
|
4.78432e-07
|
|
|
HBA1
|
[NCBI]
|
4.6038995e-07
|
|
|
OPMD
|
[NCBI]
|
4.43659e-07
|
|
|
CBX5
|
[NCBI]
|
4.32865e-07
|
|
|
HBD
|
[NCBI]
|
4.29962e-07
|
|
|
ASL
|
[NCBI]
|
4.20359e-07
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
4.17832e-07
|
|
|
AHC
|
[NCBI]
|
4.171209e-07
|
|
|
DNTT
|
[NCBI]
|
4.07979e-07
|
|
|
VIM
|
[NCBI]
|
4.01852e-07
|
|
|
PIGR
|
[NCBI]
|
4.00167e-07
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
3.907348e-07
|
|
|
MMP2
|
[NCBI]
|
3.87259e-07
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
3.7561605e-07
|
|
|
UGT1A1
|
[NCBI]
|
3.66951e-07
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
3.561405e-07
|
|
|
NOTCH1
|
[NCBI]
|
3.50398e-07
|
|
|
CLL
|
[NCBI]
|
3.33154e-07
|
|
|
LCN2
|
[NCBI]
|
3.03571e-07
|
|
|
CTNNB1
|
[NCBI]
|
2.991869e-07
|
|
|
SPARC
|
[NCBI]
|
2.9473e-07
|
|
|
HNFJ
|
[NCBI]
|
2.801969e-07
|
|
|
NSF
|
[NCBI]
|
2.382276e-07
|
|
|
CCR5
|
[NCBI]
|
2.362576e-07
|
|
|
GNAS
|
[NCBI]
|
2.298141e-07
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
2.1371841e-07
|
|
|
FPGS
|
[NCBI]
|
2.123246e-07
|
|
|
PAX6
|
[NCBI]
|
2.080062e-07
|
|
|
PCTT
|
[NCBI]
|
1.91324633e-07
|
|
|
PTGS2
|
[NCBI]
|
1.811773e-07
|
|
|
homocystinuria
|
[NCBI]
|
1.807606e-07
|
|
|
REG3A
|
[NCBI]
|
1.752054e-07
|
|
|
LMNA
|
[NCBI]
|
1.74231e-07
|
|
|
MC4R
|
[NCBI]
|
1.674806e-07
|
|
|
PAEP
|
[NCBI]
|
1.597181e-07
|
|
|
PENK
|
[NCBI]
|
1.537476e-07
|
|
|
FSHR
|
[NCBI]
|
1.445755e-07
|
|
|
SLC4A1
|
[NCBI]
|
1.236832e-07
|
|
|
GPT
|
[NCBI]
|
1.1322912e-07
|
|
|
GPI
|
[NCBI]
|
1.018751e-07
|
|
|
SPDA1
|
[NCBI]
|
9.97178e-08
|
|
|
IHH
|
[NCBI]
|
9.743597e-08
|
|
|
MTTL1
|
[NCBI]
|
8.644189e-08
|
|
|
BMP2
|
[NCBI]
|
7.859601e-08
|
|
|
FGF1
|
[NCBI]
|
7.8264e-08
|
|
|
LSA
|
[NCBI]
|
7.044365e-08
|
|
|
FGF8
|
[NCBI]
|
5.921061e-08
|
|
|
H6PD
|
[NCBI]
|
4.838186e-08
|
|
|
COL2A1
|
[NCBI]
|
4.542197e-08
|
|
|
LRP1
|
[NCBI]
|
3.907193e-08
|
|
|
TNFRSF1A
|
[NCBI]
|
3.611636e-08
|
|
|
MBL2
|
[NCBI]
|
3.3746553e-08
|
|
|
GJA1
|
[NCBI]
|
2.440449e-08
|
|
|
NMB
|
[NCBI]
|
1.968554e-08
|
|
|
KITLG
|
[NCBI]
|
1.686843e-08
|
|
|
ZFP36
|
[NCBI]
|
1.579238e-08
|
|
|
IL6
|
[NCBI]
|
1.43584287e-08
|
|
|
UGB
|
[NCBI]
|
1.071533e-08
|
|
|
CLU
|
[NCBI]
|
1.01857e-08
|
|
|
TTR
|
[NCBI]
|
9.844545e-09
|
|
|
ARNT
|
[NCBI]
|
9.707609e-09
|
|
|
BSG
|
[NCBI]
|
1.748510778e-09
|
|